ğ‹‡Â¦severeÂ¦ Â¦acuteÂ¦ Â¦respiratoryÂ¦ Â¦syndromeÂ¦ Â¦coronavirusÂ¦ Â¦2Â¦ â–( ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ )â– Â¦isÂ¦ Â¦aÂ¦ Â¦novelÂ¦ Â¦virusÂ¦ ,â– Â¦firstÂ¦ Â¦isolatedÂ¦ Â¦fromÂ¦ Â¦threeÂ¦ Â¦peopleÂ¦ Â¦withÂ¦ Â¦pneumoniaÂ¦ Â¦conn ectedÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦clusterÂ¦ Â¦ofÂ¦ Â¦acuteÂ¦ Â¦respiratoryÂ¦ Â¦illnessÂ¦ Â¦casesÂ¦ Â¦inÂ¦ ğ‹‡Â¦wuhanÂ¦ .
ğ‹‡Â¦onÂ¦ ğ‹‡Â¦thursdayÂ¦ ,â– Â¦theÂ¦ Â¦totalÂ¦ Â¦numberÂ¦ Â¦ofÂ¦ Â¦casesÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦coronavirusÂ¦ Â¦infectionsÂ¦ Â¦sur p as sedÂ¦ Â¦oneÂ¦ Â¦millionÂ¦ Â¦worldwideÂ¦ ,â– ğ‹‡Â¦johnsÂ¦ ğ‹‡Â¦hopkinsÂ¦ ğ‹‡Â¦universityÂ¦ Â¦dataÂ¦ Â¦indicatedÂ¦ .
ğ‹‡Â¦beforeÂ¦ Â¦theÂ¦ Â¦firstÂ¦ Â¦isolationÂ¦ Â¦ofÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - Â¦229ğ‹‡eÂ¦ Â¦strainÂ¦ ğ‹‡Â¦b 8 1 4Â¦ Â¦fromÂ¦ Â¦theÂ¦ Â¦nasalÂ¦ Â¦disc har geÂ¦ Â¦ofÂ¦ Â¦patientsÂ¦ Â¦whoÂ¦ Â¦hadÂ¦ Â¦contractedÂ¦ Â¦commonÂ¦ Â¦coldÂ¦ ,â– Â¦differentÂ¦ ğ‹‡Â¦coğ‹‡vsÂ¦ Â¦hadÂ¦ Â¦beenÂ¦ Â¦isolatedÂ¦ Â¦inÂ¦ Â¦variousÂ¦ Â¦infectedÂ¦ Â¦animalsÂ¦ ,â– Â¦includingÂ¦ Â¦tur k eyÂ¦ ,â– Â¦mo useÂ¦ ,â– Â¦co wÂ¦ ,â– Â¦pi gÂ¦ ,â– Â¦c atÂ¦ Â¦andÂ¦ Â¦do gÂ¦ .
ğ‹‡Â¦fe lineÂ¦ Â¦coronavirusÂ¦ â–( ğŠ£ Â¦f cğŠ¼oğ‹‡vÂ¦ )â– Â¦causesÂ¦ Â¦mildÂ¦ Â¦en teritisÂ¦ Â¦inÂ¦ Â¦ca tsÂ¦ Â¦asÂ¦ Â¦wellÂ¦ Â¦asÂ¦ Â¦severeÂ¦ ğ‹‡Â¦fe lineÂ¦ Â¦infectiousÂ¦ Â¦peri to ni tisÂ¦ â–( Â¦otherÂ¦ Â¦variantsÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦sameÂ¦ Â¦virusÂ¦ ).
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦chineseÂ¦ Â¦governmentÂ¦ ' Â¦sÂ¦ Â¦seniorÂ¦ Â¦medicalÂ¦ Â¦advis erÂ¦ ğ‹‡Â¦z h ongÂ¦ ğ‹‡Â¦na ns hanÂ¦ Â¦ar gu edÂ¦ Â¦thatÂ¦ â–" Â¦itÂ¦ Â¦couldÂ¦ Â¦beÂ¦ Â¦overÂ¦ Â¦byÂ¦ ğ‹‡Â¦juneÂ¦ "â– Â¦ifÂ¦ Â¦allÂ¦ Â¦countriesÂ¦ Â¦canÂ¦ Â¦beÂ¦ Â¦mo bi lizedÂ¦ Â¦toÂ¦ Â¦followÂ¦ Â¦theÂ¦ ğŠ£Â¦whoÂ¦ğŠ¼ ' Â¦sÂ¦ Â¦adviceÂ¦ Â¦onÂ¦ Â¦measuresÂ¦ Â¦toÂ¦ Â¦stopÂ¦ Â¦theÂ¦ Â¦spreadÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦virusÂ¦ .
ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦surveillanceÂ¦ Â¦isÂ¦ Â¦expectedÂ¦ Â¦toÂ¦ Â¦monitorÂ¦ Â¦epidemiologicalÂ¦ Â¦tr endsÂ¦ ,â– Â¦rapidlyÂ¦ Â¦detectÂ¦ Â¦newÂ¦ Â¦casesÂ¦ ,â– Â¦andÂ¦ Â¦basedÂ¦ Â¦onÂ¦ Â¦thisÂ¦ Â¦informationÂ¦ ,â– Â¦provideÂ¦ Â¦epidemiologicalÂ¦ Â¦informationÂ¦ Â¦toÂ¦ Â¦conductÂ¦ Â¦riskÂ¦ Â¦assessmentÂ¦ Â¦andÂ¦ Â¦gu ideÂ¦ Â¦diseaseÂ¦ Â¦preparednessÂ¦ .
ğ‹‡Â¦basedÂ¦ Â¦onÂ¦ Â¦clinicalÂ¦ Â¦studiesÂ¦ Â¦reportedÂ¦ Â¦thusÂ¦ Â¦farÂ¦ ,â– Â¦theÂ¦ Â¦followingÂ¦ Â¦factorsÂ¦ Â¦mayÂ¦ Â¦affectÂ¦ Â¦orÂ¦ Â¦beÂ¦ Â¦associatedÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦progn osisÂ¦ Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦patientsÂ¦ â–( ğ‹‡Â¦tableÂ¦ â– â€‹ ( ğ‹‡Â¦t ab le 33Â¦ ) :
ğ‹‡Â¦givenÂ¦ Â¦suchÂ¦ Â¦rapidÂ¦ Â¦progressÂ¦ Â¦inÂ¦ Â¦researchÂ¦ Â¦onÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ ,â– Â¦severalÂ¦ Â¦criticalÂ¦ Â¦issuesÂ¦ Â¦remainÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦sol vedÂ¦ ,â– Â¦asÂ¦ Â¦followsÂ¦ :
ğ‹‡Â¦onÂ¦ Â¦13Â¦ ğ‹‡Â¦marchÂ¦ ,â– Â¦heÂ¦ Â¦declaredÂ¦ Â¦aÂ¦ Â¦nationalÂ¦ Â¦emergencyÂ¦ ,â– Â¦whichÂ¦ Â¦madeÂ¦ Â¦federalÂ¦ Â¦fundsÂ¦ Â¦availableÂ¦ Â¦toÂ¦ Â¦respondÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦crisisÂ¦ .
ğ‹‡Â¦chineseÂ¦ Â¦clinicalÂ¦ Â¦trialsÂ¦ Â¦inÂ¦ ğ‹‡Â¦wuhanÂ¦ Â¦andÂ¦ ğ‹‡Â¦shenzhenÂ¦ Â¦claimedÂ¦ Â¦toÂ¦ Â¦showÂ¦ Â¦thatÂ¦ Â¦fa vi pi ra virÂ¦ Â¦wasÂ¦ â–" Â¦clearlyÂ¦ Â¦effectiveÂ¦ ".
ğ‹‡Â¦ma u ri z i oÂ¦ ğ‹‡Â¦m ass ariÂ¦ ,â– ğ‹‡Â¦italyÂ¦ ' Â¦sÂ¦ Â¦a mb ass ad orÂ¦ Â¦toÂ¦ Â¦theÂ¦ ğŠ£Â¦euÂ¦ ğŠ¼ ,â– Â¦saidÂ¦ Â¦thatÂ¦ â–" ğ‹‡Â¦onlyÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦respon dedÂ¦ Â¦bi la ter allyÂ¦ .
ğ‹‡Â¦someÂ¦ Â¦canÂ¦ Â¦killÂ¦ Â¦moreÂ¦ Â¦thanÂ¦ Â¦30Â¦ %â– Â¦ofÂ¦ Â¦thoseÂ¦ Â¦infectedÂ¦ ,â– Â¦suchÂ¦ Â¦asÂ¦ ğŠ£Â¦mersÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ ,â– Â¦andÂ¦ Â¦someÂ¦ Â¦areÂ¦ Â¦relativelyÂ¦ Â¦harm lessÂ¦ ,â– Â¦suchÂ¦ Â¦asÂ¦ Â¦theÂ¦ Â¦commonÂ¦ Â¦coldÂ¦ .
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦uÂ¦ . ğ‹‡Â¦sÂ¦ .â– Â¦administrationÂ¦ Â¦ofÂ¦ ğ‹‡Â¦donaldÂ¦ ğ‹‡Â¦trumpÂ¦ Â¦hasÂ¦ Â¦referredÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦asÂ¦ â–" ğ‹‡Â¦chineseÂ¦ Â¦virusÂ¦ "â– Â¦orÂ¦ â–" ğ‹‡Â¦wuhanÂ¦ Â¦virusÂ¦ "â– Â¦sayingÂ¦ Â¦thatÂ¦ ğ‹‡Â¦chinaÂ¦ ' Â¦sÂ¦ â–" Â¦ ce ns or shipÂ¦ Â¦sup erc har gedÂ¦ Â¦aÂ¦ Â¦virusÂ¦ Â¦thatÂ¦ Â¦hasÂ¦ Â¦nowÂ¦ Â¦turnedÂ¦ Â¦intoÂ¦ Â¦aÂ¦ Â¦globalÂ¦ Â¦pandemicÂ¦ ",â– Â¦whichÂ¦ Â¦hasÂ¦ Â¦inÂ¦ Â¦turnÂ¦ Â¦beenÂ¦ Â¦criticizedÂ¦ Â¦byÂ¦ Â¦someÂ¦ Â¦critic sÂ¦ Â¦asÂ¦ Â¦rac ismÂ¦ Â¦andÂ¦ â–" Â¦dis tr actÂ¦ [ Â¦ ingÂ¦ ]â– Â¦fromÂ¦ Â¦hisÂ¦ Â¦administrationÂ¦ ' Â¦sÂ¦ Â¦failureÂ¦ Â¦toÂ¦ Â¦containÂ¦ Â¦theÂ¦ Â¦diseaseÂ¦ ".
ğ‹‡Â¦inÂ¦ Â¦additionÂ¦ Â¦toÂ¦ Â¦replic atingÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦lowerÂ¦ Â¦respiratoryÂ¦ Â¦tractÂ¦ ,â– ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦canÂ¦ Â¦eff icientlyÂ¦ Â¦replic ateÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦upperÂ¦ Â¦respiratoryÂ¦ Â¦tractÂ¦ Â¦andÂ¦ Â¦causesÂ¦ Â¦mildÂ¦ Â¦orÂ¦ Â¦noÂ¦ Â¦symptomsÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦earlyÂ¦ Â¦phaseÂ¦ Â¦ofÂ¦ Â¦infectionÂ¦ ,â– Â¦similarÂ¦ Â¦toÂ¦ Â¦otherÂ¦ ğ‹‡Â¦coğ‹‡vsÂ¦ Â¦thatÂ¦ Â¦causeÂ¦ Â¦commonÂ¦ Â¦c oldsÂ¦ .
ğ‹‡ Â¦clus teredÂ¦ Â¦onsetÂ¦ Â¦oftenÂ¦ Â¦happensÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦sameÂ¦ Â¦familyÂ¦ Â¦orÂ¦ Â¦fromÂ¦ Â¦theÂ¦ Â¦sameÂ¦ Â¦gatheringÂ¦ Â¦orÂ¦ Â¦vehicleÂ¦ Â¦suchÂ¦ Â¦asÂ¦ Â¦aÂ¦ Â¦cruiseÂ¦ Â¦shipÂ¦ .
ğ‹‡ Â¦authoritiesÂ¦ Â¦worldwideÂ¦ Â¦haveÂ¦ Â¦respon dedÂ¦ Â¦byÂ¦ Â¦imp lem entingÂ¦ Â¦travelÂ¦ Â¦restrictionsÂ¦ ,â– Â¦quar ant inesÂ¦ ,â– Â¦cur fe wsÂ¦ ,â– Â¦workplaceÂ¦ Â¦hazardÂ¦ Â¦controlsÂ¦ ,â– Â¦andÂ¦ Â¦facilityÂ¦ Â¦closuresÂ¦ .
ğ‹‡Â¦aÂ¦ Â¦moreÂ¦ Â¦recentÂ¦ Â¦studyÂ¦ ,â– Â¦asÂ¦ Â¦describedÂ¦ Â¦aboveÂ¦ ,â– Â¦demons tr atesÂ¦ Â¦thatÂ¦ Â¦theÂ¦ Â¦incubationÂ¦ Â¦periodÂ¦ Â¦wasÂ¦ Â¦4Â¦ . Â¦8Â¦ â–( Â¦3Â¦ . Â¦0Â¦ - Â¦7Â¦ . Â¦2Â¦ )â– Â¦daysÂ¦ Â¦basedÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦ dem ographyÂ¦ Â¦ofÂ¦ Â¦8Â¦ , Â¦86 6Â¦ Â¦casesÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦severeÂ¦ Â¦casesÂ¦ ,â– Â¦patientsÂ¦ Â¦quicklyÂ¦ Â¦prog ressedÂ¦ Â¦toÂ¦ Â¦developÂ¦ Â¦acuteÂ¦ Â¦respiratoryÂ¦ Â¦syndromeÂ¦ ,â– Â¦sep ticÂ¦ Â¦sh ockÂ¦ ,â– Â¦met ab olicÂ¦ Â¦ac id osisÂ¦ ,â– Â¦andÂ¦ Â¦coa g ul opa thyÂ¦ .
ğ‹‡ Â¦supp ressionÂ¦ Â¦canÂ¦ Â¦beÂ¦ Â¦prefer redÂ¦ Â¦butÂ¦ Â¦needsÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦maintainedÂ¦ Â¦forÂ¦ Â¦asÂ¦ Â¦longÂ¦ Â¦asÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦isÂ¦ Â¦circulatingÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦humanÂ¦ Â¦populationÂ¦ â–( Â¦orÂ¦ Â¦untilÂ¦ Â¦aÂ¦ Â¦vaccineÂ¦ Â¦becomesÂ¦ Â¦availableÂ¦ ,â– Â¦ifÂ¦ Â¦thatÂ¦ Â¦comesÂ¦ Â¦firstÂ¦ ),â– Â¦asÂ¦ Â¦transmissionÂ¦ Â¦otherwiseÂ¦ Â¦quicklyÂ¦ Â¦re b oundsÂ¦ Â¦whenÂ¦ Â¦measuresÂ¦ Â¦areÂ¦ Â¦relaxedÂ¦ .
ğ‹‡ Â¦pres um ablyÂ¦ ,â– Â¦itÂ¦ Â¦hasÂ¦ Â¦alreadyÂ¦ Â¦beenÂ¦ Â¦adaptedÂ¦ Â¦toÂ¦ Â¦anotherÂ¦ Â¦hostÂ¦ Â¦closeÂ¦ Â¦toÂ¦ Â¦humansÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦thisÂ¦ Â¦studyÂ¦ ,â– Â¦weÂ¦ Â¦assessÂ¦ Â¦theÂ¦ Â¦tr endsÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦cumulativeÂ¦ Â¦incidenceÂ¦ Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦inÂ¦ Â¦eachÂ¦ ğ‹‡Â¦europeanÂ¦ ğ‹‡Â¦unionÂ¦ / ğ‹‡Â¦europeanÂ¦ ğ‹‡Â¦economicÂ¦ ğ‹‡ Â¦areaÂ¦ â–( ğŠ£Â¦euÂ¦ / Â¦eeaÂ¦ğŠ¼ )â– Â¦countryÂ¦ Â¦andÂ¦ Â¦theÂ¦ ğ‹‡Â¦unitedÂ¦ ğ‹‡Â¦kingdomÂ¦ â–( ğŠ£Â¦ukÂ¦ğŠ¼ )â– Â¦andÂ¦ Â¦compareÂ¦ Â¦themÂ¦ Â¦toÂ¦ Â¦thatÂ¦ Â¦ofÂ¦ ğ‹‡Â¦hubeiÂ¦ ğ‹‡ Â¦provinceÂ¦ ,â– ğ‹‡Â¦chinaÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦twoÂ¦ Â¦typesÂ¦ Â¦ofÂ¦ Â¦c an ineÂ¦ Â¦coronavirusÂ¦ â–( ğŠ£Â¦c cğŠ¼oğ‹‡vÂ¦ )â–( Â¦oneÂ¦ Â¦causingÂ¦ Â¦en teritisÂ¦ ,â– Â¦theÂ¦ Â¦otherÂ¦ Â¦foundÂ¦ Â¦inÂ¦ Â¦respiratoryÂ¦ Â¦diseasesÂ¦ ).
ğ‹‡Â¦theÂ¦ Â¦sameÂ¦ Â¦dayÂ¦ Â¦travelÂ¦ Â¦restrictionsÂ¦ Â¦wereÂ¦ Â¦ ea sedÂ¦ Â¦inÂ¦ ğ‹‡Â¦hubeiÂ¦ ,â– Â¦apartÂ¦ Â¦fromÂ¦ ğ‹‡Â¦wuhanÂ¦ ,â– Â¦twoÂ¦ Â¦monthsÂ¦ Â¦afterÂ¦ Â¦theÂ¦ Â¦lockdownÂ¦ Â¦wasÂ¦ Â¦imposedÂ¦ . ğ‹‡Â¦theÂ¦ ğ‹‡Â¦chineseÂ¦ ğ‹‡Â¦ministryÂ¦ Â¦ofÂ¦ ğ‹‡Â¦foreignÂ¦ ğ‹‡Â¦affairsÂ¦ Â¦announcedÂ¦ Â¦onÂ¦ Â¦26Â¦ ğ‹‡Â¦marchÂ¦ Â¦2020Â¦ Â¦thatÂ¦ Â¦entryÂ¦ Â¦forÂ¦ Â¦vis aÂ¦ Â¦orÂ¦ Â¦resi denceÂ¦ Â¦per mitÂ¦ Â¦hol dersÂ¦ Â¦wouldÂ¦ Â¦beÂ¦ Â¦suspendedÂ¦ Â¦fromÂ¦ Â¦28Â¦ ğ‹‡Â¦marchÂ¦ Â¦on wardsÂ¦ ,â– Â¦withÂ¦ Â¦noÂ¦ Â¦specificÂ¦ Â¦detailsÂ¦ Â¦onÂ¦ Â¦whenÂ¦ Â¦thisÂ¦ Â¦policyÂ¦ Â¦willÂ¦ Â¦endÂ¦ .
ğ‹‡ Â¦damageÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦globalÂ¦ Â¦economyÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦feltÂ¦ Â¦inÂ¦ ğ‹‡Â¦chinaÂ¦ :â– Â¦accordingÂ¦ Â¦toÂ¦ Â¦aÂ¦ Â¦mediaÂ¦ Â¦reportÂ¦ Â¦onÂ¦ Â¦16Â¦ ğ‹‡Â¦marchÂ¦ ,â– Â¦theÂ¦ Â¦economyÂ¦ Â¦inÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦wasÂ¦ Â¦veryÂ¦ Â¦hardÂ¦ Â¦hitÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦firstÂ¦ Â¦twoÂ¦ Â¦monthsÂ¦ Â¦ofÂ¦ Â¦2020Â¦ Â¦dueÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦measuresÂ¦ Â¦takenÂ¦ Â¦byÂ¦ Â¦theÂ¦ Â¦governmentÂ¦ Â¦toÂ¦ Â¦cur tailÂ¦ Â¦virusÂ¦ Â¦spreadÂ¦ ,â– Â¦andÂ¦ Â¦re tailÂ¦ Â¦salesÂ¦ Â¦pl un gedÂ¦ Â¦20Â¦ . Â¦5Â¦ %.
ğ‹‡Â¦theÂ¦ Â¦2019Â¦ Â¦novelÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ â–( Â¦2019Â¦ - Â¦n ğ‹‡coğ‹‡vÂ¦ ),â– Â¦whichÂ¦ Â¦hasÂ¦ Â¦subsequentlyÂ¦ Â¦beenÂ¦ Â¦re na medÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ ,â– Â¦isÂ¦ Â¦theÂ¦ Â¦ca us ativeÂ¦ Â¦agentÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦ongoingÂ¦ Â¦epidemicÂ¦ Â¦ofÂ¦ Â¦coronavirusÂ¦ Â¦diseaseÂ¦ Â¦2019Â¦ â–( ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ ),â– Â¦whichÂ¦ Â¦hasÂ¦ Â¦claimedÂ¦ Â¦moreÂ¦ Â¦thanÂ¦ Â¦3Â¦ , Â¦12 0Â¦ Â¦livesÂ¦ Â¦andÂ¦ Â¦infectedÂ¦ Â¦moreÂ¦ Â¦thanÂ¦ Â¦9 1Â¦ , Â¦000Â¦ Â¦peopleÂ¦ Â¦asÂ¦ Â¦ofÂ¦ ğ‹‡Â¦marchÂ¦ Â¦3Â¦ ,â– Â¦2020Â¦ .
ğ‹‡ Â¦pres um ablyÂ¦ ,â– Â¦theÂ¦ Â¦intermediateÂ¦ Â¦animalÂ¦ Â¦hostsÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦shouldÂ¦ Â¦beÂ¦ Â¦amongÂ¦ Â¦theÂ¦ Â¦wi ld li f eÂ¦ Â¦speciesÂ¦ Â¦soldÂ¦ Â¦andÂ¦ Â¦killedÂ¦ Â¦atÂ¦ Â¦theÂ¦ ğ‹‡Â¦hu an anÂ¦ ğ‹‡Â¦s ea f oodÂ¦ ğ‹‡Â¦wh oles aleÂ¦ ğ‹‡ Â¦marketÂ¦ ,â– Â¦withÂ¦ Â¦whichÂ¦ Â¦manyÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦initialÂ¦ Â¦casesÂ¦ Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦wereÂ¦ Â¦associatedÂ¦ ,â– Â¦indic ativeÂ¦ Â¦ofÂ¦ Â¦aÂ¦ Â¦pro b ableÂ¦ Â¦animalÂ¦ - Â¦toÂ¦ - Â¦humanÂ¦ Â¦transmissionÂ¦ Â¦eventÂ¦ .
ğ‹‡Â¦southÂ¦ ğ‹‡Â¦koreaÂ¦ ' Â¦sÂ¦ Â¦pro grammeÂ¦ Â¦isÂ¦ Â¦consideredÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦aÂ¦ Â¦successÂ¦ Â¦inÂ¦ Â¦controllingÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ Â¦despiteÂ¦ Â¦notÂ¦ Â¦quar anti ningÂ¦ Â¦entireÂ¦ Â¦citiesÂ¦ . ğ‹‡Â¦theÂ¦ ğ‹‡Â¦southÂ¦ ğ‹‡Â¦koreanÂ¦ Â¦societyÂ¦ Â¦wasÂ¦ Â¦initiallyÂ¦ Â¦pol ari zedÂ¦ Â¦onÂ¦ ğ‹‡Â¦presidentÂ¦ ğ‹‡Â¦m oonÂ¦ ğ‹‡Â¦ja eÂ¦ - Â¦inÂ¦ ' Â¦sÂ¦ Â¦responseÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦crisisÂ¦ .
ğ‹‡Â¦ne v ert he lessÂ¦ ,â– Â¦theÂ¦ Â¦featuresÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦includingÂ¦ Â¦itsÂ¦ Â¦transmis sibilityÂ¦ ,â– Â¦patho gen icityÂ¦ Â¦andÂ¦ Â¦s us ta in ableÂ¦ Â¦spreadingÂ¦ Â¦afterÂ¦ Â¦p ass agesÂ¦ Â¦inÂ¦ Â¦humansÂ¦ Â¦willÂ¦ Â¦beÂ¦ Â¦inf lu en tialÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦ul tim ateÂ¦ Â¦f ateÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦ongoingÂ¦ Â¦outbreakÂ¦ Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ .
ğ‹‡Â¦moreoverÂ¦ ,â– Â¦theÂ¦ Â¦highÂ¦ Â¦levelÂ¦ Â¦ofÂ¦ Â¦re activeÂ¦ Â¦oxygenÂ¦ Â¦speciesÂ¦ â–( ğŠ£ Â¦ro sÂ¦ğŠ¼ )â– Â¦generatedÂ¦ Â¦fromÂ¦ Â¦highÂ¦ Â¦met ab olicÂ¦ Â¦activityÂ¦ Â¦ofÂ¦ Â¦batsÂ¦ Â¦couldÂ¦ Â¦bothÂ¦ Â¦sup pressÂ¦ ğ‹‡Â¦coğ‹‡vÂ¦ Â¦replicationÂ¦ Â¦andÂ¦ Â¦affectsÂ¦ Â¦pr oo f rea dingÂ¦ Â¦byÂ¦ Â¦ex o rib on uc le aseÂ¦ ,â– Â¦thusÂ¦ Â¦providingÂ¦ Â¦theÂ¦ Â¦sel ectionÂ¦ Â¦pressureÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦generationÂ¦ Â¦ofÂ¦ Â¦virusÂ¦ Â¦strainsÂ¦ Â¦highlyÂ¦ Â¦pathogenicÂ¦ Â¦whenÂ¦ Â¦introducedÂ¦ Â¦intoÂ¦ Â¦aÂ¦ Â¦newÂ¦ Â¦hostÂ¦ .
ğ‹‡Â¦severalÂ¦ Â¦trainÂ¦ Â¦stationsÂ¦ Â¦andÂ¦ Â¦fer ryÂ¦ Â¦ portsÂ¦ Â¦haveÂ¦ Â¦alsoÂ¦ Â¦beenÂ¦ Â¦closedÂ¦ .
ğ‹‡Â¦coronavirusesÂ¦ Â¦varyÂ¦ Â¦significantlyÂ¦ Â¦inÂ¦ Â¦riskÂ¦ Â¦factorÂ¦ .
ğ‹‡Â¦forÂ¦ Â¦cl arityÂ¦ ,â– Â¦theÂ¦ Â¦currentÂ¦ Â¦knowledgeÂ¦ Â¦onÂ¦ Â¦animalÂ¦ Â¦originsÂ¦ Â¦ofÂ¦ Â¦knownÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vsÂ¦ Â¦isÂ¦ Â¦s um m ari zedÂ¦ Â¦inÂ¦ ğ‹‡Â¦figureÂ¦ â– â€‹ Â¦1Â¦ Â¦andÂ¦ ğ‹‡Â¦tableÂ¦ Â¦2Â¦ .
ğ‹‡Â¦inÂ¦ Â¦bothÂ¦ Â¦casesÂ¦ ,â– Â¦theÂ¦ Â¦hostsÂ¦ Â¦areÂ¦ Â¦na tur allyÂ¦ Â¦infectedÂ¦ Â¦andÂ¦ Â¦areÂ¦ Â¦theÂ¦ Â¦naturalÂ¦ Â¦hostsÂ¦ Â¦ofÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ Â¦orÂ¦ Â¦itsÂ¦ Â¦par en talÂ¦ Â¦virusÂ¦ .
ğ‹‡Â¦onÂ¦ Â¦theÂ¦ Â¦sameÂ¦ Â¦dayÂ¦ ,â– Â¦21 5Â¦ ğ‹‡Â¦ca na di ansÂ¦ â–( Â¦17 6Â¦ Â¦fromÂ¦ Â¦theÂ¦ Â¦firstÂ¦ Â¦planeÂ¦ ,â– Â¦andÂ¦ Â¦39Â¦ Â¦fromÂ¦ Â¦aÂ¦ Â¦secondÂ¦ Â¦planeÂ¦ Â¦char teredÂ¦ Â¦byÂ¦ Â¦theÂ¦ ğ‹‡Â¦uÂ¦ . ğ‹‡Â¦sÂ¦ .â– Â¦governmentÂ¦ )â– Â¦wereÂ¦ Â¦evacu atedÂ¦ Â¦fromÂ¦ ğ‹‡Â¦wuhanÂ¦ Â¦toÂ¦ ğŠ£Â¦c f bÂ¦ğŠ¼ ğ‹‡Â¦tr en tonÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦quarantinedÂ¦ Â¦forÂ¦ Â¦twoÂ¦ Â¦weeksÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦pol yp roteinÂ¦ Â¦hasÂ¦ Â¦itsÂ¦ Â¦ownÂ¦ Â¦prot ea sesÂ¦ Â¦whichÂ¦ Â¦clea veÂ¦ Â¦theÂ¦ Â¦pol yp roteinÂ¦ Â¦intoÂ¦ Â¦multipleÂ¦ Â¦non st ructuralÂ¦ Â¦proteinsÂ¦ .
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦bhar ati yaÂ¦ ğ‹‡Â¦ja na taÂ¦ ğ‹‡Â¦partyÂ¦ ' Â¦sÂ¦ ğ‹‡Â¦stateÂ¦ Â¦unitÂ¦ Â¦presidentÂ¦ Â¦inÂ¦ ğ‹‡Â¦westÂ¦ ğ‹‡Â¦bengalÂ¦ ğ‹‡Â¦dilipÂ¦ ğ‹‡Â¦g ho shÂ¦ Â¦statedÂ¦ Â¦thatÂ¦ Â¦theÂ¦ ğ‹‡Â¦chineseÂ¦ Â¦hadÂ¦ Â¦dest ro yedÂ¦ Â¦natureÂ¦ Â¦andÂ¦ â–" Â¦thatÂ¦ ' Â¦sÂ¦ Â¦whyÂ¦ Â¦theÂ¦ ğ‹‡Â¦godÂ¦ Â¦tookÂ¦ Â¦re v en geÂ¦ Â¦againstÂ¦ Â¦themÂ¦ ."
ğ‹‡ Â¦studiesÂ¦ Â¦haveÂ¦ Â¦foundÂ¦ Â¦thatÂ¦ Â¦anÂ¦ Â¦unc ov eredÂ¦ Â¦coughingÂ¦ Â¦canÂ¦ Â¦leadÂ¦ Â¦toÂ¦ Â¦dropletsÂ¦ Â¦trave llingÂ¦ Â¦upÂ¦ Â¦toÂ¦ Â¦4Â¦ . Â¦5Â¦ Â¦metresÂ¦ â–( Â¦15Â¦ Â¦feetÂ¦ )â– Â¦toÂ¦ Â¦8Â¦ . Â¦2Â¦ Â¦metresÂ¦ â–( Â¦27Â¦ Â¦feetÂ¦ ).
ğ‹‡Â¦inÂ¦ Â¦ch icke nsÂ¦ ,â– Â¦theÂ¦ Â¦infectiousÂ¦ Â¦bronchitisÂ¦ Â¦virusÂ¦ â–( ğŠ£Â¦ib vÂ¦ğŠ¼ ),â– Â¦aÂ¦ Â¦coronavirusÂ¦ ,â– Â¦targe tsÂ¦ Â¦notÂ¦ Â¦onlyÂ¦ Â¦theÂ¦ Â¦respiratoryÂ¦ Â¦tractÂ¦ Â¦butÂ¦ Â¦alsoÂ¦ Â¦theÂ¦ Â¦u ro ge ni talÂ¦ Â¦tractÂ¦ .
ğ‹‡ Â¦interes ti nglyÂ¦ ,â– Â¦theÂ¦ Â¦nucleotideÂ¦ Â¦an al og ueÂ¦ ğ‹‡Â¦remdesivirÂ¦ Â¦isÂ¦ Â¦knownÂ¦ Â¦toÂ¦ Â¦sup pressÂ¦ ğ‹‡Â¦coğ‹‡vÂ¦ Â¦replicationÂ¦ Â¦throughÂ¦ Â¦inhib itionÂ¦ Â¦ofÂ¦ Â¦thisÂ¦ Â¦ex o rib on uc le aseÂ¦ Â¦andÂ¦ Â¦theÂ¦ ğŠ£Â¦rnaÂ¦ğŠ¼ - Â¦dependentÂ¦ ğŠ£Â¦rnaÂ¦ğŠ¼ Â¦polymeraseÂ¦ .
ğ‹‡ Â¦takingÂ¦ Â¦overÂ¦ - Â¦theÂ¦ - Â¦coun terÂ¦ Â¦coldÂ¦ Â¦medicationsÂ¦ ,â– Â¦drin kingÂ¦ Â¦fluidsÂ¦ ,â– Â¦andÂ¦ Â¦r estingÂ¦ Â¦mayÂ¦ Â¦helpÂ¦ Â¦alle vi ateÂ¦ Â¦symptomsÂ¦ .
ğ‹‡Â¦thusÂ¦ ,â– Â¦ifÂ¦ Â¦neededÂ¦ ,â– Â¦s teroidsÂ¦ Â¦shouldÂ¦ Â¦beÂ¦ Â¦usedÂ¦ Â¦atÂ¦ Â¦lowÂ¦ Â¦d os ageÂ¦ Â¦andÂ¦ Â¦forÂ¦ Â¦aÂ¦ Â¦shortÂ¦ Â¦timeÂ¦ Â¦inÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦patientsÂ¦ .
ğ‹‡Â¦inÂ¦ ğ‹‡Â¦septemberÂ¦ Â¦2012Â¦ ,â– Â¦aÂ¦ Â¦newÂ¦ Â¦typeÂ¦ Â¦ofÂ¦ Â¦coronavirusÂ¦ Â¦wasÂ¦ Â¦identifiedÂ¦ ,â– Â¦initiallyÂ¦ Â¦calledÂ¦ ğ‹‡ Â¦novelÂ¦ ğ‹‡Â¦coronavirusÂ¦ Â¦2012Â¦ ,â– Â¦andÂ¦ Â¦nowÂ¦ Â¦off ici allyÂ¦ Â¦namedÂ¦ ğ‹‡Â¦middleÂ¦ ğ‹‡Â¦eastÂ¦ Â¦respiratoryÂ¦ Â¦syndromeÂ¦ Â¦coronavirusÂ¦ â–( ğŠ£Â¦mersÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ ).
ğ‹‡Â¦aÂ¦ ğŠ£Â¦c n nÂ¦ğŠ¼ Â¦reportÂ¦ Â¦indicatedÂ¦ Â¦thatÂ¦ Â¦theÂ¦ Â¦combinationÂ¦ Â¦ofÂ¦ ğ‹‡Â¦italyÂ¦ ' Â¦sÂ¦ Â¦largeÂ¦ Â¦elderlyÂ¦ Â¦populationÂ¦ Â¦andÂ¦ Â¦in abilityÂ¦ Â¦toÂ¦ Â¦testÂ¦ Â¦allÂ¦ Â¦whoÂ¦ Â¦haveÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦toÂ¦ Â¦dateÂ¦ Â¦mayÂ¦ Â¦beÂ¦ Â¦contribu tingÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦highÂ¦ Â¦fatalityÂ¦ Â¦rateÂ¦ .
ğ‹‡Â¦onÂ¦ ğ‹‡Â¦januaryÂ¦ Â¦20Â¦ ,â– Â¦theÂ¦ Â¦infectionÂ¦ Â¦ofÂ¦ Â¦healthÂ¦ - Â¦careÂ¦ Â¦providersÂ¦ Â¦wasÂ¦ Â¦reportedÂ¦ ,â– Â¦sugg estingÂ¦ Â¦thatÂ¦ Â¦humanÂ¦ - Â¦toÂ¦ - Â¦humanÂ¦ Â¦transmissionÂ¦ Â¦wasÂ¦ Â¦possibleÂ¦ .
ğ‹‡ Â¦surgicalÂ¦ Â¦masksÂ¦ Â¦areÂ¦ Â¦recommendedÂ¦ Â¦forÂ¦ Â¦thoseÂ¦ Â¦whoÂ¦ Â¦mayÂ¦ Â¦beÂ¦ Â¦infectedÂ¦ ,â– Â¦asÂ¦ Â¦wearingÂ¦ Â¦aÂ¦ Â¦maskÂ¦ Â¦canÂ¦ Â¦limitÂ¦ Â¦theÂ¦ Â¦volumeÂ¦ Â¦andÂ¦ Â¦travelÂ¦ Â¦distanceÂ¦ Â¦ofÂ¦ Â¦exp ir atoryÂ¦ Â¦dropletsÂ¦ Â¦disp er sedÂ¦ Â¦whenÂ¦ Â¦talkingÂ¦ ,â– Â¦sneezingÂ¦ ,â– Â¦andÂ¦ Â¦coughingÂ¦ .
ğ‹‡Â¦weÂ¦ Â¦alsoÂ¦ Â¦reviewÂ¦ Â¦theÂ¦ Â¦tr endÂ¦ Â¦ofÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ Â¦evolutionÂ¦ Â¦inÂ¦ Â¦whichÂ¦ Â¦theÂ¦ Â¦increaseÂ¦ Â¦inÂ¦ Â¦transmis sibilityÂ¦ Â¦oftenÂ¦ Â¦comesÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦decreaseÂ¦ Â¦inÂ¦ Â¦patho gen icityÂ¦ .
ğ‹‡Â¦sinceÂ¦ Â¦casesÂ¦ Â¦haveÂ¦ Â¦soÂ¦ Â¦farÂ¦ Â¦clus teredÂ¦ Â¦inÂ¦ Â¦certainÂ¦ Â¦regionsÂ¦ Â¦inÂ¦ ğŠ£Â¦euÂ¦ / Â¦eeaÂ¦ğŠ¼ Â¦countriesÂ¦ Â¦andÂ¦ Â¦theÂ¦ ğŠ£Â¦ukÂ¦ğŠ¼ ,â– Â¦andÂ¦ Â¦hospitalsÂ¦ Â¦andÂ¦ Â¦intensiveÂ¦ Â¦careÂ¦ Â¦unitsÂ¦ Â¦usuallyÂ¦ Â¦serveÂ¦ Â¦aÂ¦ Â¦definedÂ¦ Â¦regionalÂ¦ Â¦c at ch mentÂ¦ Â¦populationÂ¦ ,â– Â¦informationÂ¦ Â¦aboutÂ¦ Â¦casesÂ¦ Â¦andÂ¦ Â¦intensiveÂ¦ Â¦careÂ¦ Â¦bedsÂ¦ Â¦shouldÂ¦ Â¦prefer ablyÂ¦ Â¦beÂ¦ Â¦madeÂ¦ Â¦availableÂ¦ Â¦atÂ¦ Â¦theÂ¦ ğ‹‡Â¦no me nc l atureÂ¦ Â¦ofÂ¦ Â¦ter ri to rialÂ¦ Â¦unitsÂ¦ Â¦forÂ¦ Â¦statisticsÂ¦ Â¦2Â¦ â–( ğŠ£Â¦n ut sÂ¦ğŠ¼ - Â¦2Â¦ )â– Â¦levelÂ¦ .
ğ‹‡Â¦itÂ¦ Â¦isÂ¦ Â¦thereforeÂ¦ Â¦notÂ¦ Â¦tooÂ¦ Â¦sur pr isingÂ¦ Â¦thatÂ¦ Â¦batsÂ¦ Â¦mightÂ¦ Â¦trans mitÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - Â¦229ğ‹‡eÂ¦ Â¦toÂ¦ Â¦humansÂ¦ Â¦directlyÂ¦ .
ğ‹‡Â¦threeÂ¦ Â¦majorÂ¦ Â¦riskÂ¦ Â¦factorsÂ¦ Â¦forÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦wereÂ¦ Â¦sexÂ¦ â–( Â¦m aleÂ¦ ),â– Â¦ageÂ¦ â–( â‰¥ Â¦60Â¦ ),â– Â¦andÂ¦ Â¦severeÂ¦ Â¦pneumoniaÂ¦ .
ğ‹‡Â¦accordingÂ¦ Â¦toÂ¦ Â¦aÂ¦ Â¦humanÂ¦ Â¦v ol un te erÂ¦ Â¦studyÂ¦ ,â– Â¦healthyÂ¦ Â¦individualsÂ¦ Â¦infectedÂ¦ Â¦withÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - Â¦229ğ‹‡eÂ¦ Â¦developedÂ¦ Â¦mildÂ¦ Â¦commonÂ¦ Â¦coldÂ¦ .
ğ‹‡Â¦someÂ¦ Â¦art istsÂ¦ Â¦haveÂ¦ Â¦explo redÂ¦ Â¦waysÂ¦ Â¦toÂ¦ Â¦continueÂ¦ Â¦toÂ¦ Â¦produceÂ¦ Â¦andÂ¦ Â¦shareÂ¦ Â¦workÂ¦ Â¦overÂ¦ Â¦theÂ¦ Â¦internetÂ¦ Â¦asÂ¦ Â¦anÂ¦ Â¦alternativeÂ¦ Â¦toÂ¦ Â¦traditionalÂ¦ Â¦liveÂ¦ Â¦performanceÂ¦ ,â– Â¦suchÂ¦ Â¦asÂ¦ Â¦liveÂ¦ Â¦st rea mingÂ¦ Â¦conc ertsÂ¦ Â¦orÂ¦ Â¦creatingÂ¦ Â¦we bÂ¦ - Â¦basedÂ¦ â–" Â¦fes ti valsÂ¦ "â– Â¦forÂ¦ Â¦art istsÂ¦ Â¦toÂ¦ Â¦performÂ¦ ,â– Â¦dist ributeÂ¦ ,â– Â¦andÂ¦ Â¦public i zeÂ¦ Â¦theirÂ¦ Â¦workÂ¦ .
ğ‹‡Â¦onÂ¦ ğ‹‡Â¦februaryÂ¦ Â¦18Â¦ ,â– Â¦2020Â¦ ,â– ğ‹‡Â¦b oliÂ¦ ğ‹‡Â¦zhangÂ¦ Â¦andÂ¦ Â¦co wor kersÂ¦ Â¦publishedÂ¦ Â¦aÂ¦ Â¦studyÂ¦ Â¦toÂ¦ Â¦compareÂ¦ Â¦w est ernÂ¦ Â¦medicineÂ¦ â–( ğŠ£Â¦w mÂ¦ğŠ¼ )â– Â¦treatmentÂ¦ Â¦aloneÂ¦ Â¦withÂ¦ Â¦combinedÂ¦ Â¦treatmentÂ¦ Â¦ofÂ¦ ğŠ£Â¦w mÂ¦ğŠ¼ Â¦andÂ¦ ğŠ£Â¦tc mÂ¦ğŠ¼ .
ğ‹‡Â¦theÂ¦ Â¦casesÂ¦ Â¦mo stlyÂ¦ Â¦hadÂ¦ Â¦lin ksÂ¦ Â¦toÂ¦ Â¦theÂ¦ ğ‹‡Â¦hu an anÂ¦ ğ‹‡Â¦s ea f oodÂ¦ ğ‹‡Â¦wh oles aleÂ¦ ğ‹‡ Â¦marketÂ¦ Â¦andÂ¦ Â¦soÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦isÂ¦ Â¦thoughtÂ¦ Â¦toÂ¦ Â¦haveÂ¦ Â¦aÂ¦ Â¦zoonoticÂ¦ Â¦originÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦ex o rib on uc le aseÂ¦ Â¦non st ructuralÂ¦ Â¦proteinÂ¦ ,â– Â¦forÂ¦ Â¦instanceÂ¦ ,â– Â¦providesÂ¦ Â¦extraÂ¦ Â¦f id el ityÂ¦ Â¦toÂ¦ Â¦replicationÂ¦ Â¦byÂ¦ Â¦providingÂ¦ Â¦aÂ¦ Â¦pr oo f rea dingÂ¦ Â¦functionÂ¦ Â¦whichÂ¦ Â¦theÂ¦ ğŠ£Â¦rnaÂ¦ğŠ¼ - Â¦dependentÂ¦ ğŠ£Â¦rnaÂ¦ğŠ¼ Â¦polymeraseÂ¦ Â¦l acksÂ¦ . ğ‹‡Â¦oneÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦mainÂ¦ Â¦functionsÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦complexÂ¦ Â¦isÂ¦ Â¦toÂ¦ Â¦replic ateÂ¦ Â¦theÂ¦ Â¦viralÂ¦ Â¦genomeÂ¦ .
ğ‹‡ Â¦sevenÂ¦ Â¦trialsÂ¦ Â¦wereÂ¦ Â¦evalu atingÂ¦ Â¦repurp osedÂ¦ Â¦drugsÂ¦ Â¦alreadyÂ¦ Â¦approvedÂ¦ Â¦toÂ¦ Â¦treatÂ¦ Â¦mala riaÂ¦ ,â– Â¦includingÂ¦ Â¦fourÂ¦ Â¦studiesÂ¦ Â¦onÂ¦ Â¦hydroxychloroquineÂ¦ Â¦orÂ¦ Â¦chloroquineÂ¦ Â¦ph os ph ateÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦responseÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦rapidlyÂ¦ Â¦increasingÂ¦ Â¦numberÂ¦ Â¦ofÂ¦ Â¦public ationsÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦emergingÂ¦ Â¦diseaseÂ¦ ,â– Â¦thisÂ¦ Â¦art icleÂ¦ Â¦attemp tsÂ¦ Â¦toÂ¦ Â¦provideÂ¦ Â¦aÂ¦ Â¦timelyÂ¦ Â¦andÂ¦ Â¦comprehensiveÂ¦ Â¦reviewÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦sw i f t lyÂ¦ Â¦developingÂ¦ Â¦researchÂ¦ Â¦subjectÂ¦ .
ğ‹‡Â¦itÂ¦ Â¦isÂ¦ Â¦directlyÂ¦ Â¦involvedÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦replicationÂ¦ Â¦andÂ¦ Â¦transcriptionÂ¦ Â¦ofÂ¦ ğŠ£Â¦rnaÂ¦ğŠ¼ Â¦fromÂ¦ Â¦anÂ¦ ğŠ£Â¦rnaÂ¦ğŠ¼ Â¦str andÂ¦ .
ğ‹‡Â¦theÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ Â¦epidemicÂ¦ Â¦resultedÂ¦ Â¦inÂ¦ Â¦8Â¦ , Â¦0 9 6Â¦ Â¦reportedÂ¦ Â¦casesÂ¦ Â¦withÂ¦ Â¦7 7 4Â¦ Â¦deathsÂ¦ ,â– Â¦spreadingÂ¦ Â¦acrossÂ¦ Â¦manyÂ¦ Â¦countriesÂ¦ Â¦andÂ¦ Â¦con ti ne ntsÂ¦ .
ğ‹‡Â¦mostÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vsÂ¦ Â¦origin atedÂ¦ Â¦fromÂ¦ Â¦batsÂ¦ Â¦whereÂ¦ Â¦theyÂ¦ Â¦areÂ¦ Â¦nonÂ¦ - Â¦pathogenicÂ¦ .
ğŠ£Â¦mersÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ ,â– Â¦althoughÂ¦ Â¦relatedÂ¦ Â¦toÂ¦ Â¦severalÂ¦ Â¦batÂ¦ Â¦coronavirusÂ¦ Â¦speciesÂ¦ ,â– Â¦appearsÂ¦ Â¦toÂ¦ Â¦haveÂ¦ Â¦diver gedÂ¦ Â¦fromÂ¦ Â¦theseÂ¦ Â¦severalÂ¦ Â¦ cent u riesÂ¦ Â¦agoÂ¦ .
ğ‹‡ Â¦physicalÂ¦ Â¦distancingÂ¦ Â¦measuresÂ¦ Â¦areÂ¦ Â¦alsoÂ¦ Â¦recommendedÂ¦ Â¦toÂ¦ Â¦preventÂ¦ Â¦transmissionÂ¦ . ğ‹‡Â¦manyÂ¦ Â¦governmentsÂ¦ Â¦haveÂ¦ Â¦restrictedÂ¦ Â¦orÂ¦ Â¦advisedÂ¦ Â¦againstÂ¦ Â¦allÂ¦ Â¦nonÂ¦ - Â¦essentialÂ¦ Â¦travelÂ¦ Â¦toÂ¦ Â¦andÂ¦ Â¦fromÂ¦ Â¦countriesÂ¦ Â¦andÂ¦ Â¦areasÂ¦ Â¦affectedÂ¦ Â¦byÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ .
ğ‹‡Â¦asÂ¦ Â¦theÂ¦ Â¦situationÂ¦ Â¦isÂ¦ Â¦rapidlyÂ¦ Â¦ev olvingÂ¦ ,â– Â¦theÂ¦ Â¦finalÂ¦ Â¦sc opeÂ¦ Â¦andÂ¦ Â¦severityÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ Â¦remainÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦determinedÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦theÂ¦ ğ‹‡Â¦unitedÂ¦ ğ‹‡Â¦statesÂ¦ ,â– Â¦overÂ¦ Â¦24 4Â¦ Â¦thousandÂ¦ Â¦coronavirusÂ¦ Â¦casesÂ¦ Â¦wereÂ¦ Â¦recordedÂ¦ ,â– Â¦lin kingÂ¦ Â¦toÂ¦ Â¦atÂ¦ Â¦leastÂ¦ Â¦5Â¦ , Â¦900Â¦ Â¦deathsÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦st ar kÂ¦ Â¦contrastÂ¦ ,â– Â¦theÂ¦ ğŠ£Â¦rb d ğŠ¼sÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦andÂ¦ ğ‹‡Â¦ra ğŠ£ t g ğŠ¼1 3Â¦ Â¦areÂ¦ Â¦moreÂ¦ Â¦diver gentÂ¦ ,â– Â¦al be itÂ¦ Â¦aÂ¦ Â¦higherÂ¦ Â¦de gr eeÂ¦ Â¦ofÂ¦ Â¦sequenceÂ¦ Â¦homologyÂ¦ Â¦genomeÂ¦ - Â¦wideÂ¦ .
ğ‹‡Â¦asÂ¦ Â¦ofÂ¦ Â¦earlyÂ¦ ğ‹‡Â¦aprilÂ¦ Â¦2020Â¦ ,â– Â¦10 3Â¦ Â¦candidateÂ¦ Â¦therap e ut icsÂ¦ Â¦wereÂ¦ Â¦inÂ¦ Â¦preclinicalÂ¦ Â¦orÂ¦ Â¦aÂ¦ Â¦stageÂ¦ Â¦ofÂ¦ ğ‹‡Â¦phaseÂ¦ ğ‹‡Â¦iÂ¦ - ğŠ£Â¦i vÂ¦ğŠ¼ Â¦developmentÂ¦ ,â– Â¦withÂ¦ Â¦trialÂ¦ Â¦resultsÂ¦ Â¦forÂ¦ Â¦29Â¦ Â¦drugÂ¦ Â¦candidatesÂ¦ Â¦expectedÂ¦ Â¦duringÂ¦ ğ‹‡Â¦aprilÂ¦ .
ğ‹‡ Â¦batÂ¦ ğ‹‡Â¦coğ‹‡vÂ¦ - ğŠ£Â¦hkuğŠ¼ 4Â¦ Â¦andÂ¦ ğŠ£Â¦mersÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦u ti lizeÂ¦ Â¦theÂ¦ Â¦sameÂ¦ Â¦hostÂ¦ Â¦receptorÂ¦ ,â– Â¦d ip e pt id ylÂ¦ Â¦pe pt id aseÂ¦ Â¦4Â¦ â–( ğŠ£Â¦d pp ğŠ¼ 4Â¦ ),â– Â¦forÂ¦ Â¦virusÂ¦ Â¦entryÂ¦ .
ğ‹‡Â¦howeverÂ¦ ,â– ğ‹‡Â¦coğ‹‡vÂ¦ Â¦canÂ¦ Â¦inhib itÂ¦ ğ‹‡Â¦tÂ¦ Â¦cellÂ¦ Â¦functionsÂ¦ Â¦byÂ¦ Â¦indu c ingÂ¦ Â¦a po pt osisÂ¦ Â¦ofÂ¦ ğ‹‡Â¦tÂ¦ Â¦cellsÂ¦ .
ğ‹‡Â¦theyÂ¦ Â¦areÂ¦ Â¦en velop edÂ¦ Â¦virusesÂ¦ Â¦withÂ¦ Â¦aÂ¦ Â¦positiveÂ¦ - Â¦senseÂ¦ Â¦singleÂ¦ - Â¦strandedÂ¦ ğŠ£Â¦rnaÂ¦ğŠ¼ Â¦genomeÂ¦ Â¦andÂ¦ Â¦aÂ¦ Â¦nucle oc ap s idÂ¦ Â¦ofÂ¦ Â¦h el icalÂ¦ Â¦s ym me t ryÂ¦ .
ğ‹‡Â¦thisÂ¦ Â¦isÂ¦ Â¦theÂ¦ Â¦highestÂ¦ Â¦numberÂ¦ Â¦ofÂ¦ Â¦f at alitiesÂ¦ Â¦inÂ¦ Â¦aÂ¦ Â¦dayÂ¦ Â¦dueÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦virusÂ¦ .
ğ‹‡ Â¦evidenceÂ¦ Â¦toÂ¦ Â¦dateÂ¦ Â¦isÂ¦ Â¦thatÂ¦ Â¦c aÂ¦ Â¦80Â¦ %â– Â¦ofÂ¦ Â¦individualsÂ¦ Â¦withÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦haveÂ¦ Â¦aÂ¦ Â¦mildÂ¦ Â¦diseaseÂ¦ ,â– Â¦iÂ¦ . Â¦eÂ¦ .â– Â¦aÂ¦ Â¦respiratoryÂ¦ Â¦tractÂ¦ Â¦infectionÂ¦ Â¦withÂ¦ Â¦orÂ¦ Â¦withoutÂ¦ Â¦pneumoniaÂ¦ ,â– Â¦andÂ¦ Â¦mostÂ¦ Â¦ofÂ¦ Â¦theseÂ¦ Â¦recoverÂ¦ .
ğ‹‡Â¦onÂ¦ Â¦14Â¦ ğ‹‡Â¦februaryÂ¦ ,â– Â¦aÂ¦ ğŠ£Â¦whoÂ¦ğŠ¼ - Â¦ledÂ¦ ğ‹‡ Â¦jointÂ¦ ğ‹‡Â¦missionÂ¦ ğ‹‡ Â¦teamÂ¦ Â¦withÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦wasÂ¦ Â¦ac tivatedÂ¦ Â¦toÂ¦ Â¦provideÂ¦ Â¦internationalÂ¦ Â¦andÂ¦ ğŠ£Â¦whoÂ¦ğŠ¼ Â¦expertsÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦groundÂ¦ Â¦inÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦toÂ¦ Â¦ass istÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦domesticÂ¦ Â¦managementÂ¦ Â¦andÂ¦ Â¦evalu ateÂ¦ â–" Â¦theÂ¦ Â¦severityÂ¦ Â¦andÂ¦ Â¦theÂ¦ Â¦transmis sibilityÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦diseaseÂ¦ "â– Â¦byÂ¦ Â¦h os tingÂ¦ Â¦work s ho psÂ¦ Â¦andÂ¦ Â¦meetingsÂ¦ Â¦withÂ¦ Â¦keyÂ¦ Â¦nationalÂ¦ - Â¦levelÂ¦ Â¦institutionsÂ¦ Â¦andÂ¦ Â¦toÂ¦ Â¦conductÂ¦ Â¦fieldÂ¦ Â¦visitsÂ¦ Â¦toÂ¦ Â¦assessÂ¦ Â¦theÂ¦ â–" Â¦impactÂ¦ Â¦ofÂ¦ Â¦responseÂ¦ Â¦activitiesÂ¦ Â¦atÂ¦ Â¦provi n cialÂ¦ Â¦andÂ¦ Â¦coun tyÂ¦ Â¦levelsÂ¦ ,â– Â¦includingÂ¦ Â¦urbanÂ¦ Â¦andÂ¦ Â¦ruralÂ¦ Â¦settingsÂ¦ ". ğ‹‡Â¦onÂ¦ Â¦25Â¦ ğ‹‡Â¦februaryÂ¦ ,â– Â¦theÂ¦ ğŠ£Â¦whoÂ¦ğŠ¼ Â¦declaredÂ¦ Â¦thatÂ¦ â–" Â¦theÂ¦ Â¦worldÂ¦ Â¦shouldÂ¦ Â¦doÂ¦ Â¦moreÂ¦ Â¦toÂ¦ Â¦prepareÂ¦ Â¦forÂ¦ Â¦aÂ¦ Â¦possibleÂ¦ Â¦coronavirusÂ¦ Â¦pandemicÂ¦ ,"â– Â¦st atingÂ¦ Â¦thatÂ¦ Â¦whileÂ¦ Â¦itÂ¦ Â¦wasÂ¦ Â¦stillÂ¦ Â¦tooÂ¦ Â¦earlyÂ¦ Â¦toÂ¦ Â¦callÂ¦ Â¦itÂ¦ Â¦aÂ¦ Â¦pandemicÂ¦ ,â– Â¦countriesÂ¦ Â¦shouldÂ¦ Â¦no ne t he lessÂ¦ Â¦beÂ¦ â–" Â¦inÂ¦ Â¦aÂ¦ Â¦phaseÂ¦ Â¦ofÂ¦ Â¦preparednessÂ¦ ".
ğ‹‡ Â¦casesÂ¦ Â¦beganÂ¦ Â¦toÂ¦ Â¦riseÂ¦ Â¦shar p lyÂ¦ ,â– Â¦whichÂ¦ Â¦pro mptedÂ¦ Â¦theÂ¦ ğ‹‡Â¦italianÂ¦ Â¦governmentÂ¦ Â¦toÂ¦ Â¦susp endÂ¦ Â¦allÂ¦ Â¦flightsÂ¦ Â¦toÂ¦ Â¦andÂ¦ Â¦fromÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦andÂ¦ Â¦decl areÂ¦ Â¦aÂ¦ Â¦stateÂ¦ Â¦ofÂ¦ Â¦emergencyÂ¦ .
ğ‹‡Â¦aÂ¦ Â¦varietyÂ¦ Â¦ofÂ¦ Â¦zoonoticÂ¦ ğ‹‡Â¦coğ‹‡vsÂ¦ Â¦areÂ¦ Â¦circulatingÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦wi ldÂ¦ .
ğ‹‡Â¦basedÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦experienceÂ¦ Â¦fromÂ¦ ğ‹‡Â¦italyÂ¦ ,â– Â¦countriesÂ¦ ,â– Â¦hospitalsÂ¦ Â¦andÂ¦ Â¦intensiveÂ¦ Â¦careÂ¦ Â¦unitsÂ¦ Â¦shouldÂ¦ Â¦increaseÂ¦ Â¦theirÂ¦ Â¦preparednessÂ¦ Â¦forÂ¦ Â¦aÂ¦ Â¦sur geÂ¦ Â¦ofÂ¦ Â¦patientsÂ¦ Â¦withÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦whoÂ¦ Â¦willÂ¦ Â¦requireÂ¦ Â¦healthcareÂ¦ ,â– Â¦andÂ¦ Â¦inÂ¦ Â¦particularÂ¦ Â¦intensiveÂ¦ Â¦careÂ¦ .
ğ‹‡Â¦toÂ¦ Â¦conclu deÂ¦ ,â– Â¦weÂ¦ Â¦hopeÂ¦ Â¦moreÂ¦ Â¦directÂ¦ Â¦evidenceÂ¦ Â¦comingÂ¦ Â¦upÂ¦ Â¦andÂ¦ Â¦callÂ¦ Â¦forÂ¦ Â¦rea dersÂ¦ Â¦toÂ¦ Â¦provideÂ¦ Â¦theirÂ¦ Â¦com mentsÂ¦ .
ğ‹‡Â¦individualsÂ¦ Â¦mayÂ¦ Â¦applyÂ¦ Â¦socialÂ¦ Â¦distancingÂ¦ Â¦methodsÂ¦ Â¦byÂ¦ Â¦stayingÂ¦ Â¦atÂ¦ Â¦homeÂ¦ ,â– Â¦limitingÂ¦ Â¦travelÂ¦ ,â– Â¦avoidingÂ¦ Â¦crowdedÂ¦ Â¦areasÂ¦ ,â– Â¦usingÂ¦ Â¦noÂ¦ - Â¦contactÂ¦ Â¦gr ee t ingsÂ¦ ,â– Â¦andÂ¦ Â¦phys icallyÂ¦ Â¦distancingÂ¦ Â¦themselvesÂ¦ Â¦fromÂ¦ Â¦othersÂ¦ .
ğ‹‡Â¦diagn osingÂ¦ Â¦theÂ¦ Â¦confirmedÂ¦ Â¦caseÂ¦ Â¦shouldÂ¦ Â¦b aseÂ¦ Â¦onÂ¦ Â¦suspectedÂ¦ Â¦caseÂ¦ Â¦withÂ¦ Â¦anyÂ¦ Â¦oneÂ¦ Â¦i temÂ¦ Â¦ofÂ¦ Â¦pathogenicÂ¦ Â¦orÂ¦ Â¦serologicalÂ¦ Â¦evidenceÂ¦ Â¦asÂ¦ Â¦followingÂ¦ : â–( Â¦1Â¦ )â– Â¦realÂ¦ - Â¦timeÂ¦ ğŠ£Â¦pcrÂ¦ğŠ¼ Â¦testÂ¦ Â¦positiveÂ¦ Â¦forÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ ;â–( Â¦2Â¦ )â– Â¦viralÂ¦ Â¦wholeÂ¦ Â¦genomeÂ¦ Â¦sequencingÂ¦ Â¦showingÂ¦ Â¦highÂ¦ Â¦ho mo gene ityÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦knownÂ¦ Â¦novelÂ¦ Â¦coronavirusesÂ¦ ;â–( Â¦3Â¦ )â– Â¦positiveÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦specificÂ¦ ğ‹‡Â¦igğ‹‡ mÂ¦ Â¦antibodyÂ¦ Â¦andÂ¦ ğ‹‡Â¦igğ‹‡ gÂ¦ Â¦antibodyÂ¦ Â¦toÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦inÂ¦ Â¦serumÂ¦ Â¦testÂ¦ ;â– Â¦orÂ¦ Â¦aÂ¦ Â¦changeÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ - Â¦specificÂ¦ ğ‹‡Â¦igğ‹‡ gÂ¦ Â¦antibodyÂ¦ Â¦fromÂ¦ Â¦negativeÂ¦ Â¦toÂ¦ Â¦positiveÂ¦ ,â– Â¦orÂ¦ Â¦ti terÂ¦ Â¦risingÂ¦ â–â‰¥ Â¦4Â¦ Â¦timesÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦recoveryÂ¦ Â¦phaseÂ¦ Â¦aboveÂ¦ Â¦thatÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦acuteÂ¦ Â¦phaseÂ¦ .
ğ‹‡ Â¦eightÂ¦ Â¦ofÂ¦ Â¦theseÂ¦ Â¦doctorsÂ¦ ,â– Â¦includingÂ¦ ğ‹‡Â¦l iÂ¦ ğ‹‡Â¦w en li angÂ¦ ,â– Â¦wereÂ¦ Â¦ad mo ni shedÂ¦ Â¦byÂ¦ Â¦theÂ¦ Â¦policeÂ¦ Â¦forÂ¦ Â¦spreadingÂ¦ Â¦falseÂ¦ Â¦r um oursÂ¦ ,â– Â¦andÂ¦ Â¦anotherÂ¦ ,â– ğ‹‡Â¦a iÂ¦ ğ‹‡Â¦f enÂ¦ ,â– Â¦wasÂ¦ Â¦re pri ma ndedÂ¦ Â¦byÂ¦ Â¦herÂ¦ Â¦super i orsÂ¦ Â¦forÂ¦ Â¦raisingÂ¦ Â¦theÂ¦ Â¦al ar mÂ¦ .
ğ‹‡Â¦theÂ¦ ğŠ£Â¦whoÂ¦ğŠ¼ Â¦wasÂ¦ Â¦informedÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦sameÂ¦ Â¦dayÂ¦ .
ğ‹‡Â¦whenÂ¦ Â¦thisÂ¦ Â¦chestÂ¦ Â¦painÂ¦ Â¦startedÂ¦ ?
ğ‹‡Â¦shi aÂ¦ Â¦s hr inesÂ¦ Â¦inÂ¦ ğ‹‡Â¦ q omÂ¦ Â¦remainedÂ¦ Â¦openÂ¦ Â¦toÂ¦ Â¦pil g ri msÂ¦ Â¦untilÂ¦ Â¦16Â¦ ğ‹‡Â¦marchÂ¦ Â¦2020Â¦ . ğ‹‡Â¦iranÂ¦ Â¦becameÂ¦ Â¦aÂ¦ Â¦ cent reÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦spreadÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦afterÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦duringÂ¦ ğ‹‡Â¦februaryÂ¦ .
ğ‹‡ Â¦longÂ¦ - Â¦termÂ¦ Â¦inter ventionÂ¦ Â¦toÂ¦ Â¦sup pressÂ¦ Â¦theÂ¦ Â¦pandemicÂ¦ Â¦causesÂ¦ Â¦socialÂ¦ Â¦andÂ¦ Â¦economicÂ¦ Â¦c os tsÂ¦ .
ğ‹‡Â¦iÂ¦ ' Â¦veÂ¦ Â¦veryÂ¦ Â¦concernedÂ¦ Â¦ofÂ¦ Â¦thisÂ¦ Â¦chestÂ¦ Â¦painÂ¦
ğŠ£Â¦usÂ¦ğŠ¼ Â¦authoritiesÂ¦ Â¦haveÂ¦ Â¦alsoÂ¦ Â¦beenÂ¦ Â¦accusedÂ¦ Â¦ofÂ¦ Â¦diver tingÂ¦ Â¦aidÂ¦ Â¦me antÂ¦ Â¦forÂ¦ Â¦otherÂ¦ Â¦n ationsÂ¦ Â¦toÂ¦ Â¦theirÂ¦ Â¦ownÂ¦ Â¦countryÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦detectionÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ ğŠ£Â¦rnaÂ¦ğŠ¼ Â¦viaÂ¦ Â¦reverseÂ¦ - Â¦trans c ript aseÂ¦ Â¦polymeraseÂ¦ Â¦chainÂ¦ Â¦reactionÂ¦ â–( ğŠ£Â¦rtÂ¦ - Â¦pcrÂ¦ğŠ¼ )â– Â¦wasÂ¦ Â¦usedÂ¦ Â¦asÂ¦ Â¦theÂ¦ Â¦majorÂ¦ Â¦criteriaÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦diagnosisÂ¦ Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ .
ğ‹‡ Â¦emergingÂ¦ Â¦infectiousÂ¦ Â¦diseaseÂ¦ â–â€“â– ğ‹‡Â¦infectiousÂ¦ Â¦diseaseÂ¦ Â¦ofÂ¦ Â¦emergingÂ¦ Â¦path ogenÂ¦ ,â– Â¦oftenÂ¦ Â¦novelÂ¦ Â¦inÂ¦ Â¦itsÂ¦ Â¦outbreakÂ¦ Â¦rangeÂ¦ Â¦orÂ¦ Â¦transmissionÂ¦ Â¦mo deÂ¦
ğ‹‡ Â¦ki mb er lyÂ¦ - ğ‹‡ Â¦cl ar kÂ¦ ,â– Â¦whichÂ¦ Â¦makesÂ¦ ğ‹‡Â¦ kl ee ne xÂ¦ ğ‹‡ Â¦toiletÂ¦ ğ‹‡ Â¦tissueÂ¦ ,â– Â¦andÂ¦ ğ‹‡Â¦so la risÂ¦ ğ‹‡ Â¦paperÂ¦ Â¦whichÂ¦ Â¦makesÂ¦ ğ‹‡Â¦s or b entÂ¦ ,â– Â¦emp ha si zedÂ¦ Â¦theyÂ¦ Â¦wereÂ¦ Â¦workingÂ¦ Â¦24Â¦ / Â¦7Â¦ Â¦toÂ¦ Â¦maintainÂ¦ Â¦theÂ¦ Â¦supplyÂ¦ ,â– Â¦accordingÂ¦ Â¦toÂ¦ Â¦theÂ¦ ğ‹‡Â¦newsÂ¦ . Â¦comÂ¦ . Â¦a uÂ¦ Â¦reportÂ¦ .
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦aust ri anÂ¦ Â¦governmentÂ¦ Â¦mand atedÂ¦ Â¦thatÂ¦ Â¦everyoneÂ¦ Â¦enteringÂ¦ Â¦aÂ¦ Â¦groceryÂ¦ Â¦storeÂ¦ Â¦mustÂ¦ Â¦wearÂ¦ Â¦aÂ¦ Â¦faceÂ¦ Â¦maskÂ¦ .
ğ‹‡Â¦basedÂ¦ Â¦onÂ¦ Â¦theseÂ¦ ,â– ğ‹‡Â¦gi le adÂ¦ Â¦hasÂ¦ Â¦providedÂ¦ Â¦theÂ¦ Â¦compoundÂ¦ Â¦toÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦toÂ¦ Â¦conductÂ¦ Â¦aÂ¦ Â¦pa irÂ¦ Â¦ofÂ¦ Â¦trialsÂ¦ Â¦onÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ - Â¦infectedÂ¦ Â¦individualsÂ¦ ,â– Â¦andÂ¦ Â¦theÂ¦ Â¦resultsÂ¦ Â¦areÂ¦ Â¦highlyÂ¦ Â¦anticipatedÂ¦ .
ğ‹‡Â¦asÂ¦ Â¦ofÂ¦ Â¦22Â¦ ğ‹‡Â¦februaryÂ¦ ,â– Â¦amongÂ¦ Â¦9Â¦ , Â¦3 3 6Â¦ Â¦fo ll owersÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦ch ur chÂ¦ ,â– Â¦1Â¦ , Â¦2 6 1Â¦ Â¦orÂ¦ Â¦aboutÂ¦ Â¦13Â¦ %â– Â¦reportedÂ¦ Â¦symptomsÂ¦ . ğ‹‡Â¦southÂ¦ ğ‹‡Â¦koreaÂ¦ Â¦declaredÂ¦ Â¦theÂ¦ Â¦highestÂ¦ Â¦levelÂ¦ Â¦ofÂ¦ Â¦alertÂ¦ Â¦onÂ¦ Â¦23Â¦ ğ‹‡Â¦februaryÂ¦ Â¦2020Â¦ .
ğ‹‡Â¦g lo ba liz ationÂ¦ Â¦andÂ¦ Â¦diseaseÂ¦ â–â€“â– ğ‹‡ Â¦over vie wÂ¦ Â¦ofÂ¦ Â¦g lo ba liz ationÂ¦ Â¦andÂ¦ Â¦diseaseÂ¦ Â¦transmissionÂ¦
ğ‹‡Â¦atÂ¦ Â¦leastÂ¦ Â¦12Â¦ Â¦sittingÂ¦ Â¦orÂ¦ Â¦formerÂ¦ ğ‹‡Â¦ira ni anÂ¦ Â¦poli ti ciansÂ¦ Â¦andÂ¦ Â¦governmentÂ¦ Â¦officialsÂ¦ Â¦hadÂ¦ Â¦diedÂ¦ Â¦fromÂ¦ Â¦theÂ¦ Â¦diseaseÂ¦ Â¦byÂ¦ Â¦17Â¦ ğ‹‡Â¦marchÂ¦ .
ğ‹‡Â¦itÂ¦ Â¦isÂ¦ Â¦thereforeÂ¦ Â¦impossibleÂ¦ Â¦toÂ¦ Â¦s ac ri f iceÂ¦ Â¦allÂ¦ Â¦camelsÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦controlÂ¦ Â¦ofÂ¦ ğŠ£Â¦mersÂ¦ğŠ¼ ,â– Â¦asÂ¦ Â¦whatÂ¦ Â¦wasÂ¦ Â¦doneÂ¦ Â¦inÂ¦ Â¦wi ldÂ¦ Â¦animalÂ¦ Â¦marketsÂ¦ Â¦inÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦toÂ¦ Â¦preventÂ¦ Â¦theÂ¦ Â¦spreadingÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦andÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ .
ğ‹‡Â¦thisÂ¦ Â¦isÂ¦ Â¦becauseÂ¦ Â¦outsideÂ¦ Â¦theÂ¦ Â¦humanÂ¦ Â¦bodyÂ¦ ,â– Â¦theÂ¦ Â¦virusÂ¦ Â¦isÂ¦ Â¦killedÂ¦ Â¦byÂ¦ Â¦householdÂ¦ Â¦soapÂ¦ ,â– Â¦whichÂ¦ Â¦bur s tsÂ¦ Â¦itsÂ¦ Â¦protectiveÂ¦ Â¦b ub bleÂ¦ .
ğ‹‡Â¦theÂ¦ ğŠ£Â¦cdcÂ¦ğŠ¼ Â¦recommendsÂ¦ Â¦thatÂ¦ Â¦peopleÂ¦ Â¦washÂ¦ Â¦handsÂ¦ Â¦oftenÂ¦ Â¦withÂ¦ Â¦soapÂ¦ Â¦andÂ¦ Â¦waterÂ¦ Â¦forÂ¦ Â¦atÂ¦ Â¦leastÂ¦ Â¦twentyÂ¦ Â¦secondsÂ¦ ,â– Â¦especiallyÂ¦ Â¦afterÂ¦ Â¦goingÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦toiletÂ¦ Â¦orÂ¦ Â¦whenÂ¦ Â¦handsÂ¦ Â¦areÂ¦ Â¦vi sib lyÂ¦ Â¦dir tyÂ¦ ;â– Â¦beforeÂ¦ Â¦eatingÂ¦ ;â– Â¦andÂ¦ Â¦afterÂ¦ Â¦bl owingÂ¦ Â¦oneÂ¦ ' Â¦sÂ¦ Â¦noseÂ¦ ,â– Â¦coughingÂ¦ ,â– Â¦orÂ¦ Â¦sneezingÂ¦ .
ğ‹‡ Â¦rapidlyÂ¦ Â¦increasingÂ¦ Â¦cumulativeÂ¦ Â¦incidenceÂ¦ Â¦ofÂ¦ Â¦coronavirusÂ¦ Â¦diseaseÂ¦ â–( ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ )â– Â¦inÂ¦ Â¦theÂ¦ ğ‹‡Â¦europeanÂ¦ ğ‹‡Â¦unionÂ¦ / ğ‹‡Â¦europeanÂ¦ ğ‹‡Â¦economicÂ¦ ğ‹‡ Â¦areaÂ¦ Â¦andÂ¦ Â¦theÂ¦ ğ‹‡Â¦unitedÂ¦ ğ‹‡Â¦kingdomÂ¦ ,â– Â¦1Â¦ ğ‹‡Â¦januaryÂ¦ Â¦toÂ¦ Â¦15Â¦ ğ‹‡Â¦marchÂ¦ Â¦2020Â¦
ğ‹‡Â¦theÂ¦ Â¦highÂ¦ - Â¦thr ough putÂ¦ Â¦aut om atedÂ¦ Â¦systemsÂ¦ Â¦inÂ¦ Â¦manyÂ¦ Â¦clinicalÂ¦ Â¦laboratoriesÂ¦ Â¦willÂ¦ Â¦beÂ¦ Â¦ableÂ¦ Â¦toÂ¦ Â¦performÂ¦ Â¦theseÂ¦ Â¦ass aysÂ¦ Â¦butÂ¦ Â¦theirÂ¦ Â¦availabilityÂ¦ Â¦willÂ¦ Â¦dependÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦rateÂ¦ Â¦ofÂ¦ Â¦productionÂ¦ Â¦forÂ¦ Â¦eachÂ¦ Â¦systemÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦averageÂ¦ Â¦timeÂ¦ Â¦fromÂ¦ Â¦onsetÂ¦ Â¦toÂ¦ Â¦deathÂ¦ Â¦wasÂ¦ Â¦9Â¦ . Â¦5Â¦ â–( Â¦4Â¦ . Â¦8Â¦ - Â¦13Â¦ )â– Â¦daysÂ¦ .
ğ‹‡Â¦peopleÂ¦ Â¦haveÂ¦ Â¦testedÂ¦ Â¦positiveÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦diseaseÂ¦ Â¦upÂ¦ Â¦toÂ¦ Â¦threeÂ¦ Â¦daysÂ¦ Â¦beforeÂ¦ Â¦onsetÂ¦ Â¦ofÂ¦ Â¦symptomsÂ¦ Â¦sugg estingÂ¦ Â¦transmissionÂ¦ Â¦isÂ¦ Â¦possibleÂ¦ Â¦beforeÂ¦ Â¦developingÂ¦ Â¦significantÂ¦ Â¦symptomsÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦virusÂ¦ Â¦canÂ¦ Â¦spreadÂ¦ Â¦toÂ¦ Â¦differentÂ¦ Â¦organsÂ¦ Â¦throughoutÂ¦ Â¦theÂ¦ Â¦ch ic kenÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦authoritiesÂ¦ Â¦alsoÂ¦ Â¦announcedÂ¦ Â¦theÂ¦ Â¦constructionÂ¦ Â¦ofÂ¦ Â¦aÂ¦ Â¦temporaryÂ¦ Â¦hospitalÂ¦ ,â– ğ‹‡Â¦hu os he ns hanÂ¦ ğ‹‡Â¦hospitalÂ¦ ,â– Â¦whichÂ¦ Â¦wasÂ¦ Â¦completedÂ¦ Â¦inÂ¦ Â¦10Â¦ Â¦daysÂ¦ .
ğ‹‡Â¦int ri gu i nglyÂ¦ ,â– Â¦se raÂ¦ Â¦ofÂ¦ Â¦convalescentÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ Â¦patientsÂ¦ Â¦wereÂ¦ Â¦capableÂ¦ Â¦ofÂ¦ Â¦ne ut ra lizingÂ¦ ğŠ£Â¦wivğŠ¼1Â¦ .
ğ‹‡Â¦toÂ¦ Â¦furtherÂ¦ Â¦alle vi ateÂ¦ Â¦theÂ¦ Â¦shortageÂ¦ ,â– ğ‹‡Â¦co lesÂ¦ Â¦orderedÂ¦ Â¦bi g gerÂ¦ Â¦p ack agesÂ¦ Â¦fromÂ¦ Â¦suppliersÂ¦ Â¦andÂ¦ Â¦increasedÂ¦ Â¦deliveryÂ¦ Â¦fre qu encyÂ¦ ,â– ğ‹‡ Â¦wo ol wor thsÂ¦ Â¦orderedÂ¦ Â¦extraÂ¦ Â¦stockÂ¦ ,â– Â¦whileÂ¦ ğŠ£Â¦a ld iÂ¦ğŠ¼ Â¦madeÂ¦ Â¦stocksÂ¦ Â¦forÂ¦ Â¦aÂ¦ Â¦plannedÂ¦ ğ‹‡Â¦wednesdayÂ¦ Â¦specialÂ¦ Â¦availableÂ¦ Â¦earlyÂ¦ .
ğ‹‡Â¦thereÂ¦ Â¦areÂ¦ Â¦twoÂ¦ Â¦typesÂ¦ Â¦ofÂ¦ Â¦c an ineÂ¦ Â¦coronavirusÂ¦ â–( ğŠ£Â¦c cğŠ¼oğ‹‡vÂ¦ ),â– Â¦oneÂ¦ Â¦thatÂ¦ Â¦causesÂ¦ Â¦mildÂ¦ Â¦g as trointestinalÂ¦ Â¦diseaseÂ¦ Â¦andÂ¦ Â¦oneÂ¦ Â¦thatÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦foundÂ¦ Â¦toÂ¦ Â¦causeÂ¦ Â¦respiratoryÂ¦ Â¦diseaseÂ¦ .
ğ‹‡Â¦whileÂ¦ Â¦int actÂ¦ ğŠ£Â¦orf ğŠ¼ 4Â¦ Â¦couldÂ¦ Â¦beÂ¦ Â¦observedÂ¦ Â¦inÂ¦ Â¦batÂ¦ Â¦andÂ¦ Â¦cam elÂ¦ Â¦virusesÂ¦ Â¦relatedÂ¦ Â¦toÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - Â¦229ğ‹‡eÂ¦ ,â– Â¦theÂ¦ Â¦al pac aÂ¦ Â¦alphaÂ¦ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦disp l aysÂ¦ Â¦aÂ¦ Â¦singleÂ¦ Â¦nucleotideÂ¦ Â¦ins er tionÂ¦ ,â– Â¦resultingÂ¦ Â¦inÂ¦ Â¦aÂ¦ Â¦fr am es hi ftÂ¦ .
ğ‹‡Â¦someÂ¦ Â¦countriesÂ¦ Â¦inÂ¦ ğ‹‡Â¦africaÂ¦ Â¦haveÂ¦ Â¦alsoÂ¦ Â¦seenÂ¦ Â¦aÂ¦ Â¦riseÂ¦ Â¦inÂ¦ Â¦antiÂ¦ - ğ‹‡Â¦chineseÂ¦ Â¦s enti mentÂ¦ .
ğ‹‡Â¦theseÂ¦ Â¦camelsÂ¦ Â¦serveÂ¦ Â¦asÂ¦ Â¦anÂ¦ Â¦importantÂ¦ Â¦to olÂ¦ Â¦forÂ¦ Â¦transportationÂ¦ Â¦asÂ¦ Â¦wellÂ¦ Â¦asÂ¦ Â¦aÂ¦ Â¦mainÂ¦ Â¦sourceÂ¦ Â¦ofÂ¦ Â¦meatÂ¦ ,â– Â¦milkÂ¦ ,â– Â¦lea therÂ¦ Â¦andÂ¦ Â¦wo olÂ¦ Â¦productsÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦localÂ¦ Â¦peopleÂ¦ .
ğ‹‡Â¦howeverÂ¦ ,â– Â¦theirÂ¦ Â¦workÂ¦ Â¦alsoÂ¦ Â¦needsÂ¦ Â¦updateÂ¦ Â¦accordingÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦latestÂ¦ ğ‹‡ Â¦diagnosisÂ¦ Â¦andÂ¦ ğ‹‡Â¦treatmentÂ¦ ğ‹‡Â¦guidelinesÂ¦ Â¦forÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ â–( ğ‹‡ Â¦trialÂ¦ Â¦se vent hÂ¦ Â¦ver sionÂ¦ )â– Â¦andÂ¦ Â¦recentlyÂ¦ Â¦studiesÂ¦ .
ğ‹‡Â¦coronavirusesÂ¦ Â¦canÂ¦ Â¦causeÂ¦ Â¦c oldsÂ¦ Â¦withÂ¦ Â¦majorÂ¦ Â¦symptomsÂ¦ ,â– Â¦suchÂ¦ Â¦asÂ¦ Â¦feverÂ¦ ,â– Â¦andÂ¦ Â¦aÂ¦ Â¦soreÂ¦ Â¦throatÂ¦ Â¦fromÂ¦ Â¦sw o ll enÂ¦ Â¦ad en oi dsÂ¦ .
ğ‹‡Â¦aÂ¦ Â¦studyÂ¦ Â¦publishedÂ¦ Â¦byÂ¦ Â¦theÂ¦ ğŠ£Â¦usÂ¦ğŠ¼ ğ‹‡Â¦centerÂ¦ Â¦forÂ¦ ğ‹‡Â¦diseaseÂ¦ ğ‹‡Â¦controlÂ¦ Â¦andÂ¦ ğ‹‡Â¦preventionÂ¦ Â¦hasÂ¦ Â¦conclu dedÂ¦ Â¦thatÂ¦ Â¦itÂ¦ Â¦mayÂ¦ Â¦beÂ¦ Â¦5Â¦ . Â¦7Â¦ .
ğ‹‡Â¦howeverÂ¦ ,â– Â¦itÂ¦ Â¦isÂ¦ Â¦moreÂ¦ Â¦pathogenicÂ¦ Â¦thanÂ¦ Â¦communityÂ¦ - Â¦acquiredÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vsÂ¦ Â¦andÂ¦ Â¦lessÂ¦ Â¦pathogenicÂ¦ Â¦thanÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦orÂ¦ ğŠ£Â¦mersÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ .
ğ‹‡Â¦atÂ¦ Â¦leastÂ¦ Â¦52Â¦ Â¦thousandÂ¦ Â¦deathsÂ¦ Â¦wereÂ¦ Â¦linkedÂ¦ Â¦toÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ ,â– Â¦theÂ¦ Â¦diseaseÂ¦ Â¦causedÂ¦ Â¦byÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ .
ğ‹‡Â¦fourÂ¦ Â¦ofÂ¦ Â¦theseÂ¦ Â¦coronavirusesÂ¦ Â¦continu allyÂ¦ Â¦circ ul ateÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦humanÂ¦ Â¦populationÂ¦ Â¦andÂ¦ Â¦produceÂ¦ Â¦theÂ¦ Â¦generallyÂ¦ Â¦mildÂ¦ Â¦symptomsÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦commonÂ¦ Â¦coldÂ¦ Â¦inÂ¦ Â¦adultsÂ¦ Â¦andÂ¦ Â¦childrenÂ¦ Â¦worldwideÂ¦ : â–- ğŠ£ Â¦oc 43Â¦ , â–- Â¦h k u 1Â¦ ,â– Â¦h cğŠ¼oğ‹‡vÂ¦ - Â¦229ğ‹‡eÂ¦ , â–- ğŠ£Â¦nlğŠ¼63Â¦ .
ğ‹‡Â¦asÂ¦ Â¦ofÂ¦ ğ‹‡Â¦aprilÂ¦ Â¦7Â¦ ,â– Â¦2020Â¦ ,â– Â¦onlyÂ¦ Â¦aÂ¦ Â¦singleÂ¦ Â¦testÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦approvedÂ¦ Â¦byÂ¦ Â¦theÂ¦ ğŠ£Â¦fdaÂ¦ğŠ¼ Â¦underÂ¦ Â¦anÂ¦ Â¦emergencyÂ¦ Â¦useÂ¦ Â¦authori z ationÂ¦ . ğ‹‡Â¦inÂ¦ Â¦lateÂ¦ ğ‹‡Â¦marchÂ¦ Â¦2020Â¦ ,â– ğ‹‡Â¦ eu ro im m u nÂ¦ ğ‹‡Â¦medicalÂ¦ ğ‹‡ Â¦laboratoryÂ¦ ğ‹‡Â¦diagn o sticsÂ¦ Â¦andÂ¦ ğ‹‡ Â¦ep it opeÂ¦ ğ‹‡Â¦diagn o sticsÂ¦ Â¦receivedÂ¦ ğ‹‡Â¦europeanÂ¦ Â¦appro valsÂ¦ Â¦forÂ¦ Â¦theirÂ¦ Â¦testÂ¦ Â¦kitsÂ¦ ,â– Â¦whichÂ¦ Â¦canÂ¦ Â¦detectÂ¦ ğ‹‡Â¦igğ‹‡ gÂ¦ Â¦andÂ¦ ğ‹‡Â¦igğ‹‡ aÂ¦ Â¦antibodiesÂ¦ Â¦againstÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦inÂ¦ Â¦bloodÂ¦ Â¦samplesÂ¦ .
ğ‹‡ Â¦zoonoticÂ¦ Â¦originsÂ¦ Â¦ofÂ¦ Â¦humanÂ¦ Â¦coronavirusesÂ¦
ğ‹‡ Â¦anyoneÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦familyÂ¦ Â¦haveÂ¦ Â¦aÂ¦ Â¦heartÂ¦ Â¦problemÂ¦ Â¦heartÂ¦ Â¦diseaseÂ¦ Â¦heartÂ¦ Â¦attackÂ¦ Â¦highÂ¦ Â¦ch oles ter olÂ¦ Â¦highÂ¦ Â¦bloodÂ¦ Â¦pressureÂ¦
ğ‹‡ Â¦showÂ¦ Â¦meÂ¦ Â¦onÂ¦ Â¦thisÂ¦ Â¦imageÂ¦ Â¦whereÂ¦ Â¦youÂ¦ Â¦feelÂ¦ Â¦theÂ¦ Â¦painÂ¦
ğ‹‡Â¦allÂ¦ Â¦ofÂ¦ Â¦themÂ¦ Â¦hadÂ¦ Â¦liveÂ¦ Â¦birthÂ¦ Â¦p reg na nc iesÂ¦ Â¦andÂ¦ Â¦noÂ¦ Â¦severeÂ¦ Â¦ne o na talÂ¦ Â¦as phy xi aÂ¦ Â¦wasÂ¦ Â¦observedÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦contrastÂ¦ ,â– Â¦highlyÂ¦ Â¦pathogenicÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦andÂ¦ ğŠ£Â¦mersÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦haveÂ¦ Â¦notÂ¦ Â¦adaptedÂ¦ Â¦toÂ¦ Â¦humansÂ¦ Â¦wellÂ¦ Â¦andÂ¦ Â¦theirÂ¦ Â¦transmissionÂ¦ Â¦withinÂ¦ Â¦humansÂ¦ Â¦cannotÂ¦ Â¦beÂ¦ Â¦s us ta inedÂ¦ .
ğ‹‡Â¦bÂ¦ ' ğ‹‡Â¦coronavirusesÂ¦ Â¦areÂ¦ Â¦aÂ¦ Â¦groupÂ¦ Â¦ofÂ¦ Â¦relatedÂ¦ Â¦virusesÂ¦ Â¦thatÂ¦ Â¦causeÂ¦ Â¦diseasesÂ¦ Â¦inÂ¦ Â¦mammalsÂ¦ Â¦andÂ¦ Â¦birdsÂ¦ .
ğ‹‡Â¦threeÂ¦ Â¦feetÂ¦ Â¦isÂ¦ Â¦consideredÂ¦ Â¦anÂ¦ Â¦appropriateÂ¦ Â¦distanceÂ¦ Â¦forÂ¦ Â¦peopleÂ¦ Â¦toÂ¦ Â¦stayÂ¦ Â¦awayÂ¦ Â¦fromÂ¦ Â¦aÂ¦ Â¦patientÂ¦ .
ğ‹‡Â¦fromÂ¦ Â¦anotherÂ¦ Â¦per sp ectiveÂ¦ ,â– Â¦itÂ¦ Â¦mightÂ¦ Â¦alsoÂ¦ Â¦beÂ¦ Â¦trueÂ¦ Â¦thatÂ¦ Â¦humansÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦wellÂ¦ Â¦adaptedÂ¦ Â¦toÂ¦ Â¦theseÂ¦ Â¦fourÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vsÂ¦ .
ğ‹‡Â¦asÂ¦ Â¦ofÂ¦ ğ‹‡Â¦thursdayÂ¦ ,â– ğ‹‡ Â¦associatedÂ¦ ğ‹‡ Â¦pressÂ¦ Â¦reportedÂ¦ Â¦thereÂ¦ Â¦wereÂ¦ Â¦atÂ¦ Â¦leastÂ¦ Â¦12 6Â¦ , Â¦000Â¦ Â¦casesÂ¦ Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦worldwideÂ¦ ,â– Â¦resultingÂ¦ Â¦inÂ¦ Â¦overÂ¦ Â¦4Â¦ , Â¦600Â¦ Â¦deathsÂ¦ .
ğ‹‡Â¦chinaÂ¦ Â¦hasÂ¦ Â¦alsoÂ¦ Â¦calledÂ¦ Â¦forÂ¦ Â¦theÂ¦ ğŠ£Â¦usÂ¦ğŠ¼ Â¦toÂ¦ Â¦li ftÂ¦ Â¦itsÂ¦ Â¦sa nctionsÂ¦ Â¦offÂ¦ Â¦ofÂ¦ ğ‹‡ Â¦sy riaÂ¦ ,â– ğ‹‡Â¦ve ne z u el aÂ¦ Â¦andÂ¦ ğ‹‡Â¦iranÂ¦ ,â– Â¦whileÂ¦ Â¦reportedlyÂ¦ Â¦sendingÂ¦ Â¦aidÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦l at terÂ¦ Â¦twoÂ¦ Â¦countriesÂ¦ .
ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦causesÂ¦ Â¦severeÂ¦ Â¦respiratoryÂ¦ Â¦infectionÂ¦ Â¦likeÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦andÂ¦ ğŠ£Â¦mersÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ ,â– Â¦presentedÂ¦ Â¦asÂ¦ Â¦feverÂ¦ ,â– Â¦coughÂ¦ Â¦andÂ¦ Â¦d y sp n eaÂ¦ .
ğ‹‡Â¦meanwhileÂ¦ ,â– Â¦theÂ¦ Â¦epidemicÂ¦ Â¦rapidlyÂ¦ Â¦spreadÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦ne igh bo ringÂ¦ Â¦citiesÂ¦ ,â– Â¦provi n cesÂ¦ ,â– Â¦andÂ¦ Â¦countriesÂ¦ .
ğ‹‡ Â¦sportsÂ¦ Â¦eventsÂ¦ Â¦andÂ¦ Â¦seas onsÂ¦ Â¦wereÂ¦ Â¦cancelledÂ¦ . ğ‹‡Â¦onÂ¦ Â¦11Â¦ ğ‹‡Â¦marchÂ¦ ,â– ğ‹‡Â¦trumpÂ¦ Â¦announcedÂ¦ Â¦travelÂ¦ Â¦restrictionsÂ¦ Â¦forÂ¦ Â¦mostÂ¦ Â¦ofÂ¦ ğ‹‡Â¦europeÂ¦ ,â– Â¦exclu dingÂ¦ Â¦theÂ¦ ğ‹‡Â¦unitedÂ¦ ğ‹‡Â¦kingdomÂ¦ ,â– Â¦forÂ¦ Â¦30Â¦ Â¦daysÂ¦ ,â– Â¦effectiveÂ¦ Â¦13Â¦ ğ‹‡Â¦marchÂ¦ .
ğ‹‡Â¦byÂ¦ Â¦13Â¦ ğ‹‡Â¦marchÂ¦ ,â– Â¦moreÂ¦ Â¦thanÂ¦ Â¦for tyÂ¦ Â¦countriesÂ¦ Â¦andÂ¦ Â¦territoriesÂ¦ Â¦hadÂ¦ Â¦reportedÂ¦ Â¦deathsÂ¦ ,â– Â¦onÂ¦ Â¦everyÂ¦ Â¦co ntin entÂ¦ Â¦exceptÂ¦ ğ‹‡Â¦ ant ar ct ic aÂ¦ . ğ‹‡Â¦severalÂ¦ Â¦measuresÂ¦ Â¦areÂ¦ Â¦commonlyÂ¦ Â¦usedÂ¦ Â¦toÂ¦ Â¦qu anti fyÂ¦ Â¦mortalityÂ¦ .
ğ‹‡Â¦i raÂ¦ ğ‹‡Â¦lo ng in iÂ¦ ,â– Â¦etÂ¦ Â¦alÂ¦ .,â– Â¦establishedÂ¦ Â¦aÂ¦ Â¦modelÂ¦ Â¦toÂ¦ Â¦pr edic tÂ¦ Â¦theÂ¦ Â¦outcomeÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦epidemicÂ¦ Â¦andÂ¦ Â¦suggestedÂ¦ Â¦thatÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦couldÂ¦ Â¦infectÂ¦ Â¦twoÂ¦ - Â¦thir dsÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦globalÂ¦ Â¦populationÂ¦ .
ğ‹‡Â¦onÂ¦ Â¦31Â¦ ğ‹‡Â¦decemberÂ¦ Â¦2019Â¦ ,â– Â¦theÂ¦ Â¦outbreakÂ¦ Â¦wasÂ¦ Â¦tracedÂ¦ Â¦toÂ¦ Â¦aÂ¦ Â¦novelÂ¦ Â¦strainÂ¦ Â¦ofÂ¦ Â¦coronavirusÂ¦ ,â– Â¦whichÂ¦ Â¦wasÂ¦ Â¦givenÂ¦ Â¦theÂ¦ Â¦in teri mÂ¦ Â¦nameÂ¦ Â¦2019Â¦ - Â¦n ğ‹‡coğ‹‡vÂ¦ Â¦byÂ¦ Â¦theÂ¦ ğ‹‡Â¦worldÂ¦ ğ‹‡Â¦healthÂ¦ ğ‹‡Â¦organizationÂ¦ â–( ğŠ£Â¦whoÂ¦ğŠ¼ ),â– Â¦laterÂ¦ Â¦re na medÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦byÂ¦ Â¦theÂ¦ ğ‹‡Â¦internationalÂ¦ ğ‹‡Â¦committeeÂ¦ Â¦onÂ¦ ğ‹‡Â¦ta x o no myÂ¦ Â¦ofÂ¦ ğ‹‡ Â¦virusesÂ¦ .
ğ‹‡ Â¦followÂ¦ - Â¦upÂ¦ Â¦im agesÂ¦ Â¦afterÂ¦ Â¦deliveryÂ¦ Â¦showedÂ¦ Â¦noÂ¦ Â¦prog ressionÂ¦ Â¦ofÂ¦ Â¦pneumoniaÂ¦ . ğ‹‡ Â¦mediaÂ¦ Â¦reportsÂ¦ Â¦indicateÂ¦ Â¦thatÂ¦ Â¦overÂ¦ Â¦100Â¦ Â¦womenÂ¦ Â¦withÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦mightÂ¦ Â¦haveÂ¦ Â¦deliveredÂ¦ ,â– Â¦andÂ¦ Â¦inÂ¦ ğ‹‡Â¦marchÂ¦ Â¦2020Â¦ ,â– Â¦noÂ¦ Â¦ma ter nalÂ¦ Â¦deathsÂ¦ Â¦wereÂ¦ Â¦reportedÂ¦ .
ğ‹‡Â¦asÂ¦ Â¦mainlandÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦isÂ¦ Â¦aÂ¦ Â¦majorÂ¦ Â¦economyÂ¦ Â¦andÂ¦ Â¦manufacturingÂ¦ Â¦hu bÂ¦ ,â– Â¦theÂ¦ Â¦viralÂ¦ Â¦outbreakÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦seenÂ¦ Â¦toÂ¦ Â¦p oseÂ¦ Â¦aÂ¦ Â¦majorÂ¦ Â¦dest a bi lizingÂ¦ Â¦threatÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦globalÂ¦ Â¦economyÂ¦ .
ğ‹‡Â¦inÂ¦ ğ‹‡Â¦chinaÂ¦ ,â– Â¦estimatesÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦deathÂ¦ - Â¦toÂ¦ - Â¦caseÂ¦ Â¦ratioÂ¦ Â¦decreasedÂ¦ Â¦fromÂ¦ Â¦17Â¦ . Â¦3Â¦ %â–( Â¦forÂ¦ Â¦thoseÂ¦ Â¦withÂ¦ Â¦symptomÂ¦ Â¦onsetÂ¦ Â¦1Â¦ â€“ Â¦10Â¦ ğ‹‡Â¦januaryÂ¦ Â¦2020Â¦ )â– Â¦toÂ¦ Â¦0Â¦ . Â¦7Â¦ %â–( Â¦forÂ¦ Â¦thoseÂ¦ Â¦withÂ¦ Â¦symptomÂ¦ Â¦onsetÂ¦ Â¦afterÂ¦ Â¦1Â¦ ğ‹‡Â¦februaryÂ¦ Â¦2020Â¦ ). ğ‹‡Â¦otherÂ¦ Â¦measuresÂ¦ Â¦includeÂ¦ Â¦theÂ¦ Â¦caseÂ¦ Â¦fatalityÂ¦ Â¦rateÂ¦ â–( ğŠ£Â¦c f rÂ¦ğŠ¼ ),â– Â¦whichÂ¦ Â¦reflectsÂ¦ Â¦theÂ¦ Â¦percentÂ¦ Â¦ofÂ¦ Â¦diagnosedÂ¦ Â¦peopleÂ¦ Â¦whoÂ¦ Â¦dieÂ¦ Â¦fromÂ¦ Â¦aÂ¦ Â¦diseaseÂ¦ ,â– Â¦andÂ¦ Â¦theÂ¦ Â¦infectionÂ¦ Â¦fatalityÂ¦ Â¦rateÂ¦ â–( ğŠ£Â¦i f rÂ¦ğŠ¼ ),â– Â¦whichÂ¦ Â¦reflectsÂ¦ Â¦theÂ¦ Â¦percentÂ¦ Â¦ofÂ¦ Â¦infectedÂ¦ â–( Â¦diagnosedÂ¦ Â¦andÂ¦ Â¦un dia gn osedÂ¦ )â– Â¦whoÂ¦ Â¦dieÂ¦ Â¦fromÂ¦ Â¦aÂ¦ Â¦diseaseÂ¦ .
ğ‹‡Â¦currentlyÂ¦ ,â– Â¦dueÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦lackÂ¦ Â¦ofÂ¦ Â¦effectiveÂ¦ Â¦andÂ¦ Â¦specificÂ¦ Â¦therapyÂ¦ Â¦forÂ¦ ğŠ£ Â¦covidÂ¦ - Â¦19Â¦ ,â– Â¦t c mÂ¦ğŠ¼ Â¦hasÂ¦ Â¦becomeÂ¦ Â¦oneÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦majorÂ¦ Â¦alternativeÂ¦ Â¦treatmentsÂ¦ Â¦forÂ¦ Â¦patientsÂ¦ Â¦withÂ¦ Â¦lightÂ¦ Â¦toÂ¦ Â¦moderateÂ¦ Â¦symptomsÂ¦ Â¦orÂ¦ Â¦forÂ¦ Â¦thoseÂ¦ Â¦whoÂ¦ Â¦haveÂ¦ Â¦recoveredÂ¦ Â¦fromÂ¦ Â¦severeÂ¦ Â¦stagesÂ¦ .
ğ‹‡Â¦thailandÂ¦ Â¦isÂ¦ Â¦usingÂ¦ Â¦anÂ¦ Â¦appÂ¦ Â¦andÂ¦ ğŠ£ Â¦si mÂ¦ğŠ¼ Â¦cardsÂ¦ Â¦forÂ¦ Â¦allÂ¦ Â¦travelersÂ¦ Â¦toÂ¦ Â¦en forceÂ¦ Â¦theirÂ¦ Â¦quarantineÂ¦ .
ğ‹‡Â¦moreÂ¦ Â¦thanÂ¦ Â¦30Â¦ %â– Â¦ofÂ¦ Â¦patientsÂ¦ Â¦presentÂ¦ Â¦withÂ¦ Â¦g as trointestinalÂ¦ Â¦symptomsÂ¦ ,â– Â¦suchÂ¦ Â¦asÂ¦ Â¦diarrheaÂ¦ Â¦andÂ¦ Â¦vomitingÂ¦ .
ğ‹‡ Â¦misinformationÂ¦ Â¦aboutÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦hasÂ¦ Â¦spreadÂ¦ Â¦onlineÂ¦ ,â– Â¦andÂ¦ Â¦thereÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦incidentsÂ¦ Â¦ofÂ¦ Â¦ x en ophobiaÂ¦ Â¦andÂ¦ Â¦discriminationÂ¦ Â¦againstÂ¦ ğ‹‡Â¦chineseÂ¦ Â¦peopleÂ¦ ,â– Â¦otherÂ¦ Â¦peopleÂ¦ Â¦ofÂ¦ ğ‹‡Â¦eastÂ¦ Â¦andÂ¦ ğ‹‡Â¦s ou th eastÂ¦ ğ‹‡Â¦asianÂ¦ Â¦desc entÂ¦ Â¦andÂ¦ Â¦appe ar anceÂ¦ ,â– Â¦andÂ¦ Â¦othersÂ¦ Â¦fromÂ¦ Â¦areasÂ¦ Â¦withÂ¦ Â¦significantÂ¦ Â¦virusÂ¦ Â¦casesÂ¦ .
ğ‹‡ Â¦adap tiveÂ¦ Â¦design sÂ¦ Â¦withinÂ¦ Â¦ongoingÂ¦ ğ‹‡Â¦phaseÂ¦ ğŠ£Â¦i iÂ¦ - Â¦i i iÂ¦ğŠ¼ Â¦clinicalÂ¦ Â¦trialsÂ¦ Â¦onÂ¦ Â¦candidateÂ¦ Â¦therap e ut icsÂ¦ Â¦mayÂ¦ Â¦sh ort enÂ¦ Â¦trialÂ¦ Â¦d ur ationsÂ¦ Â¦andÂ¦ Â¦useÂ¦ Â¦fewerÂ¦ Â¦sub j ectsÂ¦ ,â– Â¦possiblyÂ¦ Â¦expe di tingÂ¦ Â¦decisionsÂ¦ Â¦forÂ¦ Â¦earlyÂ¦ Â¦t erm inationÂ¦ Â¦orÂ¦ Â¦successÂ¦ ,â– Â¦andÂ¦ Â¦coordin atingÂ¦ Â¦designÂ¦ Â¦changesÂ¦ Â¦forÂ¦ Â¦aÂ¦ Â¦specificÂ¦ Â¦trialÂ¦ Â¦acrossÂ¦ Â¦itsÂ¦ Â¦internationalÂ¦ Â¦locationsÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦upperÂ¦ Â¦estimateÂ¦ Â¦ofÂ¦ Â¦thisÂ¦ Â¦rangeÂ¦ Â¦isÂ¦ Â¦consistentÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦resultsÂ¦ Â¦fromÂ¦ Â¦theÂ¦ Â¦firstÂ¦ Â¦ra nd omÂ¦ Â¦testingÂ¦ Â¦forÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦inÂ¦ ğ‹‡Â¦germanyÂ¦ ,â– Â¦andÂ¦ Â¦aÂ¦ Â¦statisticalÂ¦ Â¦studyÂ¦ Â¦analy singÂ¦ Â¦theÂ¦ Â¦impactÂ¦ Â¦ofÂ¦ Â¦testingÂ¦ Â¦onÂ¦ ğŠ£Â¦c f rÂ¦ğŠ¼ Â¦estimatesÂ¦ .
ğ‹‡Â¦otherÂ¦ Â¦countriesÂ¦ Â¦alsoÂ¦ Â¦adoptedÂ¦ Â¦aÂ¦ Â¦varietyÂ¦ Â¦ofÂ¦ Â¦measuresÂ¦ Â¦ai medÂ¦ Â¦atÂ¦ Â¦limitingÂ¦ Â¦theÂ¦ Â¦spreadÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦virusÂ¦ .
ğ‹‡Â¦someÂ¦ Â¦scientistsÂ¦ Â¦ch oseÂ¦ Â¦toÂ¦ Â¦shareÂ¦ Â¦theirÂ¦ Â¦resultsÂ¦ Â¦quicklyÂ¦ Â¦onÂ¦ Â¦pre pr intÂ¦ Â¦ser versÂ¦ Â¦suchÂ¦ Â¦asÂ¦ Â¦bio ğ‹‡ r xi vÂ¦ .
ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦casesÂ¦ Â¦inÂ¦ ğŠ£Â¦euÂ¦ / Â¦eeaÂ¦ğŠ¼ Â¦countriesÂ¦ Â¦andÂ¦ Â¦theÂ¦ ğŠ£Â¦ukÂ¦ğŠ¼
ğ‹‡Â¦bothÂ¦ Â¦drugsÂ¦ Â¦haveÂ¦ Â¦extensiveÂ¦ Â¦inter actionsÂ¦ Â¦withÂ¦ Â¦presc rip tionÂ¦ Â¦drugsÂ¦ ,â– Â¦affectingÂ¦ Â¦theÂ¦ Â¦therapeuticÂ¦ Â¦doseÂ¦ Â¦andÂ¦ Â¦diseaseÂ¦ Â¦mitigationÂ¦ .
ğ‹‡Â¦althoughÂ¦ Â¦batsÂ¦ Â¦haveÂ¦ Â¦manyÂ¦ Â¦featuresÂ¦ Â¦thatÂ¦ Â¦fav oursÂ¦ Â¦theÂ¦ Â¦spreadingÂ¦ Â¦ofÂ¦ Â¦virusesÂ¦ ,â– Â¦theÂ¦ Â¦chanceÂ¦ Â¦forÂ¦ Â¦humansÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦inÂ¦ Â¦contactÂ¦ Â¦withÂ¦ Â¦batsÂ¦ Â¦andÂ¦ Â¦otherÂ¦ Â¦wi ld li f eÂ¦ Â¦speciesÂ¦ Â¦canÂ¦ Â¦beÂ¦ Â¦mini mizedÂ¦ Â¦ifÂ¦ Â¦peopleÂ¦ Â¦areÂ¦ Â¦ed uc atedÂ¦ Â¦toÂ¦ Â¦stayÂ¦ Â¦awayÂ¦ Â¦fromÂ¦ Â¦themÂ¦ .
ğ‹‡Â¦finallyÂ¦ ,â– Â¦al pac aÂ¦ Â¦alphaÂ¦ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦hasÂ¦ Â¦notÂ¦ Â¦beenÂ¦ Â¦foundÂ¦ Â¦inÂ¦ Â¦fer alÂ¦ Â¦animalsÂ¦ .
ğ‹‡Â¦manyÂ¦ Â¦d io ce sesÂ¦ Â¦haveÂ¦ Â¦recommendedÂ¦ Â¦olderÂ¦ ğ‹‡Â¦christ i ansÂ¦ Â¦toÂ¦ Â¦stayÂ¦ Â¦atÂ¦ Â¦homeÂ¦ Â¦ratherÂ¦ Â¦thanÂ¦ Â¦attendingÂ¦ ğ‹‡ Â¦massÂ¦ Â¦onÂ¦ ğ‹‡Â¦s und aysÂ¦ ;â– Â¦someÂ¦ Â¦ch ur chesÂ¦ Â¦haveÂ¦ Â¦madeÂ¦ Â¦ch ur chÂ¦ Â¦servicesÂ¦ Â¦availableÂ¦ Â¦viaÂ¦ Â¦radi oÂ¦ ,â– Â¦onlineÂ¦ Â¦liveÂ¦ Â¦st rea mingÂ¦ Â¦orÂ¦ Â¦tele vi sionÂ¦ Â¦whileÂ¦ Â¦othersÂ¦ Â¦areÂ¦ Â¦offeringÂ¦ Â¦driveÂ¦ - Â¦inÂ¦ Â¦worshipÂ¦ .
ğ‹‡ Â¦tenÂ¦ Â¦yearsÂ¦ Â¦laterÂ¦ ,â– Â¦theÂ¦ ğ‹‡Â¦middleÂ¦ ğ‹‡Â¦eastÂ¦ Â¦respiratoryÂ¦ Â¦syndromeÂ¦ â–( ğŠ£Â¦mersÂ¦ğŠ¼ )â– Â¦outbreakÂ¦ Â¦resultedÂ¦ Â¦inÂ¦ Â¦aÂ¦ Â¦persistentÂ¦ Â¦epidemicÂ¦ Â¦inÂ¦ Â¦theÂ¦ ğ‹‡Â¦ ara bi anÂ¦ ğ‹‡Â¦pe ni ns ul aÂ¦ Â¦withÂ¦ Â¦spo rad icÂ¦ Â¦spreadingÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦restÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦worldÂ¦ .
ğ‹‡Â¦onlyÂ¦ Â¦fewÂ¦ Â¦reportsÂ¦ Â¦ofÂ¦ Â¦laboratoryÂ¦ - Â¦confirmedÂ¦ Â¦asymptomaticÂ¦ Â¦casesÂ¦ Â¦existÂ¦ ,â– Â¦butÂ¦ Â¦asymptomaticÂ¦ Â¦transmissionÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦identifiedÂ¦ Â¦byÂ¦ Â¦someÂ¦ Â¦countriesÂ¦ Â¦duringÂ¦ Â¦contactÂ¦ Â¦tracingÂ¦ Â¦inves ti gationsÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦hostÂ¦ Â¦rib oso meÂ¦ Â¦trans l atesÂ¦ Â¦theÂ¦ Â¦initialÂ¦ Â¦over l appingÂ¦ Â¦openÂ¦ Â¦readingÂ¦ Â¦fra meÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦genomeÂ¦ Â¦andÂ¦ Â¦formsÂ¦ Â¦aÂ¦ Â¦longÂ¦ Â¦pol yp roteinÂ¦ .
ğ‹‡Â¦onÂ¦ Â¦29Â¦ ğ‹‡Â¦marchÂ¦ Â¦itÂ¦ Â¦wasÂ¦ Â¦reportedÂ¦ Â¦thatÂ¦ Â¦beginningÂ¦ Â¦1Â¦ ğ‹‡Â¦aprilÂ¦ Â¦allÂ¦ Â¦newÂ¦ Â¦over se asÂ¦ Â¦ar ri valsÂ¦ Â¦willÂ¦ Â¦beÂ¦ Â¦quarantinedÂ¦ Â¦forÂ¦ Â¦twoÂ¦ Â¦weeksÂ¦ .
ğ‹‡Â¦mostÂ¦ Â¦novelÂ¦ Â¦drugÂ¦ Â¦candidatesÂ¦ â–( ğŠ£Â¦n ce ğŠ¼sÂ¦ )â– Â¦fa ilÂ¦ Â¦duringÂ¦ Â¦drugÂ¦ Â¦developmentÂ¦ ,â– Â¦eitherÂ¦ Â¦becauseÂ¦ Â¦theyÂ¦ Â¦haveÂ¦ Â¦un ac ce pt ableÂ¦ Â¦tox icityÂ¦ Â¦orÂ¦ Â¦becauseÂ¦ Â¦theyÂ¦ Â¦simplyÂ¦ Â¦doÂ¦ Â¦notÂ¦ Â¦pro veÂ¦ Â¦efficacyÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦targetedÂ¦ Â¦diseaseÂ¦ ,â– Â¦asÂ¦ Â¦shownÂ¦ Â¦inÂ¦ ğ‹‡Â¦phaseÂ¦ ğŠ£Â¦i iÂ¦ - Â¦i i iÂ¦ğŠ¼ Â¦clinicalÂ¦ Â¦trialsÂ¦ .
ğŠ£Â¦euÂ¦ ğŠ¼ Â¦foreignÂ¦ Â¦policyÂ¦ Â¦chiefÂ¦ ğ‹‡Â¦jo se pÂ¦ ğ‹‡Â¦b orr ellÂ¦ Â¦warnedÂ¦ Â¦thatÂ¦ Â¦thereÂ¦ Â¦isÂ¦ â–" Â¦aÂ¦ Â¦ge oÂ¦ - Â¦politicalÂ¦ Â¦comp on entÂ¦ Â¦includingÂ¦ Â¦aÂ¦ Â¦struggleÂ¦ Â¦forÂ¦ Â¦influenceÂ¦ Â¦throughÂ¦ Â¦sp in ningÂ¦ Â¦andÂ¦ Â¦theÂ¦ â–' Â¦politicsÂ¦ Â¦ofÂ¦ Â¦gener os ityÂ¦ ' ".
ğ‹‡Â¦althoughÂ¦ Â¦severalÂ¦ Â¦countriesÂ¦ Â¦useÂ¦ Â¦chloroquineÂ¦ Â¦orÂ¦ Â¦hydroxychloroquineÂ¦ Â¦forÂ¦ Â¦treatmentÂ¦ Â¦ofÂ¦ Â¦personsÂ¦ Â¦hospitalizedÂ¦ Â¦withÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ ,â– Â¦asÂ¦ Â¦ofÂ¦ ğ‹‡Â¦marchÂ¦ Â¦2020Â¦ Â¦theÂ¦ Â¦drugÂ¦ Â¦hasÂ¦ Â¦notÂ¦ Â¦beenÂ¦ Â¦form allyÂ¦ Â¦approvedÂ¦ Â¦throughÂ¦ Â¦clinicalÂ¦ Â¦trialsÂ¦ Â¦inÂ¦ Â¦theÂ¦ ğ‹‡Â¦unitedÂ¦ ğ‹‡Â¦statesÂ¦ .
ğ‹‡Â¦ne v ert he lessÂ¦ ,â– Â¦respiratoryÂ¦ Â¦d ys f un ctionÂ¦ Â¦andÂ¦ Â¦failureÂ¦ Â¦areÂ¦ Â¦theÂ¦ Â¦majorÂ¦ Â¦threatÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦patientsÂ¦ Â¦andÂ¦ Â¦theÂ¦ Â¦majorÂ¦ Â¦causeÂ¦ Â¦ofÂ¦ Â¦deathÂ¦ .
ğ‹‡Â¦firstÂ¦ ,â– Â¦humansÂ¦ Â¦butÂ¦ Â¦notÂ¦ Â¦al pac asÂ¦ Â¦mightÂ¦ Â¦haveÂ¦ Â¦contactÂ¦ Â¦withÂ¦ Â¦batsÂ¦ Â¦inÂ¦ Â¦aÂ¦ Â¦sharedÂ¦ Â¦e co logicalÂ¦ Â¦ ni ch eÂ¦ .
ğ‹‡Â¦itÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦reportedÂ¦ Â¦thatÂ¦ Â¦aÂ¦ Â¦batÂ¦ ğ‹‡Â¦coğ‹‡vÂ¦ Â¦ter medÂ¦ ğŠ£ Â¦ar cğŠ¼oğ‹‡vÂ¦ . Â¦2Â¦ â–( ğ‹‡Â¦app al ac hi anÂ¦ ğ‹‡Â¦r id geÂ¦ ğ‹‡Â¦coğ‹‡vÂ¦ )â– Â¦detectedÂ¦ Â¦inÂ¦ ğ‹‡Â¦northÂ¦ ğ‹‡Â¦americanÂ¦ Â¦tri co lo redÂ¦ Â¦batÂ¦ Â¦dis pla yedÂ¦ Â¦closeÂ¦ Â¦rela tion shipÂ¦ Â¦withÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - ğŠ£Â¦nlğŠ¼63Â¦ .
ğ‹‡ Â¦virologicalÂ¦ Â¦surveillanceÂ¦ Â¦isÂ¦ Â¦doneÂ¦ Â¦byÂ¦ Â¦usingÂ¦ Â¦molecularÂ¦ Â¦testsÂ¦ Â¦forÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ .
ğ‹‡Â¦thereÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦supportÂ¦ Â¦forÂ¦ Â¦theÂ¦ ğ‹‡Â¦chineseÂ¦ ,â– Â¦bothÂ¦ Â¦onÂ¦ Â¦andÂ¦ Â¦off lineÂ¦ ,â– Â¦andÂ¦ Â¦towardsÂ¦ Â¦thoseÂ¦ Â¦inÂ¦ Â¦virusÂ¦ - Â¦st ric kenÂ¦ Â¦areasÂ¦ .
ğ‹‡ Â¦virusesÂ¦ Â¦canÂ¦ Â¦alsoÂ¦ Â¦infectÂ¦ Â¦anÂ¦ Â¦individualÂ¦ Â¦throughÂ¦ Â¦theÂ¦ Â¦eyesÂ¦ .
ğ‹‡Â¦onÂ¦ Â¦20Â¦ ğ‹‡Â¦marchÂ¦ ,â– Â¦theÂ¦ ğ‹‡Â¦unitedÂ¦ ğ‹‡Â¦statesÂ¦ Â¦beganÂ¦ Â¦toÂ¦ Â¦par ti allyÂ¦ Â¦withdra walÂ¦ Â¦itsÂ¦ Â¦tr oo psÂ¦ Â¦fromÂ¦ ğ‹‡Â¦ira qÂ¦ Â¦dueÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦pandemicÂ¦ .
ğ‹‡Â¦asÂ¦ Â¦aÂ¦ Â¦resultÂ¦ ,â– Â¦theÂ¦ Â¦governmentÂ¦ Â¦receivedÂ¦ Â¦criticismÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦per ce i vedÂ¦ Â¦lackÂ¦ Â¦ofÂ¦ Â¦paceÂ¦ Â¦andÂ¦ Â¦inte nsityÂ¦ Â¦inÂ¦ Â¦itsÂ¦ Â¦responseÂ¦ Â¦toÂ¦ Â¦concernsÂ¦ Â¦facedÂ¦ Â¦byÂ¦ Â¦theÂ¦ Â¦publicÂ¦ . ğ‹‡Â¦onÂ¦ Â¦16Â¦ ğ‹‡Â¦marchÂ¦ ,â– ğ‹‡Â¦primeÂ¦ ğ‹‡Â¦ministerÂ¦ ğ‹‡Â¦bo risÂ¦ ğ‹‡Â¦johnsonÂ¦ Â¦madeÂ¦ Â¦anÂ¦ Â¦announcementÂ¦ Â¦adv isingÂ¦ Â¦againstÂ¦ Â¦allÂ¦ Â¦nonÂ¦ - Â¦essentialÂ¦ Â¦travelÂ¦ Â¦andÂ¦ Â¦socialÂ¦ Â¦contactÂ¦ ,â– Â¦sugg estingÂ¦ Â¦peopleÂ¦ Â¦workÂ¦ Â¦fromÂ¦ Â¦homeÂ¦ Â¦whereÂ¦ Â¦possibleÂ¦ Â¦andÂ¦ Â¦avoidÂ¦ Â¦v en u esÂ¦ Â¦suchÂ¦ Â¦asÂ¦ Â¦pu bsÂ¦ ,â– Â¦restaurantsÂ¦ ,â– Â¦andÂ¦ Â¦th ea tr esÂ¦ .
ğ‹‡Â¦onÂ¦ Â¦11Â¦ ğ‹‡Â¦marchÂ¦ Â¦2020Â¦ ,â– ğŠ£Â¦whoÂ¦ğŠ¼ Â¦charac teri zedÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦asÂ¦ Â¦aÂ¦ Â¦pandemicÂ¦ .
ğ‹‡Â¦forÂ¦ Â¦exampleÂ¦ ,â– ğ‹‡Â¦be i j ingÂ¦ Â¦hasÂ¦ Â¦imposedÂ¦ Â¦aÂ¦ Â¦14Â¦ - Â¦dayÂ¦ Â¦mandatoryÂ¦ Â¦quarantineÂ¦ Â¦forÂ¦ Â¦allÂ¦ Â¦internationalÂ¦ Â¦travellersÂ¦ Â¦enteringÂ¦ Â¦theÂ¦ Â¦cityÂ¦ . ğ‹‡Â¦onÂ¦ Â¦23Â¦ ğ‹‡Â¦marchÂ¦ ,â– Â¦mainlandÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦onlyÂ¦ Â¦oneÂ¦ Â¦caseÂ¦ Â¦hadÂ¦ Â¦transmittedÂ¦ Â¦d om es ticallyÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦fiveÂ¦ Â¦daysÂ¦ Â¦priorÂ¦ ,â– Â¦inÂ¦ Â¦thisÂ¦ Â¦instanceÂ¦ Â¦viaÂ¦ Â¦aÂ¦ Â¦trave llerÂ¦ Â¦returningÂ¦ Â¦toÂ¦ ğ‹‡Â¦gu a ng z ho uÂ¦ Â¦fromÂ¦ ğ‹‡Â¦i st an b u lÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦theÂ¦ Â¦pastÂ¦ Â¦deca desÂ¦ ,â– Â¦sevenÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vsÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦identifiedÂ¦ .
ğ‹‡ Â¦batÂ¦ Â¦alphaÂ¦ - ğ‹‡Â¦coğ‹‡vsÂ¦ Â¦closelyÂ¦ Â¦relatedÂ¦ Â¦toÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - Â¦229ğ‹‡eÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦foundÂ¦ .
ğ‹‡Â¦howeverÂ¦ ,â– Â¦onÂ¦ Â¦12Â¦ ğ‹‡Â¦mayÂ¦ Â¦201 3Â¦ ,â– Â¦aÂ¦ Â¦caseÂ¦ Â¦ofÂ¦ Â¦humanÂ¦ - Â¦toÂ¦ - Â¦humanÂ¦ Â¦transmissionÂ¦ Â¦inÂ¦ ğ‹‡Â¦franceÂ¦ Â¦wasÂ¦ Â¦confirmedÂ¦ Â¦byÂ¦ Â¦theÂ¦ ğ‹‡Â¦fr en chÂ¦ ğ‹‡Â¦ministryÂ¦ Â¦ofÂ¦ ğ‹‡Â¦socialÂ¦ ğ‹‡Â¦affairsÂ¦ Â¦andÂ¦ ğ‹‡Â¦healthÂ¦ .
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦italianÂ¦ ğ‹‡Â¦ rad iologicalÂ¦ ğ‹‡Â¦societyÂ¦ Â¦isÂ¦ Â¦com pi lingÂ¦ Â¦anÂ¦ Â¦internationalÂ¦ Â¦onlineÂ¦ Â¦d at ab aseÂ¦ Â¦ofÂ¦ Â¦imagingÂ¦ Â¦findingsÂ¦ Â¦forÂ¦ Â¦confirmedÂ¦ Â¦casesÂ¦ .
ğ‹‡Â¦onÂ¦ Â¦28Â¦ ğ‹‡Â¦februaryÂ¦ ,â– ğ‹‡Â¦sc opeÂ¦ ğ‹‡Â¦rat ingsÂ¦ ğ‹‡Â¦g mb ğ‹‡ hÂ¦ Â¦affi r medÂ¦ ğ‹‡Â¦chinaÂ¦ ' Â¦sÂ¦ Â¦so ve re i g nÂ¦ Â¦cred itÂ¦ Â¦r atingÂ¦ ,â– Â¦butÂ¦ Â¦maintainedÂ¦ Â¦aÂ¦ ğ‹‡ Â¦negativeÂ¦ ğ‹‡ Â¦out l ookÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦epidemicÂ¦ Â¦co in ci dedÂ¦ Â¦withÂ¦ Â¦theÂ¦ ğ‹‡Â¦ch un yu nÂ¦ ,â– Â¦aÂ¦ Â¦majorÂ¦ Â¦travelÂ¦ Â¦seasonÂ¦ Â¦associatedÂ¦ Â¦withÂ¦ Â¦theÂ¦ ğ‹‡Â¦chineseÂ¦ ğ‹‡Â¦newÂ¦ ğ‹‡Â¦yearÂ¦ Â¦holidayÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦m il est oneÂ¦ Â¦cameÂ¦ Â¦theÂ¦ Â¦sameÂ¦ Â¦dayÂ¦ ğ‹‡Â¦mala w iÂ¦ Â¦confirmedÂ¦ Â¦itsÂ¦ Â¦firstÂ¦ Â¦coronavirusÂ¦ Â¦infectionsÂ¦ Â¦andÂ¦ ğ‹‡Â¦z am bi aÂ¦ Â¦hadÂ¦ Â¦itsÂ¦ Â¦firstÂ¦ Â¦coronavirusÂ¦ - Â¦relatedÂ¦ Â¦deathÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦virusÂ¦ Â¦thatÂ¦ Â¦causedÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ Â¦isÂ¦ Â¦knownÂ¦ Â¦asÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ ,â– Â¦aÂ¦ Â¦new lyÂ¦ Â¦discoveredÂ¦ Â¦virusÂ¦ Â¦closelyÂ¦ Â¦relatedÂ¦ Â¦toÂ¦ Â¦batÂ¦ Â¦coronavirusesÂ¦ ,â– Â¦pangolinÂ¦ Â¦coronavirusesÂ¦ ,â– Â¦andÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ . ğ‹‡Â¦theÂ¦ Â¦earliestÂ¦ Â¦knownÂ¦ Â¦personÂ¦ Â¦withÂ¦ Â¦symptomsÂ¦ Â¦wasÂ¦ Â¦laterÂ¦ Â¦discoveredÂ¦ Â¦toÂ¦ Â¦haveÂ¦ Â¦fa ll enÂ¦ Â¦illÂ¦ Â¦onÂ¦ Â¦1Â¦ ğ‹‡Â¦decemberÂ¦ Â¦2019Â¦ ,â– Â¦andÂ¦ Â¦thatÂ¦ Â¦personÂ¦ Â¦didÂ¦ Â¦notÂ¦ Â¦haveÂ¦ Â¦vi sibleÂ¦ Â¦conn ectionsÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦laterÂ¦ Â¦w etÂ¦ Â¦marketÂ¦ Â¦clusterÂ¦ .
ğ‹‡Â¦thusÂ¦ ,â– Â¦theyÂ¦ Â¦areÂ¦ Â¦traditionalÂ¦ Â¦mar kersÂ¦ Â¦forÂ¦ Â¦heartÂ¦ Â¦orÂ¦ Â¦liverÂ¦ Â¦d ys f u nctionsÂ¦ .
ğ‹‡Â¦inÂ¦ ğ‹‡Â¦japanÂ¦ ,â– Â¦theÂ¦ Â¦h ash ta gÂ¦ â–# ğ‹‡ Â¦chi ne se ğ‹‡ do nt ğ‹‡co me ğ‹‡ to ğ‹‡ j ap anÂ¦ Â¦tre ndedÂ¦ Â¦onÂ¦ ğ‹‡Â¦twitterÂ¦ .
ğ‹‡Â¦besidesÂ¦ ,â– Â¦thereÂ¦ Â¦areÂ¦ Â¦moreÂ¦ Â¦andÂ¦ Â¦moreÂ¦ Â¦evidenceÂ¦ Â¦thatÂ¦ Â¦remin dÂ¦ Â¦usÂ¦ Â¦toÂ¦ Â¦cau tionÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦ at yp icalÂ¦ Â¦symptomaticÂ¦ Â¦andÂ¦ Â¦asymptomaticÂ¦ Â¦patientsÂ¦ .
ğ‹‡ Â¦subsequentÂ¦ Â¦ser op re va le nceÂ¦ Â¦inves ti gationsÂ¦ Â¦indicatedÂ¦ Â¦thatÂ¦ Â¦animalÂ¦ Â¦tradersÂ¦ Â¦hadÂ¦ Â¦aÂ¦ Â¦higherÂ¦ Â¦prevalenceÂ¦ Â¦ofÂ¦ Â¦antiÂ¦ - ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ ğ‹‡Â¦igğ‹‡ gÂ¦ Â¦comparedÂ¦ Â¦withÂ¦ Â¦thatÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦generalÂ¦ Â¦populationÂ¦ .
ğ‹‡Â¦onÂ¦ Â¦31Â¦ ğ‹‡Â¦decemberÂ¦ Â¦2019Â¦ ,â– Â¦aÂ¦ Â¦clusterÂ¦ Â¦ofÂ¦ Â¦pneumoniaÂ¦ Â¦casesÂ¦ Â¦ofÂ¦ Â¦unknownÂ¦ Â¦a e t iologyÂ¦ Â¦wasÂ¦ Â¦reportedÂ¦ Â¦inÂ¦ ğ‹‡Â¦wuhanÂ¦ ,â– ğ‹‡Â¦hubeiÂ¦ ğ‹‡ Â¦provinceÂ¦ ,â– ğ‹‡Â¦chinaÂ¦ .
ğ‹‡Â¦theÂ¦ ğŠ£Â¦whoÂ¦ğŠ¼ Â¦notedÂ¦ Â¦theÂ¦ Â¦contrastÂ¦ Â¦betweenÂ¦ Â¦theÂ¦ Â¦200 2Â¦ â€“ Â¦20 04Â¦ ğŠ£Â¦sarsÂ¦ğŠ¼ Â¦outbreakÂ¦ ,â– Â¦whereÂ¦ ğ‹‡Â¦chineseÂ¦ Â¦authoritiesÂ¦ Â¦wereÂ¦ Â¦accusedÂ¦ Â¦ofÂ¦ Â¦s ec r ec yÂ¦ Â¦thatÂ¦ Â¦impe dedÂ¦ Â¦preventionÂ¦ Â¦andÂ¦ Â¦containmentÂ¦ Â¦effortsÂ¦ ,â– Â¦andÂ¦ Â¦theÂ¦ Â¦currentÂ¦ Â¦crisisÂ¦ Â¦whereÂ¦ Â¦theÂ¦ Â¦centralÂ¦ Â¦governmentÂ¦ â–" Â¦hasÂ¦ Â¦providedÂ¦ Â¦regularÂ¦ Â¦updatesÂ¦ Â¦toÂ¦ Â¦avoidÂ¦ Â¦panicÂ¦ Â¦aheadÂ¦ Â¦ofÂ¦ ğ‹‡Â¦l un arÂ¦ ğ‹‡Â¦newÂ¦ ğ‹‡Â¦yearÂ¦ Â¦holidaysÂ¦ ".
ğ‹‡Â¦howeverÂ¦ ,â– Â¦thereÂ¦ Â¦areÂ¦ Â¦someÂ¦ Â¦remar k ableÂ¦ Â¦differencesÂ¦ Â¦betweenÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦andÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ ,â– Â¦whichÂ¦ Â¦areÂ¦ Â¦essentialÂ¦ Â¦forÂ¦ Â¦containingÂ¦ Â¦theÂ¦ Â¦epidemicÂ¦ Â¦andÂ¦ Â¦treatingÂ¦ Â¦theÂ¦ Â¦patientsÂ¦ .
ğ‹‡Â¦patientsÂ¦ Â¦oftenÂ¦ Â¦developÂ¦ Â¦anÂ¦ Â¦ at yp icalÂ¦ Â¦pneumoniaÂ¦ ,â– Â¦acuteÂ¦ Â¦lungÂ¦ Â¦injuryÂ¦ ,â– Â¦andÂ¦ Â¦acuteÂ¦ Â¦respiratoryÂ¦ Â¦distressÂ¦ Â¦syndromeÂ¦ â–( ğŠ£Â¦ardsÂ¦ğŠ¼ ).
ğ‹‡Â¦ phy lo gen ticallyÂ¦ ,â– Â¦mo useÂ¦ Â¦he p atitisÂ¦ Â¦virusÂ¦ â–( ğ‹‡Â¦mur ineÂ¦ Â¦coronavirusÂ¦ ),â– Â¦whichÂ¦ Â¦infectsÂ¦ Â¦theÂ¦ Â¦mo useÂ¦ ' Â¦sÂ¦ Â¦liverÂ¦ Â¦andÂ¦ Â¦theÂ¦ Â¦centralÂ¦ Â¦ ner v ousÂ¦ Â¦systemÂ¦ ,â– Â¦isÂ¦ Â¦relatedÂ¦ Â¦toÂ¦ Â¦humanÂ¦ Â¦coronavirusÂ¦ ğŠ£Â¦ocğŠ¼43Â¦ Â¦andÂ¦ Â¦b ov ineÂ¦ Â¦coronavirusÂ¦ .
ğ‹‡ Â¦onlineÂ¦ ,â– Â¦numerousÂ¦ Â¦coronavirusÂ¦ - Â¦the medÂ¦ ğ‹‡ Â¦internetÂ¦ Â¦mem esÂ¦ Â¦haveÂ¦ Â¦spreadÂ¦ Â¦asÂ¦ Â¦manyÂ¦ Â¦turnÂ¦ Â¦toÂ¦ Â¦hu mo urÂ¦ Â¦andÂ¦ Â¦dist ra ctionÂ¦ Â¦am idÂ¦ Â¦unc ertain tyÂ¦ .
ğ‹‡Â¦someÂ¦ Â¦ofÂ¦ Â¦thoseÂ¦ Â¦infectedÂ¦ Â¦mayÂ¦ Â¦beÂ¦ Â¦asymptomaticÂ¦ ,â– Â¦withÂ¦ Â¦noÂ¦ Â¦clinicalÂ¦ Â¦symptomsÂ¦ Â¦butÂ¦ Â¦withÂ¦ Â¦testÂ¦ Â¦resultsÂ¦ Â¦thatÂ¦ Â¦confir mÂ¦ Â¦infectionÂ¦ ,â– Â¦soÂ¦ Â¦researchersÂ¦ Â¦haveÂ¦ Â¦issuedÂ¦ Â¦adviceÂ¦ Â¦thatÂ¦ Â¦thoseÂ¦ Â¦withÂ¦ Â¦closeÂ¦ Â¦contactÂ¦ Â¦toÂ¦ Â¦confirmedÂ¦ Â¦infectedÂ¦ Â¦peopleÂ¦ Â¦shouldÂ¦ Â¦beÂ¦ Â¦closelyÂ¦ Â¦monitoredÂ¦ Â¦andÂ¦ Â¦examinedÂ¦ Â¦toÂ¦ Â¦ruleÂ¦ Â¦outÂ¦ Â¦infectionÂ¦ .
ğ‹‡Â¦andÂ¦ Â¦alongÂ¦ Â¦withÂ¦ Â¦aÂ¦ Â¦feverÂ¦
ğ‹‡ Â¦ledÂ¦ Â¦byÂ¦ Â¦theÂ¦ ğ‹‡Â¦b illÂ¦ Â¦andÂ¦ ğ‹‡Â¦me lin daÂ¦ ğ‹‡Â¦g atesÂ¦ ğ‹‡Â¦foundationÂ¦ Â¦withÂ¦ Â¦part nersÂ¦ Â¦inv estingÂ¦ ğŠ£Â¦usÂ¦ğŠ¼ $ Â¦12 5Â¦ Â¦millionÂ¦ Â¦andÂ¦ Â¦coordin atingÂ¦ Â¦withÂ¦ Â¦theÂ¦ ğ‹‡Â¦worldÂ¦ ğ‹‡Â¦healthÂ¦ ğ‹‡Â¦organizationÂ¦ ,â– Â¦theÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ ğ‹‡ Â¦therap e ut icsÂ¦ ğ‹‡ Â¦accel er atorÂ¦ Â¦beganÂ¦ Â¦inÂ¦ ğ‹‡Â¦marchÂ¦ ,â– Â¦f ac il it atingÂ¦ Â¦drugÂ¦ Â¦developmentÂ¦ Â¦researchersÂ¦ Â¦toÂ¦ Â¦rapidlyÂ¦ Â¦identifyÂ¦ ,â– Â¦assessÂ¦ ,â– Â¦developÂ¦ ,â– Â¦andÂ¦ Â¦scaleÂ¦ Â¦upÂ¦ Â¦potentialÂ¦ Â¦treatmentsÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦numberÂ¦ Â¦ofÂ¦ Â¦trueÂ¦ Â¦f at alitiesÂ¦ Â¦fromÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦mayÂ¦ Â¦beÂ¦ Â¦muchÂ¦ Â¦higherÂ¦ ,â– Â¦asÂ¦ Â¦itÂ¦ Â¦mayÂ¦ Â¦notÂ¦ Â¦includeÂ¦ Â¦peopleÂ¦ Â¦whoÂ¦ Â¦dieÂ¦ Â¦withoutÂ¦ Â¦testingÂ¦ â–-â– Â¦eÂ¦ . Â¦gÂ¦ .â– Â¦atÂ¦ Â¦homeÂ¦ ,â– Â¦inÂ¦ Â¦nursingÂ¦ Â¦homesÂ¦ ,â– Â¦etcÂ¦ .
ğ‹‡Â¦c ertain lyÂ¦ ,â– Â¦thisÂ¦ Â¦isÂ¦ Â¦notÂ¦ Â¦aÂ¦ Â¦goodÂ¦ Â¦signÂ¦ Â¦ofÂ¦ ğ‹‡Â¦europeanÂ¦ Â¦sol id arityÂ¦ ."
ğ‹‡Â¦aÂ¦ Â¦medianÂ¦ Â¦costÂ¦ Â¦estimateÂ¦ Â¦ofÂ¦ Â¦2015Â¦ - Â¦16Â¦ Â¦trialsÂ¦ Â¦forÂ¦ Â¦developmentÂ¦ Â¦ofÂ¦ Â¦10Â¦ Â¦antiÂ¦ - Â¦cancerÂ¦ Â¦drugsÂ¦ Â¦wasÂ¦ â–$ Â¦6 4 8Â¦ Â¦millionÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦additionÂ¦ ,â– Â¦givenÂ¦ Â¦theÂ¦ Â¦therapeuticÂ¦ Â¦effectsÂ¦ ,â– Â¦someÂ¦ Â¦dis ad v ant agesÂ¦ Â¦associatedÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦plasmaÂ¦ Â¦shouldÂ¦ Â¦beÂ¦ Â¦consideredÂ¦ Â¦carefullyÂ¦ .
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦campaignÂ¦ Â¦forÂ¦ ğ‹‡ Â¦nucle arÂ¦ ğ‹‡ Â¦dis ar ma mentÂ¦ ' Â¦sÂ¦ Â¦generalÂ¦ Â¦secretaryÂ¦ ğ‹‡Â¦k ateÂ¦ ğ‹‡Â¦h ud s onÂ¦ Â¦criticizedÂ¦ Â¦theÂ¦ ğ‹‡Â¦def en derÂ¦ Â¦2020Â¦ Â¦exerciseÂ¦ :â–" ğ‹‡Â¦inÂ¦ Â¦theÂ¦ Â¦currentÂ¦ Â¦publicÂ¦ - Â¦healthÂ¦ Â¦crisisÂ¦ ,â– Â¦itÂ¦ Â¦j e op ardi zesÂ¦ Â¦theÂ¦ Â¦livesÂ¦ Â¦notÂ¦ Â¦onlyÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦tr oo psÂ¦ Â¦fromÂ¦ Â¦theÂ¦ ğŠ£Â¦usÂ¦ğŠ¼ Â¦andÂ¦ Â¦theÂ¦ Â¦manyÂ¦ ğ‹‡Â¦europeanÂ¦ Â¦countriesÂ¦ Â¦participatingÂ¦ Â¦butÂ¦ Â¦theÂ¦ Â¦in hab it antsÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦countriesÂ¦ Â¦inÂ¦ Â¦whichÂ¦ Â¦theyÂ¦ Â¦areÂ¦ Â¦operatingÂ¦ ." ğ‹‡Â¦theÂ¦ ğ‹‡Â¦ira ni anÂ¦ Â¦governmentÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦heavilyÂ¦ Â¦affectedÂ¦ Â¦byÂ¦ Â¦theÂ¦ Â¦virusÂ¦ ,â– Â¦withÂ¦ Â¦aroundÂ¦ Â¦twoÂ¦ Â¦do zenÂ¦ Â¦p arli a mentÂ¦ Â¦membersÂ¦ Â¦infectedÂ¦ Â¦asÂ¦ Â¦wellÂ¦ Â¦asÂ¦ Â¦fif teenÂ¦ Â¦otherÂ¦ Â¦currentÂ¦ Â¦orÂ¦ Â¦formerÂ¦ Â¦politicalÂ¦ Â¦figuresÂ¦ .
ğ‹‡Â¦asÂ¦ Â¦aÂ¦ Â¦commonÂ¦ Â¦practiceÂ¦ ,â– Â¦individualsÂ¦ Â¦exposedÂ¦ Â¦toÂ¦ ,â– Â¦orÂ¦ Â¦infectedÂ¦ Â¦byÂ¦ ,â– Â¦theÂ¦ Â¦virusÂ¦ Â¦areÂ¦ Â¦usuallyÂ¦ Â¦requiredÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦quarantinedÂ¦ Â¦forÂ¦ Â¦14Â¦ Â¦daysÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦vi ru le nceÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦co me b ackÂ¦ Â¦wouldÂ¦ Â¦dependÂ¦ Â¦onÂ¦ Â¦herdÂ¦ Â¦immunityÂ¦ Â¦andÂ¦ Â¦theÂ¦ Â¦extentÂ¦ Â¦ofÂ¦ Â¦mutationÂ¦ .
ğ‹‡Â¦howeverÂ¦ ,â– Â¦theyÂ¦ Â¦areÂ¦ Â¦e q uallyÂ¦ Â¦closelyÂ¦ Â¦relatedÂ¦ Â¦toÂ¦ ğ‹‡Â¦ra ğŠ£ t g ğŠ¼1 3Â¦ Â¦withÂ¦ Â¦aboutÂ¦ Â¦90Â¦ %â– Â¦identityÂ¦ Â¦atÂ¦ Â¦theÂ¦ Â¦levelÂ¦ Â¦ofÂ¦ Â¦nucleotideÂ¦ Â¦sequenceÂ¦ .
ğ‹‡Â¦someÂ¦ ğ‹‡Â¦chineseÂ¦ Â¦studentsÂ¦ Â¦atÂ¦ ğ‹‡Â¦americanÂ¦ Â¦universitiesÂ¦ Â¦joinedÂ¦ Â¦togetherÂ¦ Â¦toÂ¦ Â¦helpÂ¦ Â¦sendÂ¦ Â¦aidÂ¦ Â¦toÂ¦ Â¦virusÂ¦ - Â¦st ric kenÂ¦ Â¦partsÂ¦ Â¦ofÂ¦ ğ‹‡Â¦chinaÂ¦ ,â– Â¦withÂ¦ Â¦aÂ¦ Â¦jointÂ¦ Â¦groupÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦greaterÂ¦ ğ‹‡ Â¦chi ca goÂ¦ Â¦areaÂ¦ Â¦reportedlyÂ¦ Â¦managingÂ¦ Â¦toÂ¦ Â¦sendÂ¦ Â¦50Â¦ , Â¦000Â¦ ğ‹‡Â¦n95Â¦ Â¦masksÂ¦ Â¦toÂ¦ Â¦hospitalsÂ¦ Â¦inÂ¦ Â¦theÂ¦ ğ‹‡Â¦hubeiÂ¦ Â¦provinceÂ¦ Â¦onÂ¦ Â¦30Â¦ ğ‹‡Â¦januaryÂ¦ . ğ‹‡Â¦theÂ¦ Â¦human it ari anÂ¦ Â¦aidÂ¦ Â¦organizationÂ¦ ğ‹‡Â¦directÂ¦ ğ‹‡ Â¦reliefÂ¦ ,â– Â¦inÂ¦ Â¦coordin ationÂ¦ Â¦withÂ¦ ğ‹‡Â¦f ed ğ‹‡ e xÂ¦ ,â– Â¦sentÂ¦ Â¦200Â¦ , Â¦000Â¦ Â¦faceÂ¦ Â¦masksÂ¦ Â¦alongÂ¦ Â¦withÂ¦ Â¦otherÂ¦ Â¦personalÂ¦ Â¦protectiveÂ¦ Â¦equipmentÂ¦ ,â– Â¦includingÂ¦ Â¦glovesÂ¦ Â¦andÂ¦ Â¦g ownsÂ¦ ,â– Â¦byÂ¦ Â¦emergencyÂ¦ Â¦air li ftÂ¦ Â¦toÂ¦ Â¦theÂ¦ ğ‹‡Â¦wuhanÂ¦ ğ‹‡Â¦unionÂ¦ ğ‹‡Â¦hospitalÂ¦ Â¦byÂ¦ Â¦30Â¦ ğ‹‡Â¦januaryÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦humansÂ¦ ,â– Â¦coronavirusesÂ¦ Â¦causeÂ¦ Â¦respiratoryÂ¦ Â¦tractÂ¦ Â¦infectionsÂ¦ Â¦thatÂ¦ Â¦canÂ¦ Â¦rangeÂ¦ Â¦fromÂ¦ Â¦mildÂ¦ Â¦toÂ¦ Â¦lethalÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦emergenceÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦inÂ¦ Â¦centralÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦atÂ¦ Â¦theÂ¦ Â¦endÂ¦ Â¦ofÂ¦ Â¦2019Â¦ Â¦hasÂ¦ Â¦thr ustedÂ¦ ğ‹‡Â¦coğ‹‡vsÂ¦ Â¦intoÂ¦ Â¦theÂ¦ Â¦sp ot lightÂ¦ Â¦againÂ¦ Â¦andÂ¦ Â¦sur pri sedÂ¦ Â¦usÂ¦ Â¦withÂ¦ Â¦itsÂ¦ Â¦highÂ¦ Â¦transmis sibilityÂ¦ Â¦butÂ¦ Â¦reducedÂ¦ Â¦patho gen icityÂ¦ Â¦comparedÂ¦ Â¦toÂ¦ Â¦itsÂ¦ Â¦s is terÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ .
ğ‹‡Â¦forÂ¦ ğŠ£Â¦mersÂ¦ğŠ¼ ,â– Â¦basedÂ¦ Â¦onÂ¦ Â¦aÂ¦ Â¦ dem ograph icÂ¦ Â¦studyÂ¦ Â¦inÂ¦ ğ‹‡Â¦juneÂ¦ Â¦2012Â¦ ,â– Â¦theÂ¦ Â¦mortalityÂ¦ Â¦wasÂ¦ Â¦37Â¦ %â– Â¦ofÂ¦ Â¦2Â¦ , Â¦4 94Â¦ Â¦confirmedÂ¦ Â¦casesÂ¦ .
ğ‹‡Â¦someÂ¦ Â¦researchersÂ¦ Â¦haveÂ¦ Â¦suggestedÂ¦ Â¦theÂ¦ ğ‹‡Â¦hu an anÂ¦ ğ‹‡Â¦s ea f oodÂ¦ ğ‹‡Â¦wh oles aleÂ¦ ğ‹‡ Â¦marketÂ¦ Â¦mayÂ¦ Â¦notÂ¦ Â¦beÂ¦ Â¦theÂ¦ Â¦originalÂ¦ Â¦sourceÂ¦ Â¦ofÂ¦ Â¦viralÂ¦ Â¦transmissionÂ¦ Â¦toÂ¦ Â¦humansÂ¦ . ğ‹‡Â¦asÂ¦ Â¦ofÂ¦ Â¦17Â¦ ğ‹‡Â¦aprilÂ¦ Â¦2020Â¦ ,â– Â¦thereÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦atÂ¦ Â¦leastÂ¦ Â¦15 3Â¦ , Â¦8 22Â¦ Â¦confirmedÂ¦ Â¦deathsÂ¦ Â¦andÂ¦ Â¦moreÂ¦ Â¦thanÂ¦ Â¦2Â¦ , Â¦24 0Â¦ , Â¦19 1Â¦ Â¦confirmedÂ¦ Â¦casesÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦pneumoniaÂ¦ Â¦pandemicÂ¦ .
ğ‹‡Â¦im por ta ntlyÂ¦ ,â– Â¦weÂ¦ Â¦compareÂ¦ Â¦andÂ¦ Â¦contrastÂ¦ Â¦theÂ¦ Â¦differentÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vsÂ¦ Â¦fromÂ¦ Â¦aÂ¦ Â¦per sp ectiveÂ¦ Â¦ofÂ¦ Â¦virusÂ¦ Â¦evolutionÂ¦ Â¦andÂ¦ Â¦genomeÂ¦ Â¦recombinationÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦di vers ityÂ¦ Â¦ofÂ¦ Â¦batÂ¦ ğ‹‡Â¦coğ‹‡vsÂ¦ Â¦providesÂ¦ Â¦a mp leÂ¦ Â¦opportun itiesÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦emergenceÂ¦ Â¦ofÂ¦ Â¦novelÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vsÂ¦ .
ğ‹‡Â¦secondÂ¦ ,â– Â¦pangolinsÂ¦ Â¦couldÂ¦ Â¦beÂ¦ Â¦oneÂ¦ Â¦ofÂ¦ Â¦intermediateÂ¦ Â¦ampli fyingÂ¦ Â¦hostÂ¦ Â¦toÂ¦ Â¦whichÂ¦ Â¦aÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ - Â¦relatedÂ¦ Â¦virusÂ¦ Â¦hadÂ¦ Â¦beenÂ¦ Â¦new lyÂ¦ Â¦introducedÂ¦ .
ğ‹‡Â¦forÂ¦ Â¦manyÂ¦ Â¦yearsÂ¦ ,â– Â¦theÂ¦ Â¦fourÂ¦ Â¦communityÂ¦ - Â¦acquiredÂ¦ ğ‹‡Â¦coğ‹‡vsÂ¦ Â¦circ ul ateÂ¦ Â¦inÂ¦ Â¦humanÂ¦ Â¦popul ationsÂ¦ ,â– Â¦tri gg eringÂ¦ Â¦commonÂ¦ Â¦coldÂ¦ Â¦inÂ¦ Â¦immuno comp e t entÂ¦ Â¦sub j ectsÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦clinicalÂ¦ Â¦featuresÂ¦ Â¦ofÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - ğŠ£Â¦ocğŠ¼43Â¦ Â¦infectionÂ¦ Â¦appearÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦similarÂ¦ Â¦toÂ¦ Â¦thoseÂ¦ Â¦causedÂ¦ Â¦byÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - Â¦229ğ‹‡eÂ¦ ,â– Â¦whichÂ¦ Â¦areÂ¦ Â¦s ym pt om aticallyÂ¦ Â¦in di st in gu ish ableÂ¦ Â¦fromÂ¦ Â¦infectionÂ¦ Â¦withÂ¦ Â¦otherÂ¦ Â¦respiratoryÂ¦ Â¦tractÂ¦ Â¦pathogensÂ¦ Â¦suchÂ¦ Â¦asÂ¦ Â¦influenzaÂ¦ ğ‹‡Â¦aÂ¦ Â¦virusesÂ¦ Â¦andÂ¦ Â¦r hi no vi ru sesÂ¦ .
ğ‹‡Â¦inÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ Â¦patientsÂ¦ ,â– Â¦itÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦demonstratedÂ¦ Â¦thatÂ¦ Â¦feverÂ¦ â–( Â¦99Â¦ % - Â¦100Â¦ %),â– Â¦dryÂ¦ Â¦coughÂ¦ â–( Â¦29Â¦ % - Â¦75Â¦ %),â– Â¦d y sp n eaÂ¦ â–( Â¦40Â¦ % - Â¦42Â¦ %),â– Â¦diarrheaÂ¦ â–( Â¦20Â¦ - Â¦25Â¦ %),â– Â¦andÂ¦ Â¦soreÂ¦ Â¦throatÂ¦ â–( Â¦13Â¦ - Â¦25Â¦ %)â– Â¦wereÂ¦ Â¦theÂ¦ Â¦majorÂ¦ Â¦symptomsÂ¦ Â¦andÂ¦ Â¦ventilationÂ¦ Â¦supportÂ¦ Â¦wasÂ¦ Â¦requiredÂ¦ Â¦forÂ¦ Â¦approximatelyÂ¦ Â¦14Â¦ % - Â¦20Â¦ %â– Â¦ofÂ¦ Â¦theÂ¦ Â¦patientsÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦viralÂ¦ ğŠ£Â¦rnaÂ¦ğŠ¼ Â¦genomeÂ¦ Â¦isÂ¦ Â¦releasedÂ¦ Â¦intoÂ¦ Â¦theÂ¦ Â¦cyto pla s mÂ¦ ;â– Â¦afterÂ¦ Â¦replicationÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦viralÂ¦ Â¦genomeÂ¦ ,â– Â¦genom icÂ¦ ğŠ£Â¦rnaÂ¦ğŠ¼ Â¦accompan iedÂ¦ Â¦byÂ¦ Â¦envelopeÂ¦ Â¦glyc op ro te insÂ¦ Â¦andÂ¦ Â¦nucle oc ap s idÂ¦ Â¦proteinsÂ¦ Â¦formsÂ¦ Â¦vir ionÂ¦ - Â¦containingÂ¦ Â¦v es ic lesÂ¦ ,â– Â¦whichÂ¦ Â¦thenÂ¦ Â¦f useÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦plasmaÂ¦ Â¦membraneÂ¦ Â¦toÂ¦ Â¦releaseÂ¦ Â¦theÂ¦ Â¦virusÂ¦ .
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦unitedÂ¦ ğ‹‡Â¦statesÂ¦ 'â– ğ‹‡Â¦nationalÂ¦ ğ‹‡Â¦instituteÂ¦ Â¦ofÂ¦ ğ‹‡ Â¦all er g yÂ¦ Â¦andÂ¦ ğ‹‡Â¦infectiousÂ¦ ğ‹‡Â¦diseaseÂ¦ ' Â¦sÂ¦ Â¦directorÂ¦ ,â– ğ‹‡Â¦drÂ¦ .â– ğ‹‡Â¦an th onyÂ¦ ğ‹‡Â¦fa uc iÂ¦ ,â– Â¦saidÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ ,â–" Â¦bott omÂ¦ Â¦lineÂ¦ ,â– Â¦itÂ¦ ' Â¦sÂ¦ Â¦goingÂ¦ Â¦toÂ¦ Â¦getÂ¦ Â¦worseÂ¦ ."
ğ‹‡Â¦anÂ¦ Â¦animalÂ¦ Â¦ser vesÂ¦ Â¦asÂ¦ Â¦theÂ¦ Â¦ev olu tionaryÂ¦ Â¦hostÂ¦ Â¦ofÂ¦ Â¦anÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ Â¦ifÂ¦ Â¦itÂ¦ Â¦h arb oursÂ¦ Â¦aÂ¦ Â¦closelyÂ¦ Â¦relatedÂ¦ Â¦anc est orÂ¦ Â¦sharingÂ¦ Â¦highÂ¦ Â¦homologyÂ¦ Â¦atÂ¦ Â¦theÂ¦ Â¦levelÂ¦ Â¦ofÂ¦ Â¦nucleotideÂ¦ Â¦sequenceÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦n ationÂ¦ ' Â¦sÂ¦ Â¦healthÂ¦ Â¦agencyÂ¦ Â¦reportedÂ¦ Â¦aÂ¦ Â¦significantÂ¦ Â¦increaseÂ¦ Â¦inÂ¦ Â¦confirmedÂ¦ Â¦casesÂ¦ Â¦onÂ¦ Â¦20Â¦ ğ‹‡Â¦februaryÂ¦ ,â– Â¦largelyÂ¦ Â¦att rib u tedÂ¦ Â¦toÂ¦ Â¦aÂ¦ Â¦gatheringÂ¦ Â¦inÂ¦ ğ‹‡Â¦da e g uÂ¦ Â¦ofÂ¦ Â¦aÂ¦ Â¦newÂ¦ Â¦religiousÂ¦ Â¦movementÂ¦ Â¦knownÂ¦ Â¦asÂ¦ Â¦theÂ¦ ğ‹‡Â¦shi nc he on jiÂ¦ ğ‹‡Â¦ch ur chÂ¦ Â¦ofÂ¦ ğ‹‡Â¦j es usÂ¦ .
ğ‹‡ Â¦emergenceÂ¦ Â¦ofÂ¦ Â¦novelÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vsÂ¦ :â– Â¦backÂ¦ Â¦toÂ¦ Â¦groundÂ¦ Â¦z er oÂ¦
ğ‹‡ Â¦tracingÂ¦ Â¦theÂ¦ Â¦zoonoticÂ¦ Â¦originsÂ¦ Â¦ofÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vsÂ¦ Â¦providesÂ¦ Â¦aÂ¦ Â¦fra me workÂ¦ Â¦toÂ¦ Â¦understandÂ¦ Â¦theÂ¦ Â¦naturalÂ¦ Â¦historyÂ¦ ,â– Â¦dri vingÂ¦ Â¦forceÂ¦ Â¦andÂ¦ Â¦restrictionÂ¦ Â¦factorsÂ¦ Â¦ofÂ¦ Â¦speciesÂ¦ Â¦j um pingÂ¦ .
ğ‹‡Â¦thereÂ¦ ,â– Â¦theÂ¦ ğ‹‡Â¦mÂ¦ Â¦proteinsÂ¦ Â¦directÂ¦ Â¦mostÂ¦ Â¦proteinÂ¦ - Â¦proteinÂ¦ Â¦inter actionsÂ¦ Â¦requiredÂ¦ Â¦forÂ¦ Â¦assemblyÂ¦ Â¦ofÂ¦ Â¦virusesÂ¦ Â¦followingÂ¦ Â¦itsÂ¦ Â¦bindingÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦nucle oc ap s idÂ¦ .
ğ‹‡Â¦sinceÂ¦ Â¦thenÂ¦ ,â– Â¦moreÂ¦ Â¦knowledgeÂ¦ Â¦wasÂ¦ Â¦acc um ulatedÂ¦ Â¦throughÂ¦ Â¦extensiveÂ¦ Â¦studiesÂ¦ Â¦onÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - Â¦229ğ‹‡eÂ¦ Â¦andÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - ğŠ£Â¦ocğŠ¼43Â¦ ,â– Â¦bothÂ¦ Â¦ofÂ¦ Â¦whichÂ¦ Â¦causeÂ¦ Â¦selfÂ¦ - Â¦limitingÂ¦ Â¦symptomsÂ¦ .
ğ‹‡Â¦despiteÂ¦ Â¦thisÂ¦ ,â– Â¦itÂ¦ Â¦appearsÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦hadÂ¦ Â¦troubleÂ¦ Â¦spreadingÂ¦ Â¦fromÂ¦ Â¦humanÂ¦ Â¦toÂ¦ Â¦humanÂ¦ ,â– Â¦asÂ¦ Â¦mostÂ¦ Â¦individualsÂ¦ Â¦whoÂ¦ Â¦areÂ¦ Â¦infectedÂ¦ Â¦doÂ¦ Â¦notÂ¦ Â¦trans mitÂ¦ Â¦theÂ¦ Â¦virusÂ¦ .
ğ‹‡Â¦itÂ¦ Â¦isÂ¦ Â¦aÂ¦ Â¦pressureÂ¦ Â¦likeÂ¦ Â¦chestÂ¦ Â¦painÂ¦
ğ‹‡ Â¦humansÂ¦ Â¦contr actÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦throughÂ¦ Â¦b ut ch eringÂ¦ Â¦andÂ¦ Â¦con su mp tionÂ¦ Â¦ofÂ¦ Â¦gameÂ¦ Â¦meatÂ¦ .
ğ‹‡Â¦whileÂ¦ Â¦thereÂ¦ Â¦areÂ¦ Â¦concernsÂ¦ Â¦itÂ¦ Â¦mayÂ¦ Â¦spreadÂ¦ Â¦byÂ¦ Â¦fa e cesÂ¦ ,â– Â¦thisÂ¦ Â¦riskÂ¦ Â¦isÂ¦ Â¦believedÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦lowÂ¦ .
ğ‹‡Â¦thereforeÂ¦ ,â– Â¦buildingÂ¦ Â¦aÂ¦ Â¦progn osisÂ¦ Â¦modelÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦diseaseÂ¦ Â¦isÂ¦ Â¦essentialÂ¦ Â¦forÂ¦ Â¦healthÂ¦ - Â¦careÂ¦ Â¦agenciesÂ¦ Â¦toÂ¦ Â¦prioritizeÂ¦ Â¦theirÂ¦ Â¦servicesÂ¦ ,â– Â¦especiallyÂ¦ Â¦inÂ¦ Â¦res our ceÂ¦ - Â¦con st ra inedÂ¦ Â¦areasÂ¦ .
ğ‹‡Â¦doesÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦alsoÂ¦ Â¦b in dÂ¦ ğŠ£Â¦aceğŠ¼2Â¦ - Â¦exp ressingÂ¦ Â¦cellsÂ¦ Â¦inÂ¦ Â¦otherÂ¦ Â¦organsÂ¦ ?
ğ‹‡Â¦thisÂ¦ Â¦isÂ¦ Â¦doctorÂ¦ Â¦por terÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦emergencyÂ¦ Â¦roomÂ¦ Â¦tri ageÂ¦ Â¦centerÂ¦
ğ‹‡Â¦inÂ¦ Â¦theÂ¦ ğ‹‡Â¦uÂ¦ . ğ‹‡Â¦sÂ¦ .,â– Â¦theÂ¦ ğŠ£Â¦cdcÂ¦ğŠ¼ Â¦recommendsÂ¦ Â¦wearingÂ¦ Â¦nonÂ¦ - Â¦medicalÂ¦ Â¦faceÂ¦ Â¦maskÂ¦ Â¦madeÂ¦ Â¦outÂ¦ Â¦ofÂ¦ Â¦clothÂ¦ . ğ‹‡Â¦chinaÂ¦ Â¦hasÂ¦ Â¦specificallyÂ¦ Â¦recommendedÂ¦ Â¦theÂ¦ Â¦useÂ¦ Â¦ofÂ¦ Â¦disp os ableÂ¦ Â¦medicalÂ¦ Â¦masksÂ¦ Â¦byÂ¦ Â¦healthyÂ¦ Â¦membersÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦publicÂ¦ ,â– Â¦particularlyÂ¦ Â¦whenÂ¦ Â¦comingÂ¦ Â¦intoÂ¦ Â¦closeÂ¦ Â¦contactÂ¦ â–( Â¦1Â¦ Â¦met reÂ¦ â–( Â¦3Â¦ Â¦ ftÂ¦ )â– Â¦orÂ¦ Â¦lessÂ¦ )â– Â¦withÂ¦ Â¦otherÂ¦ Â¦peopleÂ¦ .
ğ‹‡Â¦l on ge v ityÂ¦ ,â– Â¦den se lyÂ¦ Â¦p ackedÂ¦ Â¦col on iesÂ¦ ,â– Â¦closeÂ¦ Â¦socialÂ¦ Â¦interactionÂ¦ Â¦andÂ¦ Â¦strongÂ¦ Â¦abilityÂ¦ Â¦toÂ¦ Â¦f lyÂ¦ Â¦areÂ¦ Â¦allÂ¦ Â¦fav our ableÂ¦ Â¦conditionsÂ¦ Â¦forÂ¦ Â¦batsÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦anÂ¦ Â¦i de alÂ¦ â–' Â¦virusÂ¦ Â¦spreaderÂ¦ '.
ğ‹‡ Â¦pneumoniaÂ¦ Â¦isÂ¦ Â¦oneÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦mostÂ¦ Â¦severeÂ¦ Â¦symptomsÂ¦ Â¦andÂ¦ Â¦canÂ¦ Â¦progressÂ¦ Â¦rapidlyÂ¦ Â¦toÂ¦ Â¦acuteÂ¦ Â¦respiratoryÂ¦ Â¦distressÂ¦ Â¦syndromeÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦lateÂ¦ ğ‹‡Â¦januaryÂ¦ ,â– Â¦theÂ¦ ğ‹‡Â¦chineseÂ¦ Â¦governmentÂ¦ Â¦launchedÂ¦ Â¦aÂ¦ Â¦radi calÂ¦ Â¦campaignÂ¦ Â¦laterÂ¦ Â¦describedÂ¦ Â¦byÂ¦ Â¦theÂ¦ ğ‹‡Â¦chineseÂ¦ ğ‹‡Â¦comm un istÂ¦ ğ‹‡Â¦partyÂ¦ Â¦generalÂ¦ Â¦secretaryÂ¦ ğ‹‡Â¦ x iÂ¦ ğ‹‡Â¦j in pingÂ¦ Â¦asÂ¦ Â¦aÂ¦ â–" Â¦peopleÂ¦ ' Â¦sÂ¦ Â¦warÂ¦ "â– Â¦toÂ¦ Â¦containÂ¦ Â¦theÂ¦ Â¦spreadÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦virusÂ¦ .
ğ‹‡ Â¦prot es tersÂ¦ Â¦inÂ¦ ğ‹‡Â¦u k ra ineÂ¦ Â¦att ackedÂ¦ Â¦busesÂ¦ Â¦carryingÂ¦ ğ‹‡Â¦u kr ai ni anÂ¦ Â¦andÂ¦ Â¦foreignÂ¦ Â¦evacu eesÂ¦ Â¦fromÂ¦ ğ‹‡Â¦wuhanÂ¦ Â¦toÂ¦ ğ‹‡Â¦no viÂ¦ ğ‹‡Â¦san z h aryÂ¦ .
ğ‹‡ Â¦yesterdayÂ¦ ,â– ğ‹‡Â¦bangladeshÂ¦ Â¦hasÂ¦ Â¦confirmedÂ¦ Â¦fiveÂ¦ Â¦newÂ¦ Â¦deathsÂ¦ Â¦dueÂ¦ Â¦toÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦onÂ¦ Â¦theÂ¦ Â¦dayÂ¦ .
ğ‹‡Â¦thisÂ¦ Â¦demandÂ¦ Â¦hasÂ¦ Â¦ledÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦increaseÂ¦ Â¦inÂ¦ Â¦pricesÂ¦ Â¦ofÂ¦ Â¦upÂ¦ Â¦toÂ¦ Â¦twentyÂ¦ Â¦timesÂ¦ Â¦theÂ¦ Â¦normalÂ¦ Â¦priceÂ¦ Â¦andÂ¦ Â¦alsoÂ¦ Â¦indu cedÂ¦ Â¦delaysÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦supplyÂ¦ Â¦ofÂ¦ Â¦medicalÂ¦ Â¦itemsÂ¦ Â¦forÂ¦ Â¦fourÂ¦ Â¦toÂ¦ Â¦sixÂ¦ Â¦monthsÂ¦ .
ğ‹‡Â¦whenÂ¦ Â¦itÂ¦ Â¦isÂ¦ Â¦noÂ¦ Â¦longerÂ¦ Â¦possibleÂ¦ Â¦toÂ¦ Â¦containÂ¦ Â¦theÂ¦ Â¦spreadÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦diseaseÂ¦ ,â– Â¦effortsÂ¦ Â¦thenÂ¦ Â¦moveÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦mitigationÂ¦ Â¦stageÂ¦ :â– Â¦measuresÂ¦ Â¦areÂ¦ Â¦takenÂ¦ Â¦toÂ¦ Â¦slowÂ¦ Â¦theÂ¦ Â¦spreadÂ¦ Â¦andÂ¦ Â¦mi tig ateÂ¦ Â¦itsÂ¦ Â¦effectsÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦healthcareÂ¦ Â¦systemÂ¦ Â¦andÂ¦ Â¦societyÂ¦ .
ğ‹‡ Â¦beginningÂ¦ Â¦onÂ¦ Â¦15Â¦ ğ‹‡Â¦marchÂ¦ ,â– Â¦manyÂ¦ Â¦businessesÂ¦ Â¦closedÂ¦ Â¦orÂ¦ Â¦reducedÂ¦ Â¦hoursÂ¦ Â¦throughoutÂ¦ Â¦theÂ¦ ğ‹‡Â¦uÂ¦ . ğ‹‡Â¦sÂ¦ .â– Â¦toÂ¦ Â¦tryÂ¦ Â¦toÂ¦ Â¦reduceÂ¦ Â¦theÂ¦ Â¦spreadÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦virusÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦numberÂ¦ Â¦variesÂ¦ Â¦byÂ¦ Â¦regionÂ¦ .
ğ‹‡Â¦pro gen yÂ¦ Â¦virusesÂ¦ Â¦areÂ¦ Â¦thenÂ¦ Â¦releasedÂ¦ Â¦fromÂ¦ Â¦theÂ¦ Â¦hostÂ¦ Â¦cellÂ¦ Â¦byÂ¦ Â¦ex ocy t osisÂ¦ Â¦throughÂ¦ Â¦secret oryÂ¦ Â¦v es ic lesÂ¦ .
ğ‹‡Â¦presidentÂ¦ ğ‹‡Â¦h ass anÂ¦ ğ‹‡Â¦r ou h aniÂ¦ Â¦saidÂ¦ Â¦onÂ¦ Â¦26Â¦ ğ‹‡Â¦februaryÂ¦ Â¦2020Â¦ Â¦thatÂ¦ Â¦thereÂ¦ Â¦wereÂ¦ Â¦noÂ¦ Â¦plansÂ¦ Â¦toÂ¦ Â¦quarantineÂ¦ Â¦areasÂ¦ Â¦affectedÂ¦ Â¦byÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ ,â– Â¦andÂ¦ Â¦onlyÂ¦ Â¦individualsÂ¦ Â¦wouldÂ¦ Â¦beÂ¦ Â¦quarantinedÂ¦ .
ğ‹‡Â¦thereforeÂ¦ ,â– Â¦infectedÂ¦ Â¦patientsÂ¦ Â¦atÂ¦ Â¦theÂ¦ Â¦earlyÂ¦ Â¦phaseÂ¦ Â¦orÂ¦ Â¦incubationÂ¦ Â¦periodÂ¦ Â¦canÂ¦ Â¦produceÂ¦ Â¦aÂ¦ Â¦largeÂ¦ Â¦amountÂ¦ Â¦ofÂ¦ Â¦virusÂ¦ Â¦duringÂ¦ Â¦dailyÂ¦ Â¦activitiesÂ¦ ,â– Â¦causingÂ¦ Â¦greatÂ¦ Â¦difficultyÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦controlÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦epidemicÂ¦ .
ğ‹‡Â¦ phylogeneticÂ¦ Â¦evidenceÂ¦ Â¦ofÂ¦ Â¦naturalÂ¦ Â¦recombinationÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦foundÂ¦ Â¦inÂ¦ Â¦bothÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - ğŠ£Â¦hkuğŠ¼1Â¦ Â¦andÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - ğŠ£Â¦ocğŠ¼43Â¦ ,â– Â¦asÂ¦ Â¦wellÂ¦ Â¦asÂ¦ Â¦animalÂ¦ ğ‹‡Â¦coğ‹‡vsÂ¦ Â¦suchÂ¦ Â¦asÂ¦ Â¦batÂ¦ ğŠ£Â¦s lÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦andÂ¦ Â¦b at ğ‹‡coğ‹‡vÂ¦ - ğŠ£Â¦hkuğŠ¼ 9Â¦ .
ğ‹‡Â¦theÂ¦ Â¦highÂ¦ Â¦failureÂ¦ Â¦ratesÂ¦ Â¦associatedÂ¦ Â¦withÂ¦ Â¦pharmaceuticalÂ¦ Â¦developmentÂ¦ Â¦areÂ¦ Â¦referredÂ¦ Â¦toÂ¦ Â¦asÂ¦ Â¦anÂ¦ â–" Â¦attr itionÂ¦ Â¦rateÂ¦ ",â– Â¦requiringÂ¦ Â¦decisionsÂ¦ Â¦duringÂ¦ Â¦theÂ¦ Â¦earlyÂ¦ Â¦stagesÂ¦ Â¦ofÂ¦ Â¦drugÂ¦ Â¦developmentÂ¦ Â¦toÂ¦ â–" Â¦killÂ¦ "â– Â¦projectsÂ¦ Â¦earlyÂ¦ Â¦toÂ¦ Â¦avoidÂ¦ Â¦co stlyÂ¦ Â¦fa il uresÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦estimatedÂ¦ Â¦meanÂ¦ Â¦incubationÂ¦ Â¦periodÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦isÂ¦ Â¦1Â¦ - Â¦14Â¦ Â¦daysÂ¦ ,â– Â¦mo stlyÂ¦ Â¦3Â¦ - Â¦7Â¦ Â¦daysÂ¦ Â¦basedÂ¦ Â¦onÂ¦ Â¦aÂ¦ Â¦studyÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦firstÂ¦ Â¦4 25Â¦ Â¦casesÂ¦ Â¦inÂ¦ ğ‹‡Â¦wuhanÂ¦ .
ğ‹‡Â¦du ba iÂ¦ ,â– ğ‹‡ Â¦sy d n eyÂ¦ ,â– Â¦andÂ¦ ğ‹‡Â¦m el b our neÂ¦ Â¦wereÂ¦ Â¦alsoÂ¦ Â¦reportedÂ¦ Â¦asÂ¦ Â¦popularÂ¦ Â¦dest in ationsÂ¦ Â¦forÂ¦ Â¦peopleÂ¦ Â¦trave llingÂ¦ Â¦fromÂ¦ ğ‹‡Â¦wuhanÂ¦ .
ğ‹‡Â¦andÂ¦ Â¦isÂ¦ Â¦thisÂ¦ Â¦theÂ¦ Â¦rightÂ¦ Â¦timeÂ¦ Â¦forÂ¦ Â¦yourÂ¦ Â¦h ayÂ¦ Â¦feverÂ¦
ğ‹‡Â¦byÂ¦ Â¦13Â¦ ğ‹‡Â¦marchÂ¦ ,â– ğ‹‡Â¦theÂ¦ ğ‹‡Â¦ at l an ticÂ¦ Â¦reportedÂ¦ Â¦thatÂ¦ Â¦lessÂ¦ Â¦thanÂ¦ Â¦14Â¦ , Â¦000Â¦ Â¦testsÂ¦ Â¦hadÂ¦ Â¦beenÂ¦ Â¦conductedÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦j uryÂ¦ Â¦isÂ¦ Â¦stillÂ¦ Â¦outÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦immediateÂ¦ Â¦zoonoticÂ¦ Â¦originÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ .
ğ‹‡Â¦ebolaÂ¦ Â¦wasÂ¦ Â¦originallyÂ¦ Â¦predictedÂ¦ Â¦toÂ¦ Â¦causeÂ¦ Â¦upÂ¦ Â¦toÂ¦ Â¦aÂ¦ Â¦millionÂ¦ Â¦casesÂ¦ Â¦withÂ¦ Â¦halfÂ¦ Â¦aÂ¦ Â¦millionÂ¦ Â¦deathsÂ¦ .
ğ‹‡ Â¦corpor ationsÂ¦ Â¦imposedÂ¦ Â¦employeeÂ¦ Â¦travelÂ¦ Â¦restrictionsÂ¦ ,â– Â¦cancelledÂ¦ Â¦con ferencesÂ¦ ,â– Â¦andÂ¦ Â¦encouragedÂ¦ Â¦employeesÂ¦ Â¦toÂ¦ Â¦workÂ¦ Â¦fromÂ¦ Â¦homeÂ¦ .
ğŠ£Â¦c b sÂ¦ğŠ¼ ğ‹‡Â¦newsÂ¦ Â¦reportedÂ¦ ,â– Â¦ci tingÂ¦ ğ‹‡Â¦johnsÂ¦ ğ‹‡Â¦hopkinsÂ¦ ğ‹‡Â¦universityÂ¦ Â¦dataÂ¦ ,â– Â¦thereÂ¦ Â¦wereÂ¦ Â¦overÂ¦ Â¦1Â¦ , Â¦000Â¦ ğŠ£Â¦usÂ¦ğŠ¼ Â¦deathsÂ¦ Â¦onÂ¦ ğ‹‡Â¦wednesdayÂ¦ Â¦causedÂ¦ Â¦byÂ¦ Â¦coronavirusÂ¦ Â¦infectionsÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦remar ksÂ¦ Â¦wereÂ¦ Â¦laterÂ¦ Â¦con dem nedÂ¦ Â¦byÂ¦ Â¦theÂ¦ ğ‹‡Â¦chineseÂ¦ Â¦consul ateÂ¦ Â¦inÂ¦ ğ‹‡Â¦kolka taÂ¦ ,â– Â¦callingÂ¦ Â¦itÂ¦ â–" Â¦er ro ne ousÂ¦ ". ğ‹‡Â¦inÂ¦ ğ‹‡Â¦chinaÂ¦ ,â– Â¦ x en ophobiaÂ¦ Â¦andÂ¦ Â¦rac ismÂ¦ Â¦a ga insÂ¦ Â¦nonÂ¦ - ğ‹‡Â¦chineseÂ¦ Â¦residentsÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦inf la medÂ¦ Â¦byÂ¦ Â¦theÂ¦ Â¦pandemicÂ¦ ,â– Â¦withÂ¦ Â¦fore i g nersÂ¦ Â¦describedÂ¦ Â¦asÂ¦ â–" Â¦foreignÂ¦ Â¦g arb ageÂ¦ "â– Â¦andÂ¦ Â¦targetedÂ¦ Â¦forÂ¦ â–" Â¦disposalÂ¦ ".
ğ‹‡Â¦theÂ¦ Â¦pol yp ro te insÂ¦ Â¦areÂ¦ Â¦furtherÂ¦ Â¦proces sedÂ¦ Â¦toÂ¦ Â¦generateÂ¦ Â¦16Â¦ Â¦nonÂ¦ - Â¦st ructuralÂ¦ Â¦proteinsÂ¦ ,â– Â¦design atedÂ¦ Â¦n sp 1Â¦ ~ Â¦16Â¦ .
ğ‹‡Â¦severalÂ¦ Â¦compoundsÂ¦ Â¦thatÂ¦ Â¦wereÂ¦ Â¦previouslyÂ¦ Â¦approvedÂ¦ Â¦forÂ¦ Â¦treatmentÂ¦ Â¦ofÂ¦ Â¦otherÂ¦ Â¦viralÂ¦ Â¦diseasesÂ¦ Â¦areÂ¦ Â¦beingÂ¦ Â¦investigatedÂ¦ Â¦forÂ¦ Â¦useÂ¦ Â¦inÂ¦ Â¦treatingÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ .
ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦ex pa ndedÂ¦ Â¦inÂ¦ Â¦clus tersÂ¦ Â¦mainlyÂ¦ Â¦inÂ¦ Â¦andÂ¦ Â¦aroundÂ¦ ğ‹‡Â¦hubeiÂ¦ .
ğ‹‡ Â¦asymptomaticÂ¦ Â¦orÂ¦ Â¦onlyÂ¦ Â¦mildÂ¦ Â¦symptomsÂ¦ Â¦wereÂ¦ Â¦detectedÂ¦ Â¦whenÂ¦ Â¦batsÂ¦ Â¦wereÂ¦ Â¦infectedÂ¦ Â¦withÂ¦ ğ‹‡Â¦coğ‹‡vsÂ¦ ,â– Â¦indicatingÂ¦ Â¦theÂ¦ Â¦m ut ualÂ¦ Â¦adaptationÂ¦ Â¦betweenÂ¦ ğ‹‡Â¦coğ‹‡vsÂ¦ Â¦andÂ¦ Â¦batsÂ¦ .
ğ‹‡Â¦humanÂ¦ Â¦rightsÂ¦ Â¦organizationsÂ¦ Â¦haveÂ¦ Â¦criticizedÂ¦ Â¦someÂ¦ Â¦ofÂ¦ Â¦theseÂ¦ Â¦measuresÂ¦ ,â– Â¦askingÂ¦ Â¦theÂ¦ Â¦governmentsÂ¦ Â¦notÂ¦ Â¦toÂ¦ Â¦useÂ¦ Â¦theÂ¦ Â¦pandemicÂ¦ Â¦asÂ¦ Â¦aÂ¦ Â¦coverÂ¦ Â¦toÂ¦ Â¦introdu ceÂ¦ Â¦in va siveÂ¦ Â¦digitalÂ¦ Â¦surveillanceÂ¦ .
ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - Â¦229ğ‹‡eÂ¦ ,â– ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - ğŠ£ Â¦oc 43Â¦ ,â– Â¦h cğŠ¼oğ‹‡vÂ¦ - ğŠ£Â¦hkuğŠ¼1Â¦ Â¦andÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - ğŠ£Â¦nlğŠ¼63Â¦ Â¦usuallyÂ¦ Â¦causeÂ¦ Â¦mildÂ¦ Â¦symptomsÂ¦ ,â– Â¦likeÂ¦ Â¦commonÂ¦ Â¦coldÂ¦ Â¦andÂ¦ / Â¦orÂ¦ Â¦diarrheaÂ¦ .
ğ‹‡ Â¦epidemiologicalÂ¦ Â¦historyÂ¦ : â–( Â¦1Â¦ )â– Â¦aÂ¦ Â¦historyÂ¦ Â¦ofÂ¦ Â¦travelÂ¦ Â¦orÂ¦ Â¦resi denceÂ¦ Â¦inÂ¦ ğ‹‡Â¦wuhanÂ¦ Â¦cityÂ¦ Â¦andÂ¦ Â¦sur ro undingÂ¦ Â¦areasÂ¦ ,â– Â¦orÂ¦ Â¦otherÂ¦ Â¦communitiesÂ¦ Â¦whereÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦casesÂ¦ Â¦hadÂ¦ Â¦beenÂ¦ Â¦reportedÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦lastÂ¦ Â¦14Â¦ Â¦daysÂ¦ Â¦beforeÂ¦ Â¦symptomÂ¦ Â¦onsetÂ¦ ;â–( Â¦2Â¦ )â– Â¦aÂ¦ Â¦historyÂ¦ Â¦ofÂ¦ Â¦contactÂ¦ Â¦withÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦infectiousÂ¦ Â¦casesÂ¦ â–( Â¦withÂ¦ Â¦positiveÂ¦ Â¦nucle icÂ¦ Â¦acidÂ¦ Â¦testÂ¦ ) ;â–( Â¦3Â¦ )â– Â¦aÂ¦ Â¦historyÂ¦ Â¦ofÂ¦ Â¦cont actingÂ¦ Â¦withÂ¦ Â¦patientsÂ¦ Â¦withÂ¦ Â¦feverÂ¦ Â¦orÂ¦ Â¦respiratoryÂ¦ Â¦symptomsÂ¦ Â¦fromÂ¦ ğ‹‡Â¦wuhanÂ¦ Â¦cityÂ¦ Â¦andÂ¦ Â¦sur ro undingÂ¦ Â¦areasÂ¦ ,â– Â¦orÂ¦ Â¦otherÂ¦ Â¦communitiesÂ¦ Â¦whereÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦hadÂ¦ Â¦beenÂ¦ Â¦reportedÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦lastÂ¦ Â¦14Â¦ Â¦daysÂ¦ Â¦beforeÂ¦ Â¦symptomÂ¦ Â¦onsetÂ¦ ;â–( Â¦4Â¦ )â– Â¦aÂ¦ Â¦historyÂ¦ Â¦ofÂ¦ Â¦cont actingÂ¦ Â¦withÂ¦ Â¦clusterÂ¦ Â¦ofÂ¦ Â¦confirmedÂ¦ Â¦casesÂ¦ â–( â‰¥ â– Â¦2Â¦ Â¦casesÂ¦ Â¦withÂ¦ Â¦feverÂ¦ Â¦andÂ¦ / Â¦orÂ¦ Â¦respiratoryÂ¦ Â¦symptomsÂ¦ Â¦occurredÂ¦ Â¦withinÂ¦ Â¦2Â¦ Â¦weeksÂ¦ Â¦inÂ¦ Â¦smallÂ¦ Â¦areasÂ¦ ,â– Â¦suchÂ¦ Â¦asÂ¦ Â¦homeÂ¦ ,â– Â¦officeÂ¦ ,â– Â¦classÂ¦ Â¦ofÂ¦ Â¦schoolÂ¦ ,â– Â¦etcÂ¦ ).
ğ‹‡Â¦doÂ¦ Â¦youÂ¦ Â¦haveÂ¦ Â¦anyÂ¦ Â¦otherÂ¦ Â¦chronicÂ¦ Â¦likeÂ¦ Â¦highÂ¦ Â¦bloodÂ¦ Â¦pressureÂ¦ Â¦orÂ¦ Â¦anythingÂ¦ Â¦likeÂ¦ Â¦thatÂ¦ ?
ğ‹‡Â¦besidesÂ¦ ,â– Â¦theÂ¦ Â¦naturalÂ¦ Â¦ki llerÂ¦ Â¦cellÂ¦ Â¦activityÂ¦ Â¦inÂ¦ Â¦batsÂ¦ Â¦isÂ¦ Â¦supp ressedÂ¦ Â¦dueÂ¦ Â¦toÂ¦ Â¦up reg ulationÂ¦ Â¦ofÂ¦ Â¦inhib it oryÂ¦ Â¦naturalÂ¦ Â¦ki llerÂ¦ Â¦cellÂ¦ Â¦receptorÂ¦ ğŠ£Â¦n k g 2Â¦ / Â¦c d ğŠ¼ 94Â¦ Â¦andÂ¦ Â¦lowÂ¦ Â¦exp ressionÂ¦ Â¦levelÂ¦ Â¦ofÂ¦ Â¦majorÂ¦ Â¦h is to comp ati b ilityÂ¦ Â¦complexÂ¦ Â¦classÂ¦ ğ‹‡Â¦iÂ¦ Â¦m ol ec u lesÂ¦ .
ğ‹‡Â¦onÂ¦ Â¦theÂ¦ Â¦otherÂ¦ Â¦handÂ¦ ,â– ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - Â¦229ğ‹‡eÂ¦ Â¦wasÂ¦ Â¦gene ticallyÂ¦ Â¦relatedÂ¦ Â¦toÂ¦ Â¦anotherÂ¦ Â¦batÂ¦ ğ‹‡Â¦coğ‹‡vÂ¦ ,â– Â¦ter medÂ¦ ğ‹‡Â¦h ip po si der osÂ¦ / ğ‹‡Â¦g ha na ğ‹‡ k w amÂ¦ / Â¦19Â¦ / Â¦200 8Â¦ ,â– Â¦whichÂ¦ Â¦wasÂ¦ Â¦detectedÂ¦ Â¦inÂ¦ ğ‹‡Â¦gh anaÂ¦ ,â– Â¦whileÂ¦ Â¦ca me li dsÂ¦ Â¦haveÂ¦ Â¦alsoÂ¦ Â¦beenÂ¦ Â¦suspectedÂ¦ Â¦asÂ¦ Â¦itsÂ¦ Â¦intermediateÂ¦ Â¦hostÂ¦ .
ğ‹‡Â¦thereÂ¦ Â¦isÂ¦ Â¦noÂ¦ Â¦evidenceÂ¦ Â¦animalsÂ¦ Â¦canÂ¦ Â¦passÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦onÂ¦ Â¦toÂ¦ Â¦humansÂ¦ ,â– Â¦thoughÂ¦ ğ‹‡Â¦britishÂ¦ Â¦authoritiesÂ¦ Â¦adv iseÂ¦ Â¦washingÂ¦ Â¦oneÂ¦ ' Â¦sÂ¦ Â¦handsÂ¦ Â¦afterÂ¦ Â¦contactÂ¦ Â¦withÂ¦ Â¦animalsÂ¦ ,â– Â¦likeÂ¦ Â¦afterÂ¦ Â¦contactÂ¦ Â¦withÂ¦ Â¦otherÂ¦ Â¦surfacesÂ¦ Â¦infectedÂ¦ Â¦peopleÂ¦ Â¦couldÂ¦ Â¦haveÂ¦ Â¦tou chedÂ¦ .
ğ‹‡Â¦hongÂ¦ ğ‹‡Â¦kongÂ¦ Â¦recommendsÂ¦ Â¦wearingÂ¦ Â¦aÂ¦ Â¦surgicalÂ¦ Â¦maskÂ¦ Â¦whenÂ¦ Â¦takingÂ¦ Â¦publicÂ¦ Â¦transportÂ¦ Â¦orÂ¦ Â¦stayingÂ¦ Â¦inÂ¦ Â¦crowdedÂ¦ Â¦placesÂ¦ .
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦worldÂ¦ ğ‹‡Â¦healthÂ¦ ğ‹‡Â¦organizationÂ¦ â–( ğŠ£Â¦whoÂ¦ğŠ¼ )â– Â¦declaredÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦aÂ¦ Â¦pandemicÂ¦ Â¦onÂ¦ ğ‹‡Â¦marchÂ¦ Â¦11Â¦ .
ğ‹‡Â¦sheÂ¦ Â¦alsoÂ¦ Â¦saidÂ¦ Â¦twoÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦victimsÂ¦ Â¦wereÂ¦ Â¦fromÂ¦ ğ‹‡Â¦d ha kaÂ¦ .
ğ‹‡Â¦andÂ¦ Â¦theyÂ¦ ' Â¦reÂ¦ Â¦havingÂ¦ Â¦someÂ¦ Â¦fe versÂ¦ Â¦asÂ¦ Â¦wellÂ¦
ğ‹‡Â¦evenÂ¦ Â¦plasmaÂ¦ Â¦fromÂ¦ Â¦recoveredÂ¦ Â¦patientsÂ¦ Â¦wasÂ¦ Â¦proposedÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦usedÂ¦ Â¦forÂ¦ Â¦treatmentÂ¦ .
ğ‹‡ Â¦inde edÂ¦ ,â– Â¦aÂ¦ Â¦cr y oÂ¦ - ğŠ£Â¦e mÂ¦ğŠ¼ Â¦studyÂ¦ Â¦indic atesÂ¦ Â¦aÂ¦ Â¦10Â¦ -â– Â¦toÂ¦ Â¦20Â¦ - Â¦fo ldÂ¦ Â¦higherÂ¦ Â¦affi n ityÂ¦ Â¦ofÂ¦ Â¦thisÂ¦ Â¦bindingÂ¦ Â¦thanÂ¦ Â¦thatÂ¦ Â¦betweenÂ¦ Â¦humanÂ¦ ğŠ£Â¦aceğŠ¼2Â¦ Â¦andÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ ğ‹‡Â¦sÂ¦ Â¦proteinÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦useÂ¦ Â¦ofÂ¦ Â¦s teroidsÂ¦ Â¦mayÂ¦ Â¦worse nÂ¦ Â¦outcomesÂ¦ .
ğ‹‡Â¦thereÂ¦ Â¦isÂ¦ Â¦noÂ¦ Â¦pre ferenceÂ¦ Â¦towardsÂ¦ Â¦aÂ¦ Â¦particularÂ¦ Â¦seasonÂ¦ Â¦inÂ¦ Â¦tr op icalÂ¦ Â¦clim atesÂ¦ .
ğ‹‡ Â¦investigatingÂ¦ ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦hostÂ¦ Â¦inter actionsÂ¦ Â¦inÂ¦ Â¦animalsÂ¦ Â¦mightÂ¦ Â¦alsoÂ¦ Â¦de ri veÂ¦ Â¦importantÂ¦ Â¦ins ightÂ¦ Â¦onÂ¦ ğ‹‡Â¦coğ‹‡vÂ¦ Â¦patho gene sisÂ¦ Â¦inÂ¦ Â¦humansÂ¦ .
ğ‹‡Â¦liveÂ¦ - Â¦att en u atedÂ¦ Â¦vaccinesÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦evalu atedÂ¦ Â¦inÂ¦ Â¦animalÂ¦ Â¦modelsÂ¦ Â¦forÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ .
ğ‹‡Â¦ar tsÂ¦ Â¦andÂ¦ Â¦c ult ureÂ¦ Â¦sectorÂ¦ Â¦organizationsÂ¦ Â¦attemp tedÂ¦ Â¦toÂ¦ Â¦up ho ldÂ¦ Â¦theirÂ¦ â–( Â¦oftenÂ¦ Â¦public lyÂ¦ Â¦fu ndedÂ¦ )â– Â¦missionÂ¦ Â¦toÂ¦ Â¦provideÂ¦ Â¦accessÂ¦ Â¦toÂ¦ Â¦culturalÂ¦ Â¦he rit ageÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦communityÂ¦ ,â– Â¦maintainÂ¦ Â¦theÂ¦ Â¦safetyÂ¦ Â¦ofÂ¦ Â¦theirÂ¦ Â¦employeesÂ¦ Â¦andÂ¦ Â¦theÂ¦ Â¦publicÂ¦ ,â– Â¦andÂ¦ Â¦supportÂ¦ Â¦art istsÂ¦ Â¦whereÂ¦ Â¦possibleÂ¦ .
ğ‹‡Â¦currentlyÂ¦ ,â– Â¦noÂ¦ Â¦detailedÂ¦ Â¦studyÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦reportedÂ¦ Â¦regardingÂ¦ Â¦theÂ¦ Â¦immuno logicalÂ¦ Â¦responseÂ¦ Â¦toÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ .
ğ‹‡Â¦onÂ¦ Â¦oneÂ¦ Â¦handÂ¦ ,â– ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦infectionÂ¦ Â¦ex hi bi tsÂ¦ Â¦featuresÂ¦ Â¦thatÂ¦ Â¦areÂ¦ Â¦moreÂ¦ Â¦commonlyÂ¦ Â¦seenÂ¦ Â¦duringÂ¦ Â¦infectionÂ¦ Â¦withÂ¦ Â¦communityÂ¦ - Â¦acquiredÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vsÂ¦ ,â– Â¦includingÂ¦ Â¦theÂ¦ Â¦pre se ntationÂ¦ Â¦ofÂ¦ Â¦nonÂ¦ - Â¦specificÂ¦ ,â– Â¦mildÂ¦ Â¦orÂ¦ Â¦evenÂ¦ Â¦noÂ¦ Â¦symptomsÂ¦ .
ğ‹‡Â¦coğ‹‡vsÂ¦ Â¦haveÂ¦ Â¦returnedÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦li me lightÂ¦ Â¦dueÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦recentÂ¦ Â¦outbreakÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ .
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦whiteÂ¦ ğ‹‡ Â¦houseÂ¦ ğ‹‡Â¦coronavirusÂ¦ ğ‹‡Â¦taskÂ¦ ğ‹‡Â¦forceÂ¦ Â¦wasÂ¦ Â¦establishedÂ¦ Â¦onÂ¦ Â¦29Â¦ ğ‹‡Â¦januaryÂ¦ .
ğ‹‡Â¦andÂ¦ Â¦withÂ¦ Â¦yourÂ¦ Â¦historyÂ¦ Â¦ofÂ¦ Â¦diabetesÂ¦
ğ‹‡Â¦onÂ¦ Â¦theÂ¦ Â¦otherÂ¦ Â¦handÂ¦ ,â– ğ‹‡Â¦chineseÂ¦ Â¦aidÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦wellÂ¦ - Â¦receivedÂ¦ Â¦inÂ¦ Â¦partsÂ¦ Â¦ofÂ¦ ğ‹‡Â¦l atinÂ¦ ğ‹‡Â¦americaÂ¦ Â¦andÂ¦ ğ‹‡Â¦africaÂ¦ . ğ‹‡Â¦onÂ¦ Â¦2Â¦ ğ‹‡Â¦aprilÂ¦ ,â– Â¦theÂ¦ ğ‹‡Â¦worldÂ¦ ğ‹‡Â¦bankÂ¦ Â¦launchedÂ¦ Â¦emergencyÂ¦ Â¦supportÂ¦ Â¦operationsÂ¦ Â¦forÂ¦ Â¦developingÂ¦ Â¦countriesÂ¦ .
ğ‹‡Â¦thisÂ¦ Â¦isÂ¦ Â¦followedÂ¦ Â¦byÂ¦ Â¦theÂ¦ Â¦transcriptionÂ¦ Â¦ofÂ¦ Â¦theseÂ¦ Â¦negativeÂ¦ - Â¦senseÂ¦ Â¦sub ge no micÂ¦ ğŠ£Â¦rnaÂ¦ğŠ¼ Â¦m ol ec u lesÂ¦ Â¦toÂ¦ Â¦theirÂ¦ Â¦correspon dingÂ¦ Â¦positiveÂ¦ - Â¦senseÂ¦ Â¦m ğŠ£r na ğŠ¼sÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦globalÂ¦ ğ‹‡Â¦solidarityÂ¦ Â¦andÂ¦ ğ‹‡Â¦europeanÂ¦ ğ‹‡ Â¦discoveryÂ¦ Â¦trialsÂ¦ Â¦ofÂ¦ Â¦hospitalizedÂ¦ Â¦peopleÂ¦ Â¦withÂ¦ Â¦severeÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦infectionÂ¦ Â¦applyÂ¦ Â¦adap tiveÂ¦ Â¦designÂ¦ Â¦toÂ¦ Â¦rapidlyÂ¦ Â¦al terÂ¦ Â¦trialÂ¦ Â¦para me tersÂ¦ Â¦asÂ¦ Â¦resultsÂ¦ Â¦fromÂ¦ Â¦theÂ¦ Â¦fourÂ¦ Â¦experimentalÂ¦ Â¦therapeuticÂ¦ Â¦strategiesÂ¦ Â¦emer geÂ¦ .
ğ‹‡Â¦theseÂ¦ Â¦statisticsÂ¦ Â¦areÂ¦ Â¦notÂ¦ Â¦ti me b oundÂ¦ Â¦andÂ¦ Â¦followÂ¦ Â¦aÂ¦ Â¦specificÂ¦ Â¦populationÂ¦ Â¦fromÂ¦ Â¦infectionÂ¦ Â¦throughÂ¦ Â¦caseÂ¦ Â¦res olu tionÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦theÂ¦ Â¦earlyÂ¦ Â¦phaseÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ Â¦outbreakÂ¦ ,â– Â¦aÂ¦ Â¦rangeÂ¦ Â¦ofÂ¦ Â¦psychiatricÂ¦ Â¦m orbiditiesÂ¦ Â¦includingÂ¦ Â¦persistentÂ¦ Â¦dep ressionÂ¦ ,â– Â¦anxietyÂ¦ ,â– Â¦panicÂ¦ Â¦attacksÂ¦ ,â– Â¦psyc h om ot orÂ¦ Â¦ex ci te mentÂ¦ ,â– Â¦psyc ho ticÂ¦ Â¦symptomsÂ¦ ,â– Â¦de li ri umÂ¦ ,â– Â¦andÂ¦ Â¦evenÂ¦ Â¦su ic id alityÂ¦ Â¦wereÂ¦ Â¦reportedÂ¦ .
ğ‹‡ Â¦wheneverÂ¦ Â¦possibleÂ¦ ,â– Â¦weÂ¦ Â¦willÂ¦ Â¦tryÂ¦ Â¦toÂ¦ Â¦compareÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦withÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ Â¦andÂ¦ Â¦anotherÂ¦ ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦causedÂ¦ Â¦diseaseÂ¦ ,â– ğ‹‡Â¦middleÂ¦ ğ‹‡Â¦eastÂ¦ Â¦respiratoryÂ¦ Â¦syndromeÂ¦ â–( ğŠ£Â¦mersÂ¦ğŠ¼ ,â– Â¦anÂ¦ Â¦outbreakÂ¦ Â¦inÂ¦ Â¦2012Â¦ ).
ğ‹‡Â¦itÂ¦ Â¦hasÂ¦ Â¦attr actedÂ¦ Â¦aÂ¦ Â¦greatÂ¦ Â¦attentionÂ¦ Â¦sinceÂ¦ Â¦publishedÂ¦ .
ğ‹‡Â¦thisÂ¦ Â¦enzymeÂ¦ Â¦isÂ¦ Â¦essentialÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦hostÂ¦ Â¦cellÂ¦ Â¦toÂ¦ Â¦reprodu ceÂ¦ Â¦theÂ¦ Â¦rib on uc le icÂ¦ Â¦acidÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦virusÂ¦ .
ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦affectsÂ¦ Â¦moreÂ¦ Â¦elderlyÂ¦ Â¦individualsÂ¦ Â¦thanÂ¦ Â¦youthÂ¦ Â¦andÂ¦ Â¦moreÂ¦ Â¦menÂ¦ Â¦thanÂ¦ Â¦womenÂ¦ ,â– Â¦andÂ¦ Â¦theÂ¦ Â¦severityÂ¦ Â¦andÂ¦ Â¦deathÂ¦ Â¦rateÂ¦ Â¦areÂ¦ Â¦alsoÂ¦ Â¦higherÂ¦ Â¦inÂ¦ Â¦elderlyÂ¦ Â¦individualÂ¦ Â¦thanÂ¦ Â¦inÂ¦ Â¦youthÂ¦ .
ğ‹‡Â¦howeverÂ¦ ,â– Â¦theÂ¦ Â¦transmissionÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦wasÂ¦ Â¦consideredÂ¦ Â¦toÂ¦ Â¦occurÂ¦ Â¦whenÂ¦ Â¦theÂ¦ Â¦patientsÂ¦ Â¦areÂ¦ Â¦severelyÂ¦ Â¦illÂ¦ ,â– Â¦whileÂ¦ Â¦mostÂ¦ Â¦transmissionÂ¦ Â¦didÂ¦ Â¦notÂ¦ Â¦happenÂ¦ Â¦atÂ¦ Â¦theÂ¦ Â¦earlyÂ¦ Â¦phaseÂ¦ .
ğ‹‡ Â¦repurp osedÂ¦ Â¦antiviralÂ¦ Â¦drugsÂ¦ Â¦makeÂ¦ Â¦upÂ¦ Â¦mostÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡Â¦chineseÂ¦ Â¦researchÂ¦ ,â– Â¦withÂ¦ Â¦9Â¦ ğ‹‡Â¦phaseÂ¦ ğŠ£Â¦iiiÂ¦ğŠ¼ Â¦trialsÂ¦ Â¦onÂ¦ Â¦remdesivirÂ¦ Â¦acrossÂ¦ Â¦severalÂ¦ Â¦countriesÂ¦ Â¦dueÂ¦ Â¦toÂ¦ Â¦reportÂ¦ Â¦byÂ¦ Â¦theÂ¦ Â¦endÂ¦ Â¦ofÂ¦ ğ‹‡Â¦aprilÂ¦ .
ğ‹‡Â¦japanÂ¦ Â¦donatedÂ¦ Â¦oneÂ¦ Â¦millionÂ¦ Â¦faceÂ¦ Â¦masksÂ¦ Â¦toÂ¦ ğ‹‡Â¦wuhanÂ¦ ,â– ğ‹‡Â¦turkeyÂ¦ Â¦disp at chedÂ¦ Â¦medicalÂ¦ Â¦equipmentÂ¦ ,â– ğ‹‡Â¦russiaÂ¦ Â¦sentÂ¦ Â¦moreÂ¦ Â¦thanÂ¦ Â¦13Â¦ Â¦tonnesÂ¦ Â¦ofÂ¦ Â¦medicalÂ¦ Â¦suppliesÂ¦ Â¦toÂ¦ ğ‹‡Â¦wuhanÂ¦ ,â– ğ‹‡Â¦mala y siaÂ¦ Â¦announcedÂ¦ Â¦aÂ¦ Â¦don ationÂ¦ Â¦ofÂ¦ Â¦18Â¦ Â¦millionÂ¦ Â¦medicalÂ¦ Â¦glovesÂ¦ Â¦toÂ¦ ğ‹‡Â¦chinaÂ¦ ,â– ğ‹‡Â¦germanyÂ¦ Â¦deliveredÂ¦ Â¦variousÂ¦ Â¦medicalÂ¦ Â¦suppliesÂ¦ Â¦includingÂ¦ Â¦10Â¦ , Â¦000Â¦ ğ‹‡Â¦ha z m atÂ¦ Â¦su i tsÂ¦ ,â– Â¦andÂ¦ Â¦theÂ¦ ğ‹‡Â¦unitedÂ¦ ğ‹‡Â¦statesÂ¦ Â¦donatedÂ¦ Â¦17Â¦ . Â¦8Â¦ Â¦tonsÂ¦ Â¦ofÂ¦ Â¦medicalÂ¦ Â¦suppliesÂ¦ Â¦toÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦andÂ¦ Â¦p romisedÂ¦ Â¦anÂ¦ Â¦additionalÂ¦ â–$ Â¦100Â¦ Â¦millionÂ¦ Â¦inÂ¦ Â¦financialÂ¦ Â¦supportÂ¦ Â¦toÂ¦ Â¦affectedÂ¦ Â¦countriesÂ¦ . ğ‹‡Â¦afterÂ¦ Â¦casesÂ¦ Â¦inÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦see medÂ¦ Â¦toÂ¦ Â¦stabi lizeÂ¦ ,â– Â¦theÂ¦ Â¦countryÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦sendingÂ¦ Â¦aidÂ¦ Â¦toÂ¦ Â¦variousÂ¦ Â¦n ationsÂ¦ Â¦hitÂ¦ Â¦byÂ¦ Â¦theÂ¦ Â¦pandemicÂ¦ .
ğ‹‡Â¦onÂ¦ Â¦22Â¦ ğ‹‡Â¦marchÂ¦ ,â– Â¦theÂ¦ ğ‹‡ Â¦associatedÂ¦ ğ‹‡ Â¦pressÂ¦ Â¦reportedÂ¦ :â–" ğ‹‡Â¦manyÂ¦ Â¦peopleÂ¦ Â¦whoÂ¦ Â¦haveÂ¦ Â¦symptomsÂ¦ Â¦andÂ¦ Â¦aÂ¦ Â¦doctorÂ¦ ' Â¦sÂ¦ Â¦orderÂ¦ Â¦haveÂ¦ Â¦wai tedÂ¦ Â¦hoursÂ¦ Â¦orÂ¦ Â¦daysÂ¦ Â¦forÂ¦ Â¦aÂ¦ Â¦testÂ¦ ." ğ‹‡Â¦afterÂ¦ Â¦theÂ¦ Â¦firstÂ¦ Â¦deathÂ¦ Â¦inÂ¦ Â¦theÂ¦ ğ‹‡Â¦unitedÂ¦ ğ‹‡Â¦statesÂ¦ Â¦wasÂ¦ Â¦reportedÂ¦ Â¦inÂ¦ ğ‹‡Â¦washingtonÂ¦ Â¦stateÂ¦ Â¦onÂ¦ Â¦29Â¦ ğ‹‡Â¦februaryÂ¦ ,â– ğ‹‡Â¦governorÂ¦ ğ‹‡Â¦j ayÂ¦ ğ‹‡ Â¦ins l eeÂ¦ Â¦declaredÂ¦ Â¦aÂ¦ Â¦stateÂ¦ Â¦ofÂ¦ Â¦emergencyÂ¦ ,â– Â¦anÂ¦ Â¦actionÂ¦ Â¦thatÂ¦ Â¦wasÂ¦ Â¦soonÂ¦ Â¦followedÂ¦ Â¦byÂ¦ Â¦otherÂ¦ Â¦statesÂ¦ .
ğ‹‡Â¦patientsÂ¦ Â¦infectedÂ¦ Â¦withÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - Â¦229ğ‹‡eÂ¦ Â¦presentedÂ¦ Â¦withÂ¦ Â¦commonÂ¦ Â¦coldÂ¦ Â¦symptomsÂ¦ ,â– Â¦includingÂ¦ Â¦headacheÂ¦ ,â– Â¦sneezingÂ¦ ,â– Â¦mala iseÂ¦ Â¦andÂ¦ Â¦soreÂ¦ - Â¦throatÂ¦ ,â– Â¦withÂ¦ Â¦feverÂ¦ Â¦andÂ¦ Â¦coughÂ¦ Â¦seenÂ¦ Â¦inÂ¦ Â¦10Â¦ ~ Â¦20Â¦ %â– Â¦casesÂ¦ .
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦thursdayÂ¦ Â¦editionÂ¦ Â¦ofÂ¦ ğŠ£Â¦n tÂ¦ğŠ¼ ğ‹‡Â¦newsÂ¦ ,â– Â¦aÂ¦ Â¦dailyÂ¦ Â¦pr intedÂ¦ Â¦inÂ¦ ğ‹‡Â¦d ar w inÂ¦ ,â– Â¦includedÂ¦ Â¦anÂ¦ Â¦eightÂ¦ - Â¦pageÂ¦ Â¦ins er tÂ¦ Â¦me antÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦cutÂ¦ Â¦upÂ¦ Â¦andÂ¦ Â¦usedÂ¦ Â¦asÂ¦ Â¦toiletÂ¦ Â¦paperÂ¦ .
ğ‹‡Â¦thisÂ¦ Â¦meansÂ¦ Â¦thatÂ¦ Â¦countriesÂ¦ Â¦mayÂ¦ Â¦haveÂ¦ Â¦moreÂ¦ Â¦orÂ¦ Â¦lessÂ¦ Â¦resourcesÂ¦ Â¦thanÂ¦ ğ‹‡Â¦italyÂ¦ â–( Â¦12Â¦ . Â¦5Â¦ Â¦intensiveÂ¦ Â¦careÂ¦ Â¦andÂ¦ Â¦intermediateÂ¦ Â¦careÂ¦ Â¦bedsÂ¦ Â¦perÂ¦ Â¦100Â¦ , Â¦000Â¦ Â¦populationÂ¦ Â¦inÂ¦ Â¦201 0Â¦ â€“ Â¦11Â¦ ).
ğ‹‡Â¦sinceÂ¦ Â¦particlesÂ¦ Â¦canÂ¦ Â¦pe ne tr ateÂ¦ Â¦evenÂ¦ Â¦fiveÂ¦ Â¦surgicalÂ¦ Â¦masksÂ¦ Â¦st ackedÂ¦ Â¦togetherÂ¦ ,â– Â¦healthÂ¦ - Â¦careÂ¦ Â¦providersÂ¦ Â¦inÂ¦ Â¦directÂ¦ Â¦contactÂ¦ Â¦withÂ¦ Â¦patientsÂ¦ Â¦mustÂ¦ Â¦wearÂ¦ ğ‹‡Â¦n95Â¦ â–( Â¦seriesÂ¦ â–#â– Â¦18 6 0sÂ¦ )â– Â¦masksÂ¦ Â¦butÂ¦ Â¦notÂ¦ Â¦surgicalÂ¦ Â¦masksÂ¦ .
ğ‹‡Â¦itÂ¦ Â¦isÂ¦ Â¦inÂ¦ Â¦myÂ¦ Â¦chestÂ¦
ğ‹‡Â¦controlÂ¦ Â¦ofÂ¦ Â¦publicÂ¦ Â¦movementÂ¦ Â¦wasÂ¦ Â¦appliedÂ¦ Â¦inÂ¦ Â¦manyÂ¦ Â¦citiesÂ¦ ,â– Â¦andÂ¦ Â¦itÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦estimatedÂ¦ Â¦thatÂ¦ Â¦aboutÂ¦ Â¦7 60Â¦ Â¦millionÂ¦ Â¦peopleÂ¦ â–( Â¦moreÂ¦ Â¦thanÂ¦ Â¦halfÂ¦ Â¦theÂ¦ Â¦populationÂ¦ )â– Â¦facedÂ¦ Â¦someÂ¦ Â¦formÂ¦ Â¦ofÂ¦ Â¦out do orÂ¦ Â¦restrictionÂ¦ . ğ‹‡Â¦afterÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ Â¦enteredÂ¦ Â¦itsÂ¦ Â¦globalÂ¦ Â¦phaseÂ¦ Â¦inÂ¦ ğ‹‡Â¦marchÂ¦ ,â– ğ‹‡Â¦chineseÂ¦ Â¦authoritiesÂ¦ Â¦tookÂ¦ Â¦strictÂ¦ Â¦measuresÂ¦ Â¦toÂ¦ Â¦preventÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦fromÂ¦ â–" Â¦im portingÂ¦ "â– Â¦fromÂ¦ Â¦otherÂ¦ Â¦countriesÂ¦ .
ğ‹‡Â¦howeverÂ¦ ,â– Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦diseaseÂ¦ Â¦2019Â¦ â–( ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ )â– Â¦isÂ¦ Â¦aÂ¦ Â¦newÂ¦ Â¦diseaseÂ¦ ,â– Â¦ourÂ¦ Â¦awarenessÂ¦ Â¦andÂ¦ Â¦knowledgeÂ¦ Â¦areÂ¦ Â¦graduallyÂ¦ Â¦increasingÂ¦ Â¦basedÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦ongoingÂ¦ Â¦researchÂ¦ Â¦findingsÂ¦ Â¦andÂ¦ Â¦clinicalÂ¦ Â¦practiceÂ¦ Â¦experienceÂ¦ ;â– Â¦he nceÂ¦ ,â– Â¦theÂ¦ Â¦strategiesÂ¦ Â¦ofÂ¦ Â¦diagnosisÂ¦ Â¦andÂ¦ Â¦treatmentÂ¦ Â¦areÂ¦ Â¦alsoÂ¦ Â¦continu allyÂ¦ Â¦updatedÂ¦ .
ğ‹‡ Â¦remoteÂ¦ Â¦workingÂ¦ Â¦measuresÂ¦ Â¦wereÂ¦ Â¦institu tedÂ¦ Â¦inÂ¦ Â¦severalÂ¦ ğ‹‡Â¦chineseÂ¦ Â¦regionsÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦experienceÂ¦ Â¦fromÂ¦ ğ‹‡Â¦italyÂ¦ Â¦andÂ¦ Â¦theÂ¦ Â¦currentÂ¦ Â¦tr endsÂ¦ Â¦inÂ¦ Â¦otherÂ¦ Â¦countriesÂ¦ Â¦showÂ¦ Â¦thatÂ¦ Â¦theÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦pandemicÂ¦ Â¦isÂ¦ Â¦prog ressingÂ¦ Â¦rapidlyÂ¦ Â¦inÂ¦ Â¦theÂ¦ ğŠ£Â¦euÂ¦ / Â¦eeaÂ¦ğŠ¼ Â¦andÂ¦ Â¦theÂ¦ ğŠ£Â¦ukÂ¦ğŠ¼ .
ğ‹‡Â¦withÂ¦ Â¦theÂ¦ Â¦or de alsÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ ,â– Â¦ mer sÂ¦ğŠ¼ Â¦andÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ ,â– Â¦aÂ¦ Â¦betterÂ¦ Â¦preparednessÂ¦ Â¦andÂ¦ Â¦responseÂ¦ Â¦planÂ¦ Â¦shouldÂ¦ Â¦beÂ¦ Â¦inÂ¦ Â¦placeÂ¦ .
ğ‹‡Â¦manyÂ¦ Â¦residentsÂ¦ Â¦ofÂ¦ ğ‹‡Â¦wuhanÂ¦ Â¦andÂ¦ ğ‹‡Â¦hubeiÂ¦ Â¦haveÂ¦ Â¦reportedÂ¦ Â¦discriminationÂ¦ Â¦basedÂ¦ Â¦onÂ¦ Â¦theirÂ¦ Â¦regionalÂ¦ Â¦originÂ¦ .
ğ‹‡Â¦aÂ¦ Â¦statisticalÂ¦ Â¦analysisÂ¦ Â¦publishedÂ¦ Â¦30Â¦ ğ‹‡Â¦marchÂ¦ Â¦estimatedÂ¦ Â¦thatÂ¦ Â¦numbersÂ¦ Â¦ofÂ¦ Â¦infectionsÂ¦ Â¦inÂ¦ ğ‹‡Â¦italyÂ¦ Â¦wereÂ¦ Â¦consider ablyÂ¦ Â¦greaterÂ¦ Â¦thanÂ¦ Â¦theÂ¦ Â¦reportedÂ¦ Â¦casesÂ¦ .
ğ‹‡Â¦onÂ¦ Â¦22Â¦ ğ‹‡Â¦marchÂ¦ ,â– Â¦afterÂ¦ Â¦aÂ¦ Â¦phoneÂ¦ Â¦callÂ¦ Â¦withÂ¦ ğ‹‡Â¦italianÂ¦ ğ‹‡Â¦primeÂ¦ ğ‹‡Â¦ministerÂ¦ ğ‹‡Â¦gi u se pp eÂ¦ ğ‹‡ Â¦con teÂ¦ ,â– ğ‹‡Â¦russianÂ¦ Â¦presidentÂ¦ ğ‹‡Â¦v l ad im irÂ¦ ğ‹‡Â¦p ut inÂ¦ Â¦arr an gedÂ¦ Â¦theÂ¦ ğ‹‡Â¦russianÂ¦ Â¦armyÂ¦ Â¦toÂ¦ Â¦sendÂ¦ Â¦ militaryÂ¦ Â¦ med icsÂ¦ ,â– Â¦specialÂ¦ Â¦disinf ectionÂ¦ Â¦vehiclesÂ¦ ,â– Â¦andÂ¦ Â¦otherÂ¦ Â¦medicalÂ¦ Â¦equipmentÂ¦ Â¦toÂ¦ ğ‹‡Â¦italyÂ¦ .
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦chineseÂ¦ Â¦governmentÂ¦ Â¦encouragedÂ¦ Â¦businessesÂ¦ Â¦andÂ¦ Â¦factoriesÂ¦ Â¦toÂ¦ Â¦reÂ¦ - Â¦openÂ¦ Â¦onÂ¦ Â¦30Â¦ ğ‹‡Â¦marchÂ¦ ,â– Â¦andÂ¦ Â¦providedÂ¦ Â¦mo ne t aryÂ¦ Â¦s ti mul usÂ¦ Â¦p ack agesÂ¦ Â¦forÂ¦ Â¦fir msÂ¦ . ğ‹‡Â¦theÂ¦ ğ‹‡Â¦stateÂ¦ ğ‹‡Â¦councilÂ¦ Â¦declaredÂ¦ Â¦aÂ¦ Â¦dayÂ¦ Â¦ofÂ¦ Â¦m our ningÂ¦ Â¦toÂ¦ Â¦beginÂ¦ Â¦withÂ¦ Â¦aÂ¦ Â¦nationalÂ¦ Â¦threeÂ¦ - Â¦minuteÂ¦ Â¦momentÂ¦ Â¦ofÂ¦ Â¦si le nceÂ¦ Â¦onÂ¦ Â¦10Â¦ : Â¦00Â¦ Â¦4Â¦ ğ‹‡Â¦aprilÂ¦ ,â– Â¦co in ci dingÂ¦ Â¦withÂ¦ ğ‹‡Â¦ q i ng mingÂ¦ ğ‹‡ Â¦festivalÂ¦ ,â– Â¦althoughÂ¦ Â¦theÂ¦ Â¦centralÂ¦ Â¦governmentÂ¦ Â¦askedÂ¦ Â¦familiesÂ¦ Â¦toÂ¦ Â¦payÂ¦ Â¦theirÂ¦ Â¦resp ectsÂ¦ Â¦onlineÂ¦ Â¦inÂ¦ Â¦observ anceÂ¦ Â¦ofÂ¦ Â¦physicalÂ¦ Â¦distancingÂ¦ Â¦asÂ¦ Â¦toÂ¦ Â¦avoidÂ¦ Â¦aÂ¦ Â¦re ne w edÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦outbreakÂ¦ .
ğ‹‡Â¦privateÂ¦ Â¦vehicleÂ¦ Â¦useÂ¦ Â¦wasÂ¦ Â¦bannedÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦cityÂ¦ .
ğ‹‡Â¦aroundÂ¦ Â¦200Â¦ Â¦countriesÂ¦ Â¦andÂ¦ Â¦territoriesÂ¦ Â¦haveÂ¦ Â¦hadÂ¦ Â¦atÂ¦ Â¦leastÂ¦ Â¦oneÂ¦ Â¦caseÂ¦ .
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦europeanÂ¦ ğ‹‡Â¦centreÂ¦ Â¦forÂ¦ ğ‹‡Â¦diseaseÂ¦ ğ‹‡Â¦preventionÂ¦ Â¦andÂ¦ ğ‹‡Â¦controlÂ¦ â–( ğŠ£Â¦ec dcÂ¦ğŠ¼ )â– Â¦statesÂ¦ Â¦thatÂ¦ Â¦whileÂ¦ Â¦itÂ¦ Â¦isÂ¦ Â¦notÂ¦ Â¦entirelyÂ¦ Â¦clearÂ¦ Â¦howÂ¦ Â¦easilyÂ¦ Â¦theÂ¦ Â¦diseaseÂ¦ Â¦spreadsÂ¦ ,â– Â¦oneÂ¦ Â¦personÂ¦ Â¦generallyÂ¦ Â¦infectsÂ¦ Â¦twoÂ¦ Â¦toÂ¦ Â¦threeÂ¦ Â¦othersÂ¦ . ğ‹‡Â¦theÂ¦ Â¦virusÂ¦ Â¦survi vesÂ¦ Â¦forÂ¦ Â¦hoursÂ¦ Â¦toÂ¦ Â¦daysÂ¦ Â¦onÂ¦ Â¦surfacesÂ¦ .
ğ‹‡Â¦apartÂ¦ Â¦fromÂ¦ Â¦theÂ¦ Â¦superÂ¦ - Â¦sp rea dersÂ¦ ,â– Â¦itÂ¦ Â¦wasÂ¦ Â¦estimatedÂ¦ Â¦thatÂ¦ Â¦eachÂ¦ Â¦caseÂ¦ Â¦couldÂ¦ Â¦giveÂ¦ Â¦riseÂ¦ Â¦toÂ¦ Â¦approximatelyÂ¦ Â¦twoÂ¦ Â¦secondaryÂ¦ Â¦casesÂ¦ ,â– Â¦withÂ¦ Â¦anÂ¦ Â¦incubationÂ¦ Â¦periodÂ¦ Â¦ofÂ¦ Â¦4Â¦ Â¦toÂ¦ Â¦7Â¦ Â¦daysÂ¦ Â¦andÂ¦ Â¦theÂ¦ Â¦peakÂ¦ Â¦ofÂ¦ Â¦viralÂ¦ Â¦loadÂ¦ Â¦appe aringÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦10thÂ¦ Â¦dayÂ¦ Â¦ofÂ¦ Â¦illnessÂ¦ .
ğ‹‡Â¦forÂ¦ Â¦thisÂ¦ Â¦toÂ¦ Â¦happenÂ¦ ,â– ğŠ£Â¦hcğŠ¼oğ‹‡vsÂ¦ Â¦haveÂ¦ Â¦toÂ¦ Â¦replic ateÂ¦ Â¦inÂ¦ Â¦humansÂ¦ Â¦toÂ¦ Â¦sufficientÂ¦ Â¦extentÂ¦ Â¦toÂ¦ Â¦allowÂ¦ Â¦theÂ¦ Â¦acc um ulationÂ¦ Â¦ofÂ¦ Â¦adap tiveÂ¦ Â¦mutationsÂ¦ Â¦thatÂ¦ Â¦coun ter actÂ¦ Â¦hostÂ¦ Â¦restrictionÂ¦ Â¦factorsÂ¦ .
ğ‹‡Â¦s teroidsÂ¦ ,â– Â¦asÂ¦ Â¦immuno s up pr ess antsÂ¦ ,â– Â¦wereÂ¦ Â¦widelyÂ¦ Â¦usedÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦treatmentÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ Â¦toÂ¦ Â¦reduceÂ¦ Â¦theÂ¦ Â¦severityÂ¦ Â¦ofÂ¦ Â¦inflammatoryÂ¦ Â¦damageÂ¦ .
ğ‹‡Â¦itÂ¦ Â¦high l igh tsÂ¦ Â¦thatÂ¦ ,â– Â¦asÂ¦ Â¦atÂ¦ Â¦15Â¦ ğ‹‡Â¦marchÂ¦ Â¦8Â¦ : Â¦00Â¦ Â¦aÂ¦ . Â¦mÂ¦ .,â– Â¦15Â¦ Â¦otherÂ¦ ğŠ£Â¦euÂ¦ / Â¦eeaÂ¦ğŠ¼ Â¦countriesÂ¦ Â¦andÂ¦ Â¦theÂ¦ ğŠ£Â¦ukÂ¦ğŠ¼ Â¦hadÂ¦ Â¦alreadyÂ¦ Â¦reportedÂ¦ Â¦aÂ¦ Â¦totalÂ¦ Â¦numberÂ¦ Â¦ofÂ¦ Â¦casesÂ¦ Â¦compar ableÂ¦ Â¦toÂ¦ Â¦thatÂ¦ Â¦ofÂ¦ ğ‹‡Â¦italyÂ¦ Â¦justÂ¦ Â¦3Â¦ Â¦weeksÂ¦ Â¦priorÂ¦ Â¦orÂ¦ Â¦lessÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦outbreakÂ¦ Â¦dis ruptedÂ¦ Â¦plansÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦2020Â¦ ğ‹‡ Â¦summerÂ¦ ğ‹‡Â¦ ol y mp icsÂ¦ ,â– Â¦whichÂ¦ Â¦wereÂ¦ Â¦originallyÂ¦ Â¦scheduledÂ¦ Â¦toÂ¦ Â¦startÂ¦ Â¦atÂ¦ Â¦theÂ¦ Â¦endÂ¦ Â¦ofÂ¦ ğ‹‡Â¦julyÂ¦ ;â– Â¦theÂ¦ ğ‹‡Â¦internationalÂ¦ ğ‹‡Â¦ ol y mp icÂ¦ ğ‹‡Â¦committeeÂ¦ Â¦announcedÂ¦ Â¦onÂ¦ Â¦24Â¦ ğ‹‡Â¦marchÂ¦ Â¦thatÂ¦ Â¦theÂ¦ Â¦eventÂ¦ Â¦willÂ¦ Â¦beÂ¦ â–" Â¦r esc he du ledÂ¦ Â¦toÂ¦ Â¦aÂ¦ Â¦dateÂ¦ Â¦beyondÂ¦ Â¦2020Â¦ Â¦butÂ¦ Â¦notÂ¦ Â¦laterÂ¦ Â¦thanÂ¦ Â¦summerÂ¦ Â¦2021Â¦ ". ğ‹‡Â¦c as in osÂ¦ Â¦andÂ¦ Â¦otherÂ¦ Â¦ga mingÂ¦ Â¦v en u esÂ¦ Â¦worldwideÂ¦ Â¦haveÂ¦ Â¦closedÂ¦ Â¦andÂ¦ Â¦liveÂ¦ Â¦po kerÂ¦ Â¦t our na mentsÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦eitherÂ¦ Â¦postponedÂ¦ Â¦orÂ¦ Â¦cancelledÂ¦ .
ğ‹‡Â¦areÂ¦ Â¦youÂ¦ Â¦havingÂ¦ Â¦anyÂ¦ Â¦shortnessÂ¦ Â¦ofÂ¦ Â¦breathÂ¦ ?
ğ‹‡ Â¦diarrheaÂ¦ â–( Â¦26Â¦ %)â– Â¦andÂ¦ Â¦soreÂ¦ Â¦throatÂ¦ â–( Â¦21Â¦ %)â– Â¦wereÂ¦ Â¦alsoÂ¦ Â¦observedÂ¦ Â¦withÂ¦ ğŠ£Â¦mersÂ¦ğŠ¼ Â¦patientsÂ¦ .
ğ‹‡Â¦healthÂ¦ Â¦organizationsÂ¦ Â¦recommendedÂ¦ Â¦thatÂ¦ Â¦peopleÂ¦ Â¦coverÂ¦ Â¦theirÂ¦ Â¦mouthÂ¦ Â¦andÂ¦ Â¦noseÂ¦ Â¦withÂ¦ Â¦aÂ¦ Â¦b entÂ¦ Â¦el bo wÂ¦ Â¦orÂ¦ Â¦aÂ¦ Â¦tissueÂ¦ Â¦whenÂ¦ Â¦coughingÂ¦ Â¦orÂ¦ Â¦sneezingÂ¦ ,â– Â¦andÂ¦ Â¦disp osingÂ¦ Â¦ofÂ¦ Â¦anyÂ¦ Â¦tissueÂ¦ Â¦immediatelyÂ¦ .
ğ‹‡Â¦aboutÂ¦ Â¦36 4Â¦ , Â¦000Â¦ Â¦peopleÂ¦ Â¦haveÂ¦ Â¦recoveredÂ¦ .
ğ‹‡Â¦coronavirusesÂ¦ Â¦canÂ¦ Â¦causeÂ¦ Â¦pneumoniaÂ¦ â–( Â¦eitherÂ¦ Â¦directÂ¦ Â¦viralÂ¦ Â¦pneumoniaÂ¦ Â¦orÂ¦ Â¦secondaryÂ¦ Â¦bacterialÂ¦ Â¦pneumoniaÂ¦ )â– Â¦andÂ¦ Â¦bronchitisÂ¦ â–( Â¦eitherÂ¦ Â¦directÂ¦ Â¦viralÂ¦ Â¦bronchitisÂ¦ Â¦orÂ¦ Â¦secondaryÂ¦ Â¦bacterialÂ¦ Â¦bronchitisÂ¦ ).
ğ‹‡Â¦inÂ¦ Â¦theÂ¦ Â¦19 5 0sÂ¦ ,â– Â¦theÂ¦ Â¦humanÂ¦ Â¦coronavirusÂ¦ ğŠ£Â¦ocğŠ¼43Â¦ Â¦beganÂ¦ Â¦toÂ¦ Â¦diver geÂ¦ Â¦intoÂ¦ Â¦itsÂ¦ Â¦presentÂ¦ Â¦ gen ot yp esÂ¦ .
ğ‹‡Â¦beforeÂ¦ Â¦disc us singÂ¦ Â¦theÂ¦ Â¦animalÂ¦ Â¦originsÂ¦ Â¦ofÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vsÂ¦ ,â– Â¦itÂ¦ Â¦willÂ¦ Â¦serveÂ¦ Â¦usÂ¦ Â¦wellÂ¦ Â¦toÂ¦ Â¦discussÂ¦ Â¦theÂ¦ Â¦defini tionsÂ¦ Â¦andÂ¦ Â¦charac teri sticsÂ¦ Â¦ofÂ¦ Â¦ev olu tionaryÂ¦ ,â– Â¦naturalÂ¦ ,â– Â¦reservoirÂ¦ ,â– Â¦intermediateÂ¦ Â¦andÂ¦ Â¦ampli fyingÂ¦ Â¦hostsÂ¦ Â¦ofÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vsÂ¦ .
ğ‹‡Â¦theÂ¦ ğŠ£Â¦whoÂ¦ğŠ¼ Â¦hasÂ¦ Â¦issuedÂ¦ Â¦instructionsÂ¦ Â¦onÂ¦ Â¦whenÂ¦ Â¦andÂ¦ Â¦howÂ¦ Â¦toÂ¦ Â¦useÂ¦ Â¦masksÂ¦ .
ğ‹‡Â¦anotherÂ¦ Â¦hospitalÂ¦ Â¦wasÂ¦ Â¦builtÂ¦ Â¦af ter wardsÂ¦ ,â– ğ‹‡ Â¦le is he ns hanÂ¦ ğ‹‡Â¦hospitalÂ¦ ,â– Â¦toÂ¦ Â¦handleÂ¦ Â¦additionalÂ¦ Â¦patientsÂ¦ .
ğ‹‡Â¦onÂ¦ Â¦6Â¦ ğ‹‡Â¦februaryÂ¦ Â¦2020Â¦ ,â– Â¦ourÂ¦ Â¦teamÂ¦ Â¦hadÂ¦ Â¦publishedÂ¦ Â¦aÂ¦ Â¦rapidÂ¦ Â¦adviceÂ¦ Â¦gui de lineÂ¦ Â¦forÂ¦ Â¦diagnosisÂ¦ Â¦andÂ¦ Â¦treatmentÂ¦ Â¦ofÂ¦ Â¦2019Â¦ Â¦novelÂ¦ Â¦coronavirusÂ¦ â–( Â¦2019Â¦ - Â¦n ğ‹‡coğ‹‡vÂ¦ )â– Â¦infectionÂ¦ ,â– Â¦andÂ¦ Â¦thisÂ¦ Â¦gui de lineÂ¦ Â¦providedÂ¦ Â¦ourÂ¦ Â¦experienceÂ¦ Â¦andÂ¦ Â¦makeÂ¦ Â¦wellÂ¦ Â¦referenceÂ¦ Â¦forÂ¦ Â¦fightingÂ¦ Â¦againstÂ¦ Â¦thisÂ¦ Â¦pandemicÂ¦ Â¦worldwideÂ¦ .
ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦hasÂ¦ Â¦featuresÂ¦ Â¦thatÂ¦ Â¦areÂ¦ Â¦similarÂ¦ Â¦toÂ¦ Â¦bothÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ / ğŠ£Â¦mersÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦andÂ¦ Â¦theÂ¦ Â¦fourÂ¦ Â¦communityÂ¦ - Â¦acquiredÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vsÂ¦ .
ğ‹‡Â¦theirÂ¦ Â¦guidelinesÂ¦ Â¦thusÂ¦ Â¦adv iseÂ¦ Â¦thatÂ¦ Â¦anyÂ¦ Â¦pregnantÂ¦ Â¦personÂ¦ Â¦admittedÂ¦ Â¦toÂ¦ Â¦hospitalÂ¦ Â¦withÂ¦ Â¦aÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦infectionÂ¦ Â¦shouldÂ¦ Â¦receiveÂ¦ Â¦atÂ¦ Â¦leastÂ¦ Â¦10Â¦ Â¦daysÂ¦ Â¦ofÂ¦ Â¦pro phy l ac ticÂ¦ Â¦lowÂ¦ - Â¦molecularÂ¦ - Â¦we ightÂ¦ Â¦he par inÂ¦ Â¦afterÂ¦ Â¦beingÂ¦ Â¦dischargedÂ¦ Â¦fromÂ¦ Â¦theÂ¦ Â¦hospitalÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦originÂ¦ Â¦andÂ¦ Â¦intermediateÂ¦ Â¦hostÂ¦
ğ‹‡Â¦forÂ¦ Â¦thoseÂ¦ Â¦whoÂ¦ Â¦doÂ¦ Â¦notÂ¦ ,â– Â¦theÂ¦ Â¦timeÂ¦ Â¦fromÂ¦ Â¦developmentÂ¦ Â¦ofÂ¦ Â¦symptomsÂ¦ Â¦toÂ¦ Â¦deathÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦betweenÂ¦ Â¦6Â¦ Â¦andÂ¦ Â¦41Â¦ Â¦daysÂ¦ ,â– Â¦withÂ¦ Â¦theÂ¦ Â¦mostÂ¦ Â¦commonÂ¦ Â¦beingÂ¦ Â¦14Â¦ Â¦daysÂ¦ .
ğ‹‡Â¦aÂ¦ Â¦smallÂ¦ Â¦studyÂ¦ Â¦inv olvingÂ¦ Â¦6Â¦ Â¦confirmedÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦mo thersÂ¦ Â¦showedÂ¦ Â¦noÂ¦ Â¦indic ationÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ - Â¦co vÂ¦ğŠ¼ - Â¦19Â¦ Â¦inÂ¦ Â¦theirÂ¦ Â¦new bor nsÂ¦ 'â– Â¦thro a tsÂ¦ Â¦orÂ¦ Â¦serumÂ¦ Â¦butÂ¦ Â¦antibodiesÂ¦ Â¦wereÂ¦ Â¦presentÂ¦ Â¦inÂ¦ Â¦ne o na talÂ¦ Â¦bloodÂ¦ Â¦se raÂ¦ Â¦samplesÂ¦ ,â– Â¦includingÂ¦ ğ‹‡Â¦igğ‹‡ mÂ¦ Â¦inÂ¦ Â¦twoÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦inf antsÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦patientsÂ¦ Â¦withÂ¦ Â¦severeÂ¦ Â¦casesÂ¦ ,â– Â¦theÂ¦ Â¦levelÂ¦ Â¦ofÂ¦ ğ‹‡Â¦dÂ¦ - Â¦di merÂ¦ ,â– Â¦aÂ¦ Â¦fi br inÂ¦ Â¦de g rad ationÂ¦ Â¦productÂ¦ Â¦presentÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦bloodÂ¦ ,â– Â¦wasÂ¦ Â¦elevatedÂ¦ ,â– Â¦andÂ¦ Â¦lymphocy teÂ¦ Â¦countÂ¦ Â¦wasÂ¦ Â¦prog res si velyÂ¦ Â¦reducedÂ¦ .
ğ‹‡Â¦onÂ¦ Â¦23Â¦ ğ‹‡Â¦januaryÂ¦ ,â– Â¦inÂ¦ Â¦reactionÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦centralÂ¦ Â¦authoritiesÂ¦ 'â– Â¦decisionÂ¦ Â¦toÂ¦ Â¦implementÂ¦ Â¦aÂ¦ Â¦transportationÂ¦ Â¦banÂ¦ Â¦inÂ¦ ğ‹‡Â¦wuhanÂ¦ ,â– ğŠ£Â¦whoÂ¦ğŠ¼ Â¦representativeÂ¦ ğ‹‡Â¦ga u denÂ¦ ğ‹‡Â¦gal eaÂ¦ Â¦remar kedÂ¦ Â¦thatÂ¦ Â¦whileÂ¦ Â¦itÂ¦ Â¦wasÂ¦ â–" Â¦c ertain lyÂ¦ Â¦notÂ¦ Â¦aÂ¦ Â¦rec om mend ationÂ¦ Â¦theÂ¦ ğŠ£Â¦whoÂ¦ğŠ¼ Â¦hasÂ¦ Â¦madeÂ¦ ",â– Â¦itÂ¦ Â¦wasÂ¦ Â¦alsoÂ¦ â–" Â¦aÂ¦ Â¦veryÂ¦ Â¦importantÂ¦ Â¦indic ationÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦comm itmentÂ¦ Â¦toÂ¦ Â¦containÂ¦ Â¦theÂ¦ Â¦epidemicÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦placeÂ¦ Â¦whereÂ¦ Â¦itÂ¦ Â¦isÂ¦ Â¦mostÂ¦ Â¦concentr atedÂ¦ "â– Â¦andÂ¦ Â¦calledÂ¦ Â¦itÂ¦ â–" Â¦unprecedentedÂ¦ Â¦inÂ¦ Â¦publicÂ¦ Â¦healthÂ¦ Â¦historyÂ¦ ". ğ‹‡Â¦onÂ¦ Â¦30Â¦ ğ‹‡Â¦januaryÂ¦ ,â– Â¦followingÂ¦ Â¦confir mationÂ¦ Â¦ofÂ¦ Â¦humanÂ¦ - Â¦toÂ¦ - Â¦humanÂ¦ Â¦transmissionÂ¦ Â¦outsideÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦andÂ¦ Â¦theÂ¦ Â¦increaseÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦numberÂ¦ Â¦ofÂ¦ Â¦casesÂ¦ Â¦inÂ¦ Â¦otherÂ¦ Â¦countriesÂ¦ ,â– Â¦theÂ¦ ğŠ£Â¦whoÂ¦ğŠ¼ Â¦declaredÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ Â¦aÂ¦ ğ‹‡Â¦publicÂ¦ ğ‹‡Â¦healthÂ¦ ğ‹‡Â¦emergencyÂ¦ Â¦ofÂ¦ ğ‹‡Â¦internationalÂ¦ ğ‹‡ Â¦concernÂ¦ â–( ğŠ£Â¦p he i cÂ¦ğŠ¼ ),â– Â¦theÂ¦ Â¦six thÂ¦ ğŠ£Â¦p he i cÂ¦ğŠ¼ Â¦sinceÂ¦ Â¦theÂ¦ Â¦measureÂ¦ Â¦wasÂ¦ Â¦firstÂ¦ Â¦inv o kedÂ¦ Â¦duringÂ¦ Â¦theÂ¦ Â¦2009Â¦ Â¦swineÂ¦ Â¦fluÂ¦ Â¦pandemicÂ¦ .
ğ‹‡Â¦theseÂ¦ Â¦therap iesÂ¦ Â¦includeÂ¦ Â¦currentÂ¦ Â¦andÂ¦ Â¦potentialÂ¦ Â¦treatmentsÂ¦ Â¦withÂ¦ Â¦antiviralÂ¦ Â¦drugsÂ¦ ,â– Â¦immuno s up pr ess antsÂ¦ ,â– Â¦s teroidsÂ¦ ,â– Â¦plasmaÂ¦ Â¦fromÂ¦ Â¦recoveredÂ¦ Â¦patientsÂ¦ ,â– ğ‹‡Â¦chineseÂ¦ Â¦medicineÂ¦ ,â– Â¦andÂ¦ Â¦psyc ho logicalÂ¦ Â¦supportÂ¦ .
ğ‹‡Â¦severalÂ¦ Â¦recentÂ¦ Â¦studiesÂ¦ Â¦basedÂ¦ Â¦onÂ¦ Â¦me ta ge no micÂ¦ Â¦sequencingÂ¦ Â¦haveÂ¦ Â¦suggestedÂ¦ Â¦thatÂ¦ Â¦aÂ¦ Â¦groupÂ¦ Â¦ofÂ¦ Â¦enda ng eredÂ¦ Â¦smallÂ¦ Â¦mammalsÂ¦ Â¦knownÂ¦ Â¦asÂ¦ Â¦pangolinsÂ¦ â–( ğ‹‡Â¦ma ni sÂ¦ Â¦j av an ic aÂ¦ )â– Â¦couldÂ¦ Â¦alsoÂ¦ Â¦har bo urÂ¦ Â¦anc es tr alÂ¦ Â¦betaÂ¦ - ğ‹‡Â¦coğ‹‡vsÂ¦ Â¦relatedÂ¦ Â¦toÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ .
ğ‹‡Â¦theyÂ¦ Â¦areÂ¦ Â¦widelyÂ¦ Â¦distributedÂ¦ Â¦acrossÂ¦ Â¦theÂ¦ ğ‹‡Â¦middleÂ¦ ğ‹‡Â¦eastÂ¦ Â¦andÂ¦ ğ‹‡Â¦africaÂ¦ .
ğ‹‡Â¦ifÂ¦ Â¦youÂ¦ Â¦continueÂ¦ Â¦toÂ¦ Â¦haveÂ¦ Â¦highÂ¦ Â¦fe versÂ¦
ğ‹‡Â¦primeÂ¦ ğ‹‡Â¦ministerÂ¦ ğ‹‡Â¦gi u se pp eÂ¦ ğ‹‡ Â¦con teÂ¦ Â¦saidÂ¦ ,â–" ğ‹‡Â¦inÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ Â¦areasÂ¦ ,â– Â¦entryÂ¦ Â¦andÂ¦ Â¦ex itÂ¦ Â¦willÂ¦ Â¦notÂ¦ Â¦beÂ¦ Â¦providedÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦sourceÂ¦ Â¦accusedÂ¦ ğ‹‡Â¦russiaÂ¦ Â¦ofÂ¦ Â¦e mb ar kingÂ¦ Â¦onÂ¦ Â¦aÂ¦ â–" Â¦ge op ol it icalÂ¦ Â¦andÂ¦ Â¦diplo maticÂ¦ "â– Â¦char mÂ¦ Â¦off ensiveÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦additionÂ¦ ,â– Â¦theÂ¦ Â¦requirementsÂ¦ Â¦forÂ¦ Â¦successfulÂ¦ Â¦hostÂ¦ Â¦sw it chesÂ¦ Â¦andÂ¦ Â¦theÂ¦ Â¦implicationsÂ¦ Â¦ofÂ¦ Â¦virusÂ¦ Â¦evolutionÂ¦ Â¦onÂ¦ Â¦diseaseÂ¦ Â¦severityÂ¦ Â¦areÂ¦ Â¦alsoÂ¦ Â¦high l igh tedÂ¦ .
ğ‹‡ Â¦salesÂ¦ Â¦wentÂ¦ Â¦upÂ¦ Â¦inÂ¦ Â¦aÂ¦ â–" Â¦sharpÂ¦ Â¦increaseÂ¦ "â– Â¦lastÂ¦ Â¦weekÂ¦ ,â– Â¦accordingÂ¦ Â¦toÂ¦ Â¦aÂ¦ ğ‹‡ Â¦wo ol wor thsÂ¦ Â¦spokespersonÂ¦ .
ğ‹‡Â¦throughÂ¦ Â¦differentÂ¦ Â¦path w aysÂ¦ ,â– Â¦theÂ¦ Â¦virusÂ¦ Â¦indu cesÂ¦ Â¦theÂ¦ Â¦exp ressionÂ¦ Â¦ofÂ¦ Â¦inflammatoryÂ¦ Â¦factorsÂ¦ ,â– Â¦ma tur ationÂ¦ Â¦ofÂ¦ Â¦de nd ri ticÂ¦ Â¦cellsÂ¦ ,â– Â¦andÂ¦ Â¦sy nt he sisÂ¦ Â¦ofÂ¦ Â¦typeÂ¦ ğ‹‡Â¦iÂ¦ Â¦interfer onsÂ¦ â–( ğŠ£Â¦i f n ğŠ¼sÂ¦ )â– Â¦whichÂ¦ Â¦limitÂ¦ Â¦theÂ¦ Â¦spreadingÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦andÂ¦ Â¦accel erateÂ¦ Â¦m ac ro ph ageÂ¦ Â¦p ha g ocy t osisÂ¦ Â¦ofÂ¦ Â¦viralÂ¦ Â¦anti ge nsÂ¦ .
ğ‹‡Â¦amongÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦acc ess oryÂ¦ Â¦proteinsÂ¦ ,â– ğŠ£Â¦orf ğŠ¼ 8Â¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦thoughtÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦importantÂ¦ Â¦inÂ¦ Â¦adaptationÂ¦ Â¦toÂ¦ Â¦humansÂ¦ ,â– Â¦asÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦relatedÂ¦ Â¦batÂ¦ Â¦virusesÂ¦ Â¦wereÂ¦ Â¦isolatedÂ¦ Â¦butÂ¦ Â¦foundÂ¦ Â¦toÂ¦ Â¦enco deÂ¦ Â¦diver gentÂ¦ ğŠ£Â¦orf ğŠ¼ 8Â¦ Â¦proteinsÂ¦ .
ğ‹‡Â¦aÂ¦ Â¦numberÂ¦ Â¦ofÂ¦ Â¦provi n cialÂ¦ - Â¦levelÂ¦ Â¦administr atorsÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡Â¦comm un istÂ¦ ğ‹‡Â¦partyÂ¦ Â¦ofÂ¦ ğ‹‡Â¦chinaÂ¦ â–( ğŠ£Â¦c p cÂ¦ğŠ¼ )â– Â¦wereÂ¦ Â¦dism is sedÂ¦ Â¦overÂ¦ Â¦theirÂ¦ Â¦handlingÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦quarantineÂ¦ Â¦effortsÂ¦ Â¦inÂ¦ ğ‹‡Â¦centralÂ¦ ğ‹‡Â¦chinaÂ¦ ,â– Â¦aÂ¦ Â¦signÂ¦ Â¦ofÂ¦ Â¦disco nt entÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦politicalÂ¦ Â¦est ab l ish mentÂ¦ ' Â¦sÂ¦ Â¦responseÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ Â¦inÂ¦ Â¦thoseÂ¦ Â¦regionsÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦theÂ¦ ğŠ£Â¦usÂ¦ğŠ¼ Â¦thereÂ¦ Â¦isÂ¦ Â¦alsoÂ¦ Â¦theÂ¦ Â¦rec om mend ationÂ¦ Â¦thatÂ¦ Â¦new bor nsÂ¦ Â¦andÂ¦ Â¦mo thersÂ¦ Â¦shouldÂ¦ Â¦beÂ¦ Â¦temporarilyÂ¦ Â¦se par atedÂ¦ Â¦untilÂ¦ Â¦transmissionÂ¦ - Â¦basedÂ¦ Â¦precautionsÂ¦ Â¦areÂ¦ Â¦disco ntin u edÂ¦ ,â– Â¦andÂ¦ Â¦thatÂ¦ Â¦whereÂ¦ Â¦thisÂ¦ Â¦isÂ¦ Â¦notÂ¦ Â¦possibleÂ¦ Â¦theÂ¦ Â¦new bor nÂ¦ Â¦shouldÂ¦ Â¦beÂ¦ Â¦keptÂ¦ Â¦2Â¦ Â¦metresÂ¦ Â¦awayÂ¦ Â¦fromÂ¦ Â¦theÂ¦ Â¦motherÂ¦ .
ğ‹‡ Â¦reportsÂ¦ Â¦fromÂ¦ ğ‹‡Â¦februaryÂ¦ â–( Â¦whenÂ¦ Â¦theÂ¦ Â¦majorityÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦casesÂ¦ Â¦hadÂ¦ Â¦stillÂ¦ Â¦beenÂ¦ Â¦conf inedÂ¦ Â¦toÂ¦ ğ‹‡Â¦chinaÂ¦ )â– Â¦haveÂ¦ Â¦d oc um entedÂ¦ Â¦rac istÂ¦ Â¦s enti mentsÂ¦ Â¦expressedÂ¦ Â¦inÂ¦ Â¦variousÂ¦ Â¦groupsÂ¦ Â¦worldwideÂ¦ Â¦ofÂ¦ ğ‹‡Â¦chineseÂ¦ Â¦peopleÂ¦ Â¦d es er vingÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦orÂ¦ Â¦receivingÂ¦ Â¦whatÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦claimedÂ¦ Â¦asÂ¦ Â¦j usti fiedÂ¦ Â¦ret rib u tionÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦thisÂ¦ Â¦senseÂ¦ ,â– Â¦theÂ¦ Â¦longerÂ¦ Â¦theÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦outbreakÂ¦ Â¦per s istsÂ¦ Â¦andÂ¦ Â¦theÂ¦ Â¦moreÂ¦ Â¦peopleÂ¦ Â¦thatÂ¦ Â¦itÂ¦ Â¦infectsÂ¦ ,â– Â¦theÂ¦ Â¦greaterÂ¦ Â¦chanceÂ¦ Â¦thatÂ¦ Â¦itÂ¦ Â¦willÂ¦ Â¦fullyÂ¦ Â¦adap tÂ¦ Â¦toÂ¦ Â¦humansÂ¦ .
ğ‹‡Â¦thisÂ¦ Â¦v ari abilityÂ¦ Â¦isÂ¦ Â¦alsoÂ¦ Â¦likelyÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦significantlyÂ¦ Â¦affectingÂ¦ Â¦reportedÂ¦ Â¦caseÂ¦ Â¦fatalityÂ¦ Â¦ratesÂ¦ ,â– Â¦whichÂ¦ Â¦areÂ¦ Â¦likelyÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦significantlyÂ¦ Â¦overÂ¦ - Â¦estimatedÂ¦ Â¦inÂ¦ Â¦someÂ¦ Â¦countriesÂ¦ .
ğ‹‡ Â¦compar ablyÂ¦ ,â– Â¦theÂ¦ Â¦mortalityÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ Â¦byÂ¦ ğ‹‡Â¦novemberÂ¦ Â¦200 2Â¦ Â¦wasÂ¦ Â¦10Â¦ %â– Â¦ofÂ¦ Â¦8Â¦ , Â¦0 9 6Â¦ Â¦confirmedÂ¦ Â¦casesÂ¦ .
ğ‹‡Â¦manyÂ¦ Â¦ofÂ¦ ğ‹‡Â¦chinaÂ¦ ' Â¦sÂ¦ Â¦nearlyÂ¦ Â¦300Â¦ Â¦millionÂ¦ Â¦ruralÂ¦ Â¦migrantÂ¦ Â¦workersÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦strandedÂ¦ Â¦atÂ¦ Â¦homeÂ¦ Â¦inÂ¦ Â¦in landÂ¦ Â¦provi n cesÂ¦ Â¦orÂ¦ Â¦tra ppedÂ¦ Â¦inÂ¦ ğ‹‡Â¦hubeiÂ¦ Â¦provinceÂ¦ . ğ‹‡Â¦inÂ¦ ğ‹‡Â¦marchÂ¦ Â¦2020Â¦ ,â– Â¦moreÂ¦ Â¦thanÂ¦ Â¦10Â¦ Â¦millionÂ¦ ğ‹‡Â¦a me ric ansÂ¦ Â¦lostÂ¦ Â¦theirÂ¦ Â¦jobsÂ¦ Â¦andÂ¦ Â¦appliedÂ¦ Â¦forÂ¦ Â¦governmentÂ¦ Â¦aidÂ¦ .
ğ‹‡Â¦clinicalÂ¦ Â¦ma ni f est ationsÂ¦ Â¦ofÂ¦ ğŠ£Â¦mersÂ¦ğŠ¼ Â¦re semb leÂ¦ Â¦thoseÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ ,â– Â¦charac teri zedÂ¦ Â¦byÂ¦ Â¦prog ressiveÂ¦ Â¦acuteÂ¦ Â¦pneumoniaÂ¦ .
ğ‹‡ Â¦containmentÂ¦ Â¦isÂ¦ Â¦under ta kenÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦earlyÂ¦ Â¦stagesÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ Â¦andÂ¦ Â¦aimsÂ¦ Â¦toÂ¦ Â¦tr aceÂ¦ Â¦andÂ¦ Â¦isolateÂ¦ Â¦thoseÂ¦ Â¦infectedÂ¦ Â¦asÂ¦ Â¦wellÂ¦ Â¦asÂ¦ Â¦introdu ceÂ¦ Â¦otherÂ¦ Â¦measuresÂ¦ Â¦ofÂ¦ Â¦infectionÂ¦ Â¦controlÂ¦ Â¦andÂ¦ Â¦vaccinationsÂ¦ Â¦toÂ¦ Â¦stopÂ¦ Â¦theÂ¦ Â¦diseaseÂ¦ Â¦fromÂ¦ Â¦spreadingÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦restÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦populationÂ¦ .
ğ‹‡Â¦hongÂ¦ ğ‹‡Â¦kongÂ¦ Â¦hasÂ¦ Â¦setÂ¦ Â¦upÂ¦ Â¦aÂ¦ Â¦schemeÂ¦ Â¦whereÂ¦ Â¦suspectedÂ¦ Â¦patientsÂ¦ Â¦canÂ¦ Â¦stayÂ¦ Â¦homeÂ¦ ,â–" Â¦emergencyÂ¦ Â¦departmentÂ¦ Â¦willÂ¦ Â¦giveÂ¦ Â¦aÂ¦ Â¦specimenÂ¦ Â¦t ubeÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦patientÂ¦ ",â– Â¦theyÂ¦ Â¦sp itÂ¦ Â¦intoÂ¦ Â¦itÂ¦ ,â– Â¦sendÂ¦ Â¦itÂ¦ Â¦backÂ¦ Â¦andÂ¦ Â¦getÂ¦ Â¦aÂ¦ Â¦testÂ¦ Â¦resultÂ¦ Â¦aÂ¦ Â¦whileÂ¦ Â¦afterÂ¦ . ğ‹‡Â¦theÂ¦ ğ‹‡Â¦britishÂ¦ ğŠ£Â¦nh sÂ¦ğŠ¼ Â¦hasÂ¦ Â¦announcedÂ¦ Â¦thatÂ¦ Â¦itÂ¦ Â¦isÂ¦ Â¦pi lo tingÂ¦ Â¦aÂ¦ Â¦schemeÂ¦ Â¦toÂ¦ Â¦testÂ¦ Â¦suspectedÂ¦ Â¦casesÂ¦ Â¦atÂ¦ Â¦homeÂ¦ ,â– Â¦whichÂ¦ Â¦remo vesÂ¦ Â¦theÂ¦ Â¦riskÂ¦ Â¦ofÂ¦ Â¦aÂ¦ Â¦patientÂ¦ Â¦inf ectingÂ¦ Â¦othersÂ¦ Â¦ifÂ¦ Â¦theyÂ¦ Â¦comeÂ¦ Â¦toÂ¦ Â¦aÂ¦ Â¦hospitalÂ¦ Â¦orÂ¦ Â¦havingÂ¦ Â¦toÂ¦ Â¦disinfectÂ¦ Â¦anÂ¦ Â¦ambulanceÂ¦ Â¦ifÂ¦ Â¦oneÂ¦ Â¦isÂ¦ Â¦usedÂ¦ . ğ‹‡Â¦inÂ¦ Â¦driveÂ¦ - Â¦throughÂ¦ Â¦testingÂ¦ Â¦forÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦forÂ¦ Â¦suspectedÂ¦ Â¦casesÂ¦ ,â– Â¦aÂ¦ Â¦healthcareÂ¦ Â¦profession alÂ¦ Â¦takesÂ¦ Â¦sampleÂ¦ Â¦usingÂ¦ Â¦appropriateÂ¦ Â¦precautionsÂ¦ .
ğ‹‡Â¦forÂ¦ Â¦exampleÂ¦ ,â– ğ‹‡Â¦sh uÂ¦ ğ‹‡Â¦f en gÂ¦ ğ‹‡Â¦ji eÂ¦ ğ‹‡Â¦d uÂ¦ Â¦cap su lesÂ¦ Â¦andÂ¦ ğ‹‡Â¦ lianÂ¦ ğ‹‡Â¦hu aÂ¦ ğ‹‡Â¦ q ingÂ¦ ğ‹‡Â¦w enÂ¦ Â¦cap su lesÂ¦ Â¦wereÂ¦ Â¦foundÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦effectiveÂ¦ Â¦forÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦treatmentÂ¦ .
ğ‹‡Â¦inÂ¦ ğ‹‡Â¦decemberÂ¦ Â¦2019Â¦ ,â– Â¦theÂ¦ Â¦2019Â¦ Â¦novelÂ¦ Â¦coronavirusÂ¦ â–( Â¦2019Â¦ - Â¦n ğ‹‡coğ‹‡vÂ¦ )â– Â¦hasÂ¦ Â¦causedÂ¦ Â¦anÂ¦ Â¦outbreakÂ¦ ,â– Â¦whichÂ¦ Â¦isÂ¦ Â¦nowÂ¦ Â¦off ici allyÂ¦ Â¦namedÂ¦ Â¦asÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦diseaseÂ¦ Â¦2019Â¦ â–( ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ )â– Â¦andÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦namedÂ¦ Â¦severeÂ¦ Â¦acuteÂ¦ Â¦respiratoryÂ¦ Â¦syndromeÂ¦ Â¦coronavirusÂ¦ Â¦2Â¦ â–( ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ ).
ğ‹‡Â¦r us s ellÂ¦ ğ‹‡Â¦z im mer manÂ¦ Â¦addedÂ¦ Â¦thatÂ¦ Â¦otherÂ¦ Â¦productsÂ¦ Â¦areÂ¦ Â¦alsoÂ¦ Â¦inÂ¦ Â¦highÂ¦ Â¦demandÂ¦ ,â– Â¦includingÂ¦ Â¦masksÂ¦ ,â– Â¦sanit is erÂ¦ ,â– Â¦d riedÂ¦ Â¦goodsÂ¦ ,â– Â¦hand w ashÂ¦ Â¦andÂ¦ Â¦f lo urÂ¦ .
ğ‹‡ Â¦oc ca si on allyÂ¦ ğ‹‡Â¦iÂ¦ Â¦haveÂ¦ Â¦someÂ¦ Â¦chestÂ¦ Â¦painÂ¦
ğ‹‡Â¦theyÂ¦ Â¦canÂ¦ Â¦beÂ¦ Â¦divi dedÂ¦ Â¦intoÂ¦ Â¦fourÂ¦ Â¦gene raÂ¦ ,â– Â¦iÂ¦ . Â¦eÂ¦ .,â– Â¦alphaÂ¦ ,â– Â¦betaÂ¦ ,â– Â¦g am maÂ¦ ,â– Â¦andÂ¦ Â¦d el taÂ¦ ,â– Â¦ofÂ¦ Â¦whichÂ¦ Â¦alphaÂ¦ -â– Â¦andÂ¦ Â¦betaÂ¦ - ğ‹‡Â¦coğ‹‡vsÂ¦ Â¦areÂ¦ Â¦knownÂ¦ Â¦toÂ¦ Â¦infectÂ¦ Â¦humansÂ¦ .
ğ‹‡Â¦thusÂ¦ ,â– Â¦itÂ¦ Â¦isÂ¦ Â¦moreÂ¦ Â¦criticalÂ¦ Â¦andÂ¦ Â¦pract icalÂ¦ Â¦toÂ¦ Â¦isolateÂ¦ ğ‹‡Â¦bÂ¦ Â¦cellsÂ¦ Â¦fromÂ¦ Â¦recoveredÂ¦ Â¦patientsÂ¦ Â¦andÂ¦ Â¦identifyÂ¦ Â¦theÂ¦ Â¦geneticÂ¦ Â¦codesÂ¦ Â¦enco dingÂ¦ Â¦effectiveÂ¦ Â¦antibodiesÂ¦ Â¦orÂ¦ Â¦screenÂ¦ Â¦forÂ¦ Â¦effectiveÂ¦ Â¦antibodiesÂ¦ Â¦againstÂ¦ Â¦essentialÂ¦ Â¦proteinsÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦virusÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦theÂ¦ ğŠ£Â¦usÂ¦ğŠ¼ Â¦aÂ¦ Â¦serologicalÂ¦ Â¦testÂ¦ Â¦developedÂ¦ Â¦byÂ¦ ğ‹‡Â¦c el le xÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦approvedÂ¦ Â¦forÂ¦ Â¦emergencyÂ¦ Â¦useÂ¦ Â¦byÂ¦ Â¦certi fiedÂ¦ Â¦laboratoriesÂ¦ Â¦onlyÂ¦ .
ğ‹‡Â¦itÂ¦ Â¦isÂ¦ Â¦alsoÂ¦ Â¦suggestedÂ¦ Â¦thatÂ¦ ğ‹‡Â¦uÂ¦ . ğ‹‡Â¦sÂ¦ .â– Â¦sa nctionsÂ¦ Â¦onÂ¦ ğ‹‡Â¦iranÂ¦ Â¦mayÂ¦ Â¦beÂ¦ Â¦affectingÂ¦ Â¦theÂ¦ Â¦countryÂ¦ ' Â¦sÂ¦ Â¦financialÂ¦ Â¦abilityÂ¦ Â¦toÂ¦ Â¦respondÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦viralÂ¦ Â¦outbreakÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦contrastÂ¦ ,â– ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ ,â– ğŠ£Â¦mersÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦andÂ¦ Â¦theÂ¦ Â¦new lyÂ¦ - Â¦identifiedÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦areÂ¦ Â¦highlyÂ¦ Â¦pathogenicÂ¦ ,â– Â¦causingÂ¦ Â¦severeÂ¦ Â¦lowerÂ¦ Â¦respiratoryÂ¦ Â¦tractÂ¦ Â¦infectionÂ¦ Â¦inÂ¦ Â¦relativelyÂ¦ Â¦moreÂ¦ Â¦patientsÂ¦ Â¦withÂ¦ Â¦aÂ¦ Â¦higherÂ¦ Â¦chanceÂ¦ Â¦toÂ¦ Â¦developÂ¦ Â¦acuteÂ¦ Â¦respiratoryÂ¦ Â¦distressÂ¦ Â¦syndromeÂ¦ â–( ğŠ£Â¦ardsÂ¦ğŠ¼ )â– Â¦andÂ¦ Â¦extr ap ulmon aryÂ¦ Â¦ma ni f est ationsÂ¦ .
ğ‹‡ Â¦upÂ¦ Â¦toÂ¦ Â¦nowÂ¦ ,â– Â¦noÂ¦ Â¦liveÂ¦ ğŠ£Â¦mersÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦canÂ¦ Â¦beÂ¦ Â¦foundÂ¦ Â¦inÂ¦ Â¦wi ldÂ¦ Â¦batsÂ¦ .
ğ‹‡Â¦heÂ¦ Â¦saidÂ¦ ,â– Â¦inÂ¦ Â¦remar ksÂ¦ Â¦publishedÂ¦ Â¦byÂ¦ ğŠ£Â¦c n nÂ¦ğŠ¼ Â¦inÂ¦ ğ‹‡Â¦februaryÂ¦ ,â–" Â¦otherÂ¦ Â¦thanÂ¦ Â¦influenzaÂ¦ ,â– Â¦noÂ¦ Â¦otherÂ¦ Â¦respiratoryÂ¦ Â¦virusÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦tr ackedÂ¦ Â¦fromÂ¦ Â¦emergenceÂ¦ Â¦toÂ¦ Â¦continu ousÂ¦ Â¦globalÂ¦ Â¦spreadÂ¦ ."
ğ‹‡Â¦inÂ¦ Â¦responseÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦imp le ment ationsÂ¦ Â¦ofÂ¦ Â¦travelÂ¦ Â¦restrictionsÂ¦ ,â– ğ‹‡Â¦tedrosÂ¦ Â¦statedÂ¦ Â¦thatÂ¦ â–" Â¦thereÂ¦ Â¦isÂ¦ Â¦noÂ¦ Â¦reasonÂ¦ Â¦forÂ¦ Â¦measuresÂ¦ Â¦thatÂ¦ Â¦un n ec ess arilyÂ¦ Â¦interfer eÂ¦ Â¦withÂ¦ Â¦internationalÂ¦ Â¦travelÂ¦ Â¦andÂ¦ Â¦tradeÂ¦ "â– Â¦andÂ¦ Â¦thatÂ¦ Â¦theÂ¦ â–" ğŠ£Â¦whoÂ¦ğŠ¼ Â¦doesnÂ¦ ' Â¦tÂ¦ Â¦recommendÂ¦ Â¦limitingÂ¦ Â¦tradeÂ¦ Â¦andÂ¦ Â¦movementÂ¦ ."
ğ‹‡Â¦thisÂ¦ Â¦dele tionÂ¦ Â¦sp li tsÂ¦ ğŠ£Â¦orf ğŠ¼ 8Â¦ Â¦intoÂ¦ ğŠ£Â¦orf ğŠ¼ 8 aÂ¦ Â¦andÂ¦ ğŠ£Â¦orf ğŠ¼ 8 bÂ¦ Â¦andÂ¦ Â¦isÂ¦ Â¦thoughtÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦anÂ¦ Â¦adap tiveÂ¦ Â¦mutationÂ¦ Â¦thatÂ¦ Â¦promo tesÂ¦ Â¦theÂ¦ Â¦sw it chÂ¦ Â¦ofÂ¦ Â¦hostsÂ¦ .
ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦shar esÂ¦ Â¦96Â¦ . Â¦2Â¦ %â– Â¦nucleotideÂ¦ Â¦homologyÂ¦ Â¦withÂ¦ Â¦aÂ¦ Â¦batÂ¦ ğ‹‡Â¦coğ‹‡vÂ¦ ğ‹‡Â¦ra ğŠ£ t g ğŠ¼1 3Â¦ Â¦isolatedÂ¦ Â¦fromÂ¦ ğ‹‡Â¦r hi no lo ph usÂ¦ Â¦affi ni sÂ¦ Â¦batsÂ¦ .
ğ‹‡Â¦aÂ¦ ğŠ£Â¦unÂ¦ğŠ¼ ğ‹‡ Â¦crisisÂ¦ ğ‹‡Â¦managementÂ¦ ğ‹‡ Â¦teamÂ¦ Â¦wasÂ¦ Â¦ac tivatedÂ¦ Â¦asÂ¦ Â¦aÂ¦ Â¦resultÂ¦ ,â– Â¦allowingÂ¦ Â¦coordin ationÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦entireÂ¦ ğ‹‡Â¦unitedÂ¦ ğ‹‡Â¦n ationsÂ¦ Â¦responseÂ¦ ,â– Â¦whichÂ¦ Â¦theÂ¦ ğŠ£Â¦whoÂ¦ğŠ¼ Â¦statesÂ¦ Â¦willÂ¦ Â¦allowÂ¦ Â¦themÂ¦ Â¦toÂ¦ â–" Â¦focusÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦healthÂ¦ Â¦responseÂ¦ Â¦whileÂ¦ Â¦theÂ¦ Â¦otherÂ¦ Â¦agenciesÂ¦ Â¦canÂ¦ Â¦bringÂ¦ Â¦theirÂ¦ Â¦exp ert iseÂ¦ Â¦toÂ¦ Â¦be arÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦wi derÂ¦ Â¦socialÂ¦ ,â– Â¦economicÂ¦ Â¦andÂ¦ Â¦develop mentalÂ¦ Â¦implicationsÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ ".
ğ‹‡Â¦allÂ¦ Â¦theseÂ¦ Â¦fourÂ¦ Â¦communityÂ¦ - Â¦acquiredÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vsÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦wellÂ¦ Â¦adaptedÂ¦ Â¦toÂ¦ Â¦humansÂ¦ Â¦andÂ¦ Â¦areÂ¦ Â¦generallyÂ¦ Â¦lessÂ¦ Â¦likelyÂ¦ Â¦toÂ¦ Â¦m ut ateÂ¦ Â¦toÂ¦ Â¦causeÂ¦ Â¦highlyÂ¦ Â¦pathogenicÂ¦ Â¦diseasesÂ¦ ,â– Â¦thoughÂ¦ Â¦acci dentsÂ¦ Â¦didÂ¦ Â¦occurÂ¦ Â¦forÂ¦ Â¦unknownÂ¦ Â¦reasonsÂ¦ Â¦asÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦rareÂ¦ Â¦caseÂ¦ Â¦ofÂ¦ Â¦aÂ¦ Â¦moreÂ¦ Â¦vir ul entÂ¦ Â¦sub t yp eÂ¦ Â¦ofÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - ğŠ£Â¦nlğŠ¼63Â¦ ,â– Â¦whichÂ¦ Â¦hasÂ¦ Â¦recentlyÂ¦ Â¦beenÂ¦ Â¦reportedÂ¦ Â¦toÂ¦ Â¦causeÂ¦ Â¦severeÂ¦ Â¦lowerÂ¦ Â¦respiratoryÂ¦ Â¦tractÂ¦ Â¦infectionÂ¦ Â¦inÂ¦ ğ‹‡Â¦chinaÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦anÂ¦ Â¦onlineÂ¦ Â¦newsÂ¦ Â¦br ie f ingÂ¦ ,â– Â¦theÂ¦ Â¦directorÂ¦ Â¦ofÂ¦ ğŠ£Â¦i ed c rÂ¦ğŠ¼ ,â– ğ‹‡Â¦drÂ¦ ğ‹‡Â¦me er j ad yÂ¦ ğ‹‡Â¦sab ri naÂ¦ ğ‹‡Â¦f lo raÂ¦ ,â– Â¦saidÂ¦ Â¦theÂ¦ Â¦f at alitiesÂ¦ Â¦includedÂ¦ Â¦fourÂ¦ Â¦ma lesÂ¦ Â¦andÂ¦ Â¦oneÂ¦ Â¦femaleÂ¦ .
ğŠ£Â¦mersÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦andÂ¦ Â¦itsÂ¦ Â¦cl os estÂ¦ Â¦relativeÂ¦ Â¦batÂ¦ ğ‹‡Â¦coğ‹‡vÂ¦ - ğŠ£Â¦hkuğŠ¼ 25Â¦ Â¦shareÂ¦ Â¦onlyÂ¦ Â¦8 7Â¦ %â– Â¦nucleotideÂ¦ Â¦sequenceÂ¦ Â¦homologyÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦theÂ¦ Â¦5Â¦ ğ‹‡Â¦marchÂ¦ Â¦issueÂ¦ Â¦ofÂ¦ ğ‹‡Â¦e ur os ur ve i ll anceÂ¦ Â¦2020Â¦ ,â– ğ‹‡Â¦s pi te riÂ¦ Â¦etÂ¦ Â¦alÂ¦ .â– Â¦reportedÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦firstÂ¦ ğ‹‡Â¦europeanÂ¦ Â¦confirmedÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦casesÂ¦ Â¦accordingÂ¦ Â¦toÂ¦ Â¦theÂ¦ ğŠ£Â¦whoÂ¦ğŠ¼ Â¦caseÂ¦ Â¦defini tionÂ¦ .
ğ‹‡ Â¦generallyÂ¦ ,â– Â¦whenÂ¦ Â¦theseÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vsÂ¦ Â¦ac qui reÂ¦ Â¦theÂ¦ Â¦ab ilitiesÂ¦ Â¦toÂ¦ Â¦trans mitÂ¦ Â¦eff icientlyÂ¦ Â¦andÂ¦ Â¦toÂ¦ Â¦maintainÂ¦ Â¦themselvesÂ¦ Â¦continu ouslyÂ¦ Â¦withinÂ¦ Â¦humansÂ¦ ,â– Â¦theyÂ¦ Â¦alsoÂ¦ Â¦becomeÂ¦ Â¦lessÂ¦ Â¦vir ul entÂ¦ Â¦orÂ¦ Â¦pathogenicÂ¦ .
ğ‹‡Â¦si al od ac r yo a de ni tisÂ¦ Â¦virusÂ¦ â–( ğŠ£Â¦s d a vÂ¦ğŠ¼ )â– Â¦isÂ¦ Â¦highlyÂ¦ Â¦infectiousÂ¦ Â¦coronavirusÂ¦ Â¦ofÂ¦ Â¦laboratoryÂ¦ Â¦ra tsÂ¦ ,â– Â¦whichÂ¦ Â¦canÂ¦ Â¦beÂ¦ Â¦transmittedÂ¦ Â¦betweenÂ¦ Â¦individualsÂ¦ Â¦byÂ¦ Â¦directÂ¦ Â¦contactÂ¦ Â¦andÂ¦ Â¦i nd ir ectlyÂ¦ Â¦byÂ¦ Â¦aerosolÂ¦ .
ğ‹‡ Â¦immuno su pp ressionÂ¦ Â¦isÂ¦ Â¦essentialÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦treatmentÂ¦ Â¦ofÂ¦ Â¦cytokineÂ¦ Â¦stor msÂ¦ ,â– Â¦especiallyÂ¦ Â¦inÂ¦ Â¦severeÂ¦ Â¦patientsÂ¦ .
ğ‹‡Â¦aÂ¦ Â¦largeÂ¦ Â¦studyÂ¦ Â¦inÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦comparedÂ¦ Â¦chestÂ¦ ğŠ£Â¦ctÂ¦ğŠ¼ Â¦resultsÂ¦ Â¦toÂ¦ ğŠ£Â¦pcrÂ¦ğŠ¼ Â¦andÂ¦ Â¦demonstratedÂ¦ Â¦thatÂ¦ Â¦thoughÂ¦ Â¦imagingÂ¦ Â¦isÂ¦ Â¦lessÂ¦ Â¦specificÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦infectionÂ¦ ,â– Â¦itÂ¦ Â¦isÂ¦ Â¦fasterÂ¦ Â¦andÂ¦ Â¦moreÂ¦ Â¦sensitiveÂ¦ ,â– Â¦sugg estingÂ¦ Â¦itsÂ¦ Â¦consider ationÂ¦ Â¦asÂ¦ Â¦aÂ¦ Â¦screeningÂ¦ Â¦to olÂ¦ Â¦inÂ¦ Â¦epidemicÂ¦ Â¦areasÂ¦ .
ğ‹‡Â¦howeverÂ¦ ,â– ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦hasÂ¦ Â¦lowerÂ¦ Â¦severityÂ¦ Â¦andÂ¦ Â¦mortalityÂ¦ Â¦thanÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ Â¦butÂ¦ Â¦isÂ¦ Â¦muchÂ¦ Â¦moreÂ¦ Â¦transmis siveÂ¦ Â¦andÂ¦ Â¦affectsÂ¦ Â¦moreÂ¦ Â¦elderlyÂ¦ Â¦individualsÂ¦ Â¦thanÂ¦ Â¦youthÂ¦ Â¦andÂ¦ Â¦moreÂ¦ Â¦menÂ¦ Â¦thanÂ¦ Â¦womenÂ¦ .
ğ‹‡Â¦andÂ¦ Â¦thereÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦maskÂ¦ - Â¦relatedÂ¦ Â¦disp u tesÂ¦ Â¦reportedÂ¦ Â¦betweenÂ¦ Â¦otherÂ¦ Â¦countriesÂ¦ ,â– Â¦suchÂ¦ Â¦asÂ¦ ğ‹‡Â¦germanyÂ¦ ,â– ğ‹‡Â¦austriaÂ¦ Â¦andÂ¦ ğ‹‡Â¦switzerlandÂ¦ ;â– Â¦andÂ¦ Â¦theÂ¦ ğ‹‡Â¦c z echÂ¦ ğ‹‡Â¦republ icÂ¦ Â¦andÂ¦ ğ‹‡Â¦italyÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦additionÂ¦ Â¦toÂ¦ Â¦cell ularÂ¦ Â¦receptorsÂ¦ ,â– Â¦theÂ¦ Â¦outcomeÂ¦ Â¦ofÂ¦ Â¦interspeciesÂ¦ Â¦transmissionÂ¦ Â¦ofÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vsÂ¦ Â¦isÂ¦ Â¦alsoÂ¦ Â¦govern edÂ¦ Â¦byÂ¦ Â¦otherÂ¦ Â¦hostÂ¦ Â¦dep e nd encyÂ¦ Â¦andÂ¦ Â¦restrictionÂ¦ Â¦factorsÂ¦ .
ğ‹‡Â¦schoolsÂ¦ Â¦inÂ¦ Â¦theÂ¦ ğ‹‡Â¦se att leÂ¦ Â¦areaÂ¦ Â¦cancelledÂ¦ Â¦classesÂ¦ Â¦onÂ¦ Â¦3Â¦ ğ‹‡Â¦marchÂ¦ ,â– Â¦andÂ¦ Â¦byÂ¦ Â¦midÂ¦ - ğ‹‡Â¦marchÂ¦ ,â– Â¦schoolsÂ¦ Â¦acrossÂ¦ Â¦theÂ¦ Â¦countryÂ¦ Â¦wereÂ¦ Â¦sh uttingÂ¦ Â¦downÂ¦ . ğ‹‡Â¦onÂ¦ Â¦6Â¦ ğ‹‡Â¦marchÂ¦ Â¦2020Â¦ ,â– Â¦theÂ¦ ğ‹‡Â¦unitedÂ¦ ğ‹‡Â¦statesÂ¦ Â¦wasÂ¦ Â¦advisedÂ¦ Â¦ofÂ¦ Â¦pro j ectionsÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦impactÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦newÂ¦ Â¦coronavirusÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦countryÂ¦ Â¦byÂ¦ Â¦aÂ¦ Â¦groupÂ¦ Â¦ofÂ¦ Â¦epidem i ologistsÂ¦ Â¦atÂ¦ ğ‹‡ Â¦impe rialÂ¦ ğ‹‡Â¦collegeÂ¦ ğ‹‡Â¦londonÂ¦ .
ğ‹‡Â¦manyÂ¦ Â¦scientificÂ¦ Â¦p ubl ish ersÂ¦ Â¦madeÂ¦ Â¦scientificÂ¦ Â¦papersÂ¦ Â¦relatedÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ Â¦availableÂ¦ Â¦withÂ¦ Â¦openÂ¦ Â¦accessÂ¦ .
ğ‹‡Â¦manyÂ¦ ğ‹‡Â¦l un arÂ¦ ğ‹‡Â¦newÂ¦ ğ‹‡Â¦yearÂ¦ Â¦eventsÂ¦ Â¦andÂ¦ Â¦t our istÂ¦ Â¦attr actionsÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦closedÂ¦ Â¦toÂ¦ Â¦preventÂ¦ Â¦massÂ¦ Â¦gatheringsÂ¦ ,â– Â¦includingÂ¦ Â¦theÂ¦ ğ‹‡Â¦for b iddenÂ¦ ğ‹‡Â¦cityÂ¦ Â¦inÂ¦ ğ‹‡Â¦be i j ingÂ¦ Â¦andÂ¦ Â¦traditionalÂ¦ Â¦temp leÂ¦ Â¦fa irsÂ¦ .
ğ‹‡Â¦thereÂ¦ Â¦isÂ¦ Â¦noÂ¦ Â¦dataÂ¦ Â¦yetÂ¦ Â¦onÂ¦ Â¦earlyÂ¦ Â¦pregnancyÂ¦ .
ğ‹‡Â¦althoughÂ¦ Â¦theÂ¦ Â¦wordÂ¦ â–" Â¦pandemicÂ¦ "â– Â¦onlyÂ¦ Â¦ref ersÂ¦ Â¦toÂ¦ Â¦howÂ¦ Â¦widelyÂ¦ Â¦aÂ¦ Â¦diseaseÂ¦ Â¦hasÂ¦ Â¦spreadÂ¦ ,â– Â¦notÂ¦ Â¦howÂ¦ Â¦dangerousÂ¦ Â¦specificÂ¦ Â¦casesÂ¦ Â¦areÂ¦ ,â– Â¦theÂ¦ ğŠ£Â¦whoÂ¦ğŠ¼ Â¦notedÂ¦ Â¦theÂ¦ Â¦needÂ¦ Â¦toÂ¦ Â¦driveÂ¦ Â¦governmentsÂ¦ Â¦toÂ¦ Â¦actionÂ¦ :
ğ‹‡ Â¦per va siveÂ¦ Â¦evidenceÂ¦ Â¦hasÂ¦ Â¦shownÂ¦ Â¦thatÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ ,â– ğŠ£Â¦mersÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦andÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦haveÂ¦ Â¦aÂ¦ Â¦batÂ¦ Â¦originÂ¦ Â¦andÂ¦ Â¦areÂ¦ Â¦transmittedÂ¦ Â¦toÂ¦ Â¦humansÂ¦ Â¦viaÂ¦ Â¦intermediateÂ¦ Â¦hostsÂ¦ .
ğ‹‡Â¦areÂ¦ Â¦youÂ¦ Â¦havingÂ¦ Â¦anyÂ¦ Â¦otherÂ¦ Â¦symptomsÂ¦ ?
ğ‹‡Â¦aÂ¦ Â¦globalÂ¦ Â¦safetyÂ¦ Â¦monitoringÂ¦ Â¦boardÂ¦ Â¦ofÂ¦ ğŠ£Â¦whoÂ¦ğŠ¼ Â¦phys i ciansÂ¦ Â¦exam ineÂ¦ Â¦in teri mÂ¦ Â¦resultsÂ¦ Â¦toÂ¦ Â¦ass istÂ¦ Â¦decisionsÂ¦ Â¦onÂ¦ Â¦safetyÂ¦ Â¦andÂ¦ Â¦effectivenessÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦trialÂ¦ Â¦drugsÂ¦ ,â– Â¦andÂ¦ Â¦al terÂ¦ Â¦theÂ¦ Â¦trialÂ¦ Â¦designÂ¦ Â¦orÂ¦ Â¦recommendÂ¦ Â¦anÂ¦ Â¦effectiveÂ¦ Â¦therapyÂ¦ .
ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - ğŠ£Â¦nlğŠ¼63Â¦ Â¦isÂ¦ Â¦associatedÂ¦ Â¦withÂ¦ Â¦obs truc tiveÂ¦ Â¦l ar y n gi tisÂ¦ ,â– Â¦alsoÂ¦ Â¦knownÂ¦ Â¦asÂ¦ Â¦c ro upÂ¦ .
ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦isÂ¦ Â¦ap pa re ntlyÂ¦ Â¦lessÂ¦ Â¦pathogenicÂ¦ Â¦butÂ¦ Â¦moreÂ¦ Â¦transmis sibleÂ¦ Â¦comparedÂ¦ Â¦toÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦andÂ¦ ğŠ£Â¦mersÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦initialÂ¦ Â¦estimatesÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦basicÂ¦ Â¦reprodu ctionÂ¦ Â¦numberÂ¦ â–( ğ‹‡Â¦r 0Â¦ )â– Â¦forÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦wereÂ¦ Â¦1Â¦ . Â¦4Â¦ Â¦toÂ¦ Â¦2Â¦ . Â¦4Â¦ .
ğ‹‡Â¦itÂ¦ Â¦statedÂ¦ Â¦thatÂ¦ Â¦muchÂ¦ Â¦wasÂ¦ Â¦yetÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦discoveredÂ¦ Â¦aboutÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ ,â– Â¦andÂ¦ Â¦thatÂ¦ ğ‹‡Â¦australiaÂ¦ Â¦wouldÂ¦ Â¦emp ha si zeÂ¦ Â¦borderÂ¦ Â¦controlÂ¦ Â¦andÂ¦ Â¦communicationÂ¦ Â¦inÂ¦ Â¦itsÂ¦ Â¦responseÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦pandemicÂ¦ .
ğ‹‡Â¦asÂ¦ Â¦ofÂ¦ ğ‹‡Â¦februaryÂ¦ Â¦14Â¦ ,â– Â¦2020Â¦ ,â– Â¦overÂ¦ Â¦25 00Â¦ Â¦laboratoryÂ¦ Â¦confirmedÂ¦ Â¦casesÂ¦ Â¦wereÂ¦ Â¦reportedÂ¦ Â¦withÂ¦ Â¦aÂ¦ Â¦highÂ¦ Â¦caseÂ¦ Â¦fatalityÂ¦ Â¦ofÂ¦ Â¦34Â¦ . Â¦4Â¦ %,â– Â¦makingÂ¦ ğŠ£Â¦mersÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦oneÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦mostÂ¦ Â¦devast atingÂ¦ Â¦virusesÂ¦ Â¦knownÂ¦ Â¦toÂ¦ Â¦humansÂ¦ .
ğ‹‡ Â¦withinÂ¦ Â¦aÂ¦ Â¦monthÂ¦ ,â– Â¦theÂ¦ Â¦numberÂ¦ Â¦ofÂ¦ Â¦coronavirusÂ¦ Â¦casesÂ¦ Â¦inÂ¦ ğ‹‡Â¦hubeiÂ¦ Â¦graduallyÂ¦ Â¦increasedÂ¦ .
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦worldÂ¦ ğ‹‡Â¦healthÂ¦ ğ‹‡Â¦organizationÂ¦ Â¦andÂ¦ ğ‹‡Â¦centersÂ¦ Â¦forÂ¦ ğ‹‡Â¦diseaseÂ¦ ğ‹‡Â¦controlÂ¦ Â¦andÂ¦ ğ‹‡Â¦preventionÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡Â¦unitedÂ¦ ğ‹‡Â¦statesÂ¦ Â¦advis esÂ¦ Â¦pregnantÂ¦ Â¦womenÂ¦ Â¦toÂ¦ Â¦doÂ¦ Â¦theÂ¦ Â¦sameÂ¦ Â¦thingsÂ¦ Â¦asÂ¦ Â¦theÂ¦ Â¦generalÂ¦ Â¦publicÂ¦ Â¦toÂ¦ Â¦avoidÂ¦ Â¦infectionÂ¦ ,â– Â¦suchÂ¦ Â¦asÂ¦ Â¦coveringÂ¦ Â¦coughÂ¦ ,â– Â¦avoidÂ¦ Â¦interactingÂ¦ Â¦withÂ¦ Â¦sickÂ¦ Â¦peopleÂ¦ ,â– Â¦cleaningÂ¦ Â¦handsÂ¦ Â¦withÂ¦ Â¦soapÂ¦ Â¦andÂ¦ Â¦waterÂ¦ Â¦orÂ¦ Â¦sanitizerÂ¦ .
ğ‹‡Â¦inÂ¦ ğ‹‡Â¦australiaÂ¦ ,â– Â¦theÂ¦ Â¦pandemicÂ¦ Â¦providedÂ¦ Â¦aÂ¦ Â¦newÂ¦ Â¦opportunityÂ¦ Â¦forÂ¦ Â¦d ai go uÂ¦ Â¦sho pp ersÂ¦ Â¦toÂ¦ Â¦sellÂ¦ ğ‹‡Â¦aust ra lianÂ¦ Â¦productsÂ¦ Â¦intoÂ¦ ğ‹‡Â¦chinaÂ¦ .
ğ‹‡Â¦theseÂ¦ Â¦modi fic ationsÂ¦ Â¦basedÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦researchersÂ¦ Â¦continuedÂ¦ Â¦workÂ¦ Â¦thatÂ¦ Â¦toÂ¦ Â¦searchÂ¦ Â¦forÂ¦ Â¦anÂ¦ Â¦op ti malÂ¦ Â¦nucle icÂ¦ Â¦acidÂ¦ Â¦detectionÂ¦ Â¦kitÂ¦ Â¦forÂ¦ Â¦rapidÂ¦ Â¦diagnosisÂ¦ ,â– Â¦asÂ¦ Â¦wellÂ¦ Â¦asÂ¦ Â¦theÂ¦ Â¦samplesÂ¦ Â¦fromÂ¦ Â¦respiratoryÂ¦ Â¦tractÂ¦ Â¦includingÂ¦ Â¦bloodÂ¦ Â¦samplingÂ¦ ,â– Â¦whichÂ¦ Â¦increasedÂ¦ Â¦theÂ¦ Â¦availabilityÂ¦ Â¦ofÂ¦ Â¦differentÂ¦ Â¦specimensÂ¦ ,â– Â¦andÂ¦ Â¦sup portedÂ¦ Â¦bringingÂ¦ Â¦theÂ¦ Â¦specificÂ¦ Â¦antibodyÂ¦ Â¦positiveÂ¦ Â¦resultÂ¦ Â¦intoÂ¦ Â¦theÂ¦ Â¦confirmedÂ¦ Â¦criteriaÂ¦ .
ğ‹‡ Â¦continu ousÂ¦ Â¦surveillanceÂ¦ Â¦inÂ¦ Â¦mammalsÂ¦ Â¦isÂ¦ Â¦necessaryÂ¦ Â¦forÂ¦ Â¦betterÂ¦ Â¦underst an dingÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦ ec ologyÂ¦ Â¦ofÂ¦ ğ‹‡Â¦coğ‹‡vsÂ¦ Â¦andÂ¦ Â¦theirÂ¦ Â¦naturalÂ¦ Â¦hostsÂ¦ ,â– Â¦whichÂ¦ Â¦willÂ¦ Â¦pro veÂ¦ Â¦usefulÂ¦ Â¦inÂ¦ Â¦preventingÂ¦ Â¦animalÂ¦ - Â¦toÂ¦ - Â¦humanÂ¦ Â¦transmissionÂ¦ Â¦andÂ¦ Â¦futureÂ¦ Â¦outbreaksÂ¦ .
ğ‹‡Â¦itÂ¦ Â¦hur tsÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦middleÂ¦ Â¦ofÂ¦ Â¦myÂ¦ Â¦chestÂ¦
ğ‹‡Â¦theÂ¦ Â¦entireÂ¦ Â¦humanÂ¦ Â¦populationÂ¦ Â¦generallyÂ¦ Â¦l acksÂ¦ Â¦immunityÂ¦ Â¦toÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦andÂ¦ Â¦he nceÂ¦ Â¦isÂ¦ Â¦suscepti bleÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦novelÂ¦ Â¦virusÂ¦ .
ğ‹‡Â¦toÂ¦ Â¦conclu deÂ¦ ,â– Â¦theÂ¦ Â¦mostÂ¦ Â¦effectiveÂ¦ Â¦wayÂ¦ Â¦toÂ¦ Â¦preventÂ¦ Â¦viralÂ¦ Â¦z o on osisÂ¦ Â¦isÂ¦ Â¦forÂ¦ Â¦humansÂ¦ Â¦toÂ¦ Â¦stayÂ¦ Â¦awayÂ¦ Â¦fromÂ¦ Â¦theÂ¦ Â¦e co logicalÂ¦ Â¦ ni chesÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦naturalÂ¦ Â¦reserv o irsÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦zoonoticÂ¦ Â¦virusesÂ¦ .
ğ‹‡ Â¦mentalÂ¦ Â¦stressÂ¦ :â– ğ‹‡Â¦asÂ¦ Â¦describedÂ¦ Â¦aboveÂ¦ ,â– Â¦duringÂ¦ Â¦theÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦outbreakÂ¦ Â¦manyÂ¦ Â¦patientsÂ¦ Â¦haveÂ¦ Â¦sufferedÂ¦ Â¦fromÂ¦ Â¦ext ra ord in aryÂ¦ Â¦stressÂ¦ Â¦asÂ¦ Â¦theyÂ¦ Â¦oftenÂ¦ Â¦end uredÂ¦ Â¦longÂ¦ Â¦per io dsÂ¦ Â¦ofÂ¦ Â¦quarantineÂ¦ Â¦andÂ¦ Â¦ext re meÂ¦ Â¦unc ertain tyÂ¦ Â¦andÂ¦ Â¦witnes sedÂ¦ Â¦theÂ¦ Â¦deathÂ¦ Â¦ofÂ¦ Â¦closeÂ¦ Â¦familyÂ¦ Â¦membersÂ¦ Â¦andÂ¦ Â¦f ellowÂ¦ Â¦patientsÂ¦ .
ğ‹‡Â¦pre t tyÂ¦ Â¦muchÂ¦ Â¦theÂ¦ Â¦sameÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦feverÂ¦ Â¦andÂ¦ Â¦theÂ¦ Â¦coughÂ¦ Â¦headacheÂ¦ Â¦andÂ¦ Â¦muscleÂ¦ Â¦pa insÂ¦
ğ‹‡Â¦besidesÂ¦ Â¦theÂ¦ Â¦highlyÂ¦ Â¦pathogenicÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vsÂ¦ ,â– Â¦theÂ¦ Â¦zoonoticÂ¦ Â¦originÂ¦ Â¦ofÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - Â¦229ğ‹‡eÂ¦ ,â– ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - ğŠ£ Â¦oc 43Â¦ ,â– Â¦h cğŠ¼oğ‹‡vÂ¦ - ğŠ£Â¦nlğŠ¼63Â¦ Â¦andÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - ğŠ£Â¦hkuğŠ¼1Â¦ Â¦haveÂ¦ Â¦alsoÂ¦ Â¦beenÂ¦ Â¦studiedÂ¦ .
ğ‹‡Â¦aÂ¦ Â¦studyÂ¦ Â¦publishedÂ¦ Â¦onÂ¦ Â¦16Â¦ ğ‹‡Â¦marchÂ¦ Â¦foundÂ¦ Â¦thatÂ¦ Â¦inÂ¦ ğ‹‡Â¦chinaÂ¦ ,â– Â¦upÂ¦ Â¦toÂ¦ Â¦23Â¦ ğ‹‡Â¦januaryÂ¦ ,â– Â¦anÂ¦ Â¦estimatedÂ¦ Â¦8 6Â¦ %â– Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦infectionsÂ¦ Â¦hadÂ¦ Â¦notÂ¦ Â¦beenÂ¦ Â¦detectedÂ¦ ,â– Â¦andÂ¦ Â¦thatÂ¦ Â¦theseÂ¦ Â¦ und oc um entedÂ¦ Â¦infectionsÂ¦ Â¦wereÂ¦ Â¦theÂ¦ Â¦infectionÂ¦ Â¦sourceÂ¦ Â¦forÂ¦ Â¦79Â¦ %â– Â¦ofÂ¦ Â¦d oc um entedÂ¦ Â¦casesÂ¦ .
ğ‹‡Â¦medicalÂ¦ Â¦screeningÂ¦ Â¦wasÂ¦ Â¦performedÂ¦ Â¦priorÂ¦ Â¦toÂ¦ Â¦dep art ureÂ¦ ,â– Â¦andÂ¦ Â¦fourÂ¦ ğ‹‡Â¦southÂ¦ ğ‹‡ Â¦af ric ansÂ¦ Â¦whoÂ¦ Â¦wereÂ¦ Â¦showingÂ¦ Â¦signsÂ¦ Â¦ofÂ¦ Â¦coronavirusÂ¦ Â¦wereÂ¦ Â¦leftÂ¦ Â¦behindÂ¦ Â¦toÂ¦ Â¦mi tig ateÂ¦ Â¦riskÂ¦ .
ğ‹‡Â¦pharmaceuticalÂ¦ Â¦companiesÂ¦ Â¦areÂ¦ Â¦rac ingÂ¦ Â¦toÂ¦ Â¦developÂ¦ Â¦antibodiesÂ¦ Â¦andÂ¦ Â¦vaccinesÂ¦ Â¦againstÂ¦ Â¦theÂ¦ Â¦virusÂ¦ .
ğ‹‡Â¦itsÂ¦ Â¦spo rad icÂ¦ Â¦transmissionÂ¦ Â¦toÂ¦ Â¦humansÂ¦ Â¦isÂ¦ Â¦anÂ¦ Â¦accidentÂ¦ Â¦andÂ¦ Â¦humansÂ¦ Â¦remainÂ¦ Â¦aÂ¦ Â¦deadÂ¦ - Â¦endÂ¦ Â¦hostÂ¦ Â¦ofÂ¦ ğŠ£Â¦mersÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦asÂ¦ Â¦itsÂ¦ Â¦transmissionÂ¦ Â¦cannotÂ¦ Â¦beÂ¦ Â¦s us ta inedÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦openÂ¦ Â¦readingÂ¦ Â¦fr amesÂ¦ Â¦ 1 aÂ¦ Â¦andÂ¦ Â¦ 1 bÂ¦ ,â– Â¦whichÂ¦ Â¦ occ up yÂ¦ Â¦theÂ¦ Â¦firstÂ¦ Â¦twoÂ¦ - Â¦thir dsÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦genomeÂ¦ ,â– Â¦enco deÂ¦ Â¦theÂ¦ Â¦replic aseÂ¦ / Â¦trans c ript aseÂ¦ Â¦pol yp roteinÂ¦ .
ğ‹‡Â¦althoughÂ¦ Â¦theseÂ¦ Â¦actionsÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦dr am aticallyÂ¦ Â¦da ma gingÂ¦ Â¦theÂ¦ Â¦economyÂ¦ Â¦andÂ¦ Â¦otherÂ¦ Â¦sectorsÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦countryÂ¦ ,â– Â¦theÂ¦ Â¦numberÂ¦ Â¦ofÂ¦ Â¦newÂ¦ Â¦patientsÂ¦ Â¦isÂ¦ Â¦decliningÂ¦ ,â– Â¦indicatingÂ¦ Â¦theÂ¦ Â¦sl ow d ownÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦epidemicÂ¦ .
ğ‹‡Â¦byÂ¦ Â¦23Â¦ ğ‹‡Â¦marchÂ¦ ,â– Â¦noÂ¦ Â¦countryÂ¦ Â¦hadÂ¦ Â¦testedÂ¦ Â¦moreÂ¦ Â¦thanÂ¦ Â¦3Â¦ %â– Â¦ofÂ¦ Â¦theirÂ¦ Â¦populationÂ¦ ,â– Â¦andÂ¦ Â¦thereÂ¦ Â¦areÂ¦ Â¦massiveÂ¦ Â¦v ari ationsÂ¦ Â¦inÂ¦ Â¦howÂ¦ Â¦muchÂ¦ Â¦testingÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦doneÂ¦ Â¦acrossÂ¦ Â¦countriesÂ¦ .
ğ‹‡Â¦hongÂ¦ ğ‹‡Â¦kongÂ¦ Â¦raisedÂ¦ Â¦itsÂ¦ Â¦infectiousÂ¦ Â¦diseaseÂ¦ Â¦responseÂ¦ Â¦levelÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦highestÂ¦ Â¦andÂ¦ Â¦declaredÂ¦ Â¦anÂ¦ Â¦emergencyÂ¦ ,â– Â¦closingÂ¦ Â¦schoolsÂ¦ Â¦untilÂ¦ ğ‹‡Â¦marchÂ¦ Â¦andÂ¦ Â¦cancellingÂ¦ Â¦itsÂ¦ ğ‹‡Â¦newÂ¦ ğ‹‡Â¦yearÂ¦ Â¦celebr ationsÂ¦ . ğ‹‡Â¦theÂ¦ Â¦re tailÂ¦ Â¦sectorÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦impactedÂ¦ Â¦globallyÂ¦ ,â– Â¦withÂ¦ Â¦r ed uc tionsÂ¦ Â¦inÂ¦ Â¦storeÂ¦ Â¦hoursÂ¦ Â¦orÂ¦ Â¦temporaryÂ¦ Â¦closuresÂ¦ .
ğ‹‡Â¦despiteÂ¦ Â¦doingÂ¦ Â¦soÂ¦ ,â– Â¦theÂ¦ ğ‹‡Â¦unitedÂ¦ ğ‹‡Â¦statesÂ¦ Â¦hadÂ¦ Â¦aÂ¦ Â¦slowÂ¦ Â¦startÂ¦ Â¦inÂ¦ Â¦testingÂ¦ ,â– Â¦whichÂ¦ Â¦obs c uredÂ¦ Â¦theÂ¦ Â¦trueÂ¦ Â¦extentÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ Â¦atÂ¦ Â¦theÂ¦ Â¦timeÂ¦ .
ğ‹‡Â¦theseÂ¦ Â¦virusesÂ¦ Â¦doÂ¦ Â¦notÂ¦ Â¦needÂ¦ Â¦anÂ¦ Â¦animalÂ¦ Â¦reservoirÂ¦ .
ğ‹‡Â¦someÂ¦ Â¦haveÂ¦ Â¦proposedÂ¦ Â¦thatÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦mayÂ¦ Â¦alsoÂ¦ Â¦beÂ¦ Â¦transmittedÂ¦ Â¦byÂ¦ Â¦smallÂ¦ Â¦dropletsÂ¦ Â¦thatÂ¦ Â¦stayÂ¦ Â¦forÂ¦ Â¦moreÂ¦ Â¦pr ol on gedÂ¦ Â¦per io dsÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦airÂ¦ ,â– Â¦thatÂ¦ Â¦mayÂ¦ Â¦beÂ¦ Â¦generatedÂ¦ Â¦duringÂ¦ Â¦speechÂ¦ . ğ‹‡ Â¦respiratoryÂ¦ Â¦dropletsÂ¦ Â¦mayÂ¦ Â¦alsoÂ¦ Â¦beÂ¦ Â¦producedÂ¦ Â¦duringÂ¦ Â¦breathingÂ¦ Â¦outÂ¦ ,â– Â¦includingÂ¦ Â¦whenÂ¦ Â¦talkingÂ¦ ,â– Â¦thoughÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦isÂ¦ Â¦notÂ¦ Â¦generallyÂ¦ Â¦airborneÂ¦ .
ğ‹‡ Â¦whereasÂ¦ Â¦civetsÂ¦ Â¦andÂ¦ Â¦otherÂ¦ Â¦animalsÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦marketsÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦foundÂ¦ Â¦toÂ¦ Â¦har bo urÂ¦ Â¦virusesÂ¦ Â¦identi calÂ¦ Â¦toÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ ,â– Â¦immediateÂ¦ Â¦intermediateÂ¦ Â¦hostsÂ¦ Â¦forÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦haveÂ¦ Â¦notÂ¦ Â¦beenÂ¦ Â¦identifiedÂ¦ .
ğ‹‡Â¦useÂ¦ Â¦ofÂ¦ Â¦s teroidsÂ¦ :â– ğ‹‡Â¦asÂ¦ Â¦describedÂ¦ Â¦aboveÂ¦ ,â– Â¦s teroidsÂ¦ Â¦areÂ¦ Â¦immuno s up pr ess antÂ¦ Â¦commonlyÂ¦ Â¦usedÂ¦ Â¦asÂ¦ Â¦anÂ¦ Â¦adj u nc tiveÂ¦ Â¦therapyÂ¦ Â¦forÂ¦ Â¦infectiousÂ¦ Â¦diseasesÂ¦ Â¦toÂ¦ Â¦reduceÂ¦ Â¦theÂ¦ Â¦severityÂ¦ Â¦ofÂ¦ Â¦inflammatoryÂ¦ Â¦damageÂ¦ .
ğ‹‡Â¦aÂ¦ Â¦comparisonÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦epidemicÂ¦ Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦withÂ¦ Â¦thatÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ Â¦andÂ¦ ğŠ£Â¦mersÂ¦ğŠ¼ Â¦isÂ¦ Â¦providedÂ¦ Â¦belowÂ¦ â–( ğ‹‡Â¦figÂ¦ .â– â€‹ ( ğ‹‡Â¦figÂ¦ . Â¦55Â¦ ).
ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦wasÂ¦ Â¦foundÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦aÂ¦ Â¦newÂ¦ Â¦typeÂ¦ Â¦ofÂ¦ Â¦betaÂ¦ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦withÂ¦ Â¦moreÂ¦ Â¦thanÂ¦ Â¦99Â¦ . Â¦98Â¦ %â– Â¦geneticÂ¦ Â¦identityÂ¦ Â¦amongÂ¦ Â¦10Â¦ Â¦se que ncedÂ¦ Â¦samplesÂ¦ Â¦collectedÂ¦ Â¦fromÂ¦ Â¦theÂ¦ Â¦originalÂ¦ Â¦siteÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ ,â– Â¦theÂ¦ ğ‹‡Â¦hu an anÂ¦ ğ‹‡Â¦s ea f oodÂ¦ ğ‹‡ Â¦marketÂ¦ Â¦inÂ¦ ğ‹‡Â¦wuhanÂ¦ .
ğ‹‡Â¦onÂ¦ ğ‹‡Â¦januaryÂ¦ Â¦23Â¦ ,â– Â¦theÂ¦ Â¦cityÂ¦ Â¦ofÂ¦ ğ‹‡Â¦wuhanÂ¦ Â¦wasÂ¦ Â¦l ockedÂ¦ Â¦downÂ¦ Â¦withÂ¦ Â¦allÂ¦ Â¦itsÂ¦ Â¦publicÂ¦ Â¦transportationÂ¦ Â¦stoppedÂ¦ .
ğ‹‡Â¦secondÂ¦ ,â– ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - Â¦229ğ‹‡eÂ¦ - Â¦relatedÂ¦ Â¦batÂ¦ Â¦alphaÂ¦ - ğ‹‡Â¦coğ‹‡vsÂ¦ Â¦areÂ¦ Â¦diver seÂ¦ Â¦andÂ¦ Â¦nonÂ¦ - Â¦pathogenicÂ¦ Â¦inÂ¦ Â¦batsÂ¦ ,â– Â¦whereasÂ¦ Â¦al pac aÂ¦ Â¦alphaÂ¦ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦causedÂ¦ Â¦anÂ¦ Â¦outbreakÂ¦ Â¦ofÂ¦ Â¦respiratoryÂ¦ Â¦diseaseÂ¦ Â¦inÂ¦ Â¦infectedÂ¦ Â¦animalsÂ¦ .
ğ‹‡Â¦butÂ¦ Â¦youÂ¦ ' Â¦reÂ¦ Â¦breathingÂ¦ Â¦allÂ¦ Â¦rightÂ¦ Â¦rightÂ¦ Â¦nowÂ¦ Â¦rightÂ¦ ?
ğ‹‡Â¦inÂ¦ Â¦aÂ¦ Â¦201 6Â¦ Â¦reviewÂ¦ Â¦ofÂ¦ Â¦10 6Â¦ Â¦drugÂ¦ Â¦candidatesÂ¦ Â¦asses sedÂ¦ Â¦throughÂ¦ Â¦clinicalÂ¦ Â¦trialsÂ¦ ,â– Â¦theÂ¦ Â¦totalÂ¦ Â¦capitalÂ¦ Â¦expe nd it ureÂ¦ Â¦forÂ¦ Â¦aÂ¦ Â¦manufacturerÂ¦ Â¦havingÂ¦ Â¦aÂ¦ Â¦drugÂ¦ Â¦approvedÂ¦ Â¦throughÂ¦ Â¦successfulÂ¦ ğ‹‡Â¦phaseÂ¦ ğŠ£Â¦iiiÂ¦ğŠ¼ Â¦trialsÂ¦ Â¦wasÂ¦ â–$ Â¦2Â¦ . Â¦6Â¦ Â¦billionÂ¦ â–( Â¦inÂ¦ Â¦201 3Â¦ Â¦do ll arsÂ¦ ),â– Â¦anÂ¦ Â¦amountÂ¦ Â¦increasingÂ¦ Â¦atÂ¦ Â¦anÂ¦ Â¦annualÂ¦ Â¦rateÂ¦ Â¦ofÂ¦ Â¦8Â¦ . Â¦5Â¦ %.
ğ‹‡Â¦asÂ¦ Â¦ofÂ¦ Â¦5Â¦ ğ‹‡Â¦marchÂ¦ Â¦2020Â¦ ğ‹‡Â¦l ab ğ‹‡co r pÂ¦ Â¦announcedÂ¦ Â¦nationwideÂ¦ Â¦availabilityÂ¦ Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦testingÂ¦ Â¦basedÂ¦ Â¦onÂ¦ ğŠ£Â¦rtÂ¦ - Â¦pcrÂ¦ğŠ¼ .
ğ‹‡Â¦testsÂ¦ Â¦usingÂ¦ Â¦twoÂ¦ Â¦componentsÂ¦ Â¦wereÂ¦ Â¦notÂ¦ Â¦determinedÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦reliableÂ¦ Â¦untilÂ¦ Â¦28Â¦ ğ‹‡Â¦februaryÂ¦ Â¦2020Â¦ ,â– Â¦andÂ¦ Â¦itÂ¦ Â¦wasÂ¦ Â¦notÂ¦ Â¦untilÂ¦ Â¦thenÂ¦ Â¦thatÂ¦ Â¦stateÂ¦ Â¦andÂ¦ Â¦localÂ¦ Â¦laboratoriesÂ¦ Â¦wereÂ¦ Â¦permittedÂ¦ Â¦toÂ¦ Â¦beginÂ¦ Â¦testingÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦aÂ¦ Â¦hostÂ¦ Â¦thatÂ¦ Â¦ser vesÂ¦ Â¦asÂ¦ Â¦theÂ¦ Â¦mi x ingÂ¦ Â¦v ess elÂ¦ ,â– Â¦str andÂ¦ Â¦sw it chingÂ¦ Â¦occursÂ¦ Â¦frequentlyÂ¦ Â¦duringÂ¦ ğ‹‡Â¦coğ‹‡vÂ¦ ğŠ£Â¦rnaÂ¦ğŠ¼ Â¦transcriptionÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦earlyÂ¦ Â¦2020Â¦ ,â– Â¦numerousÂ¦ Â¦establishedÂ¦ Â¦antiviralÂ¦ Â¦compoundsÂ¦ Â¦forÂ¦ Â¦treatingÂ¦ Â¦otherÂ¦ Â¦infectionsÂ¦ Â¦wereÂ¦ Â¦beingÂ¦ Â¦repurp osedÂ¦ Â¦orÂ¦ Â¦developedÂ¦ Â¦inÂ¦ Â¦newÂ¦ Â¦clinicalÂ¦ Â¦researchÂ¦ Â¦effortsÂ¦ Â¦toÂ¦ Â¦alle vi ateÂ¦ Â¦theÂ¦ Â¦illnessÂ¦ Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ .
ğ‹‡Â¦theÂ¦ Â¦firstÂ¦ Â¦recordedÂ¦ Â¦incidentsÂ¦ Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦infectionÂ¦ Â¦inÂ¦ ğ‹‡Â¦bangladeshÂ¦ Â¦wereÂ¦ Â¦onÂ¦ ğ‹‡Â¦marchÂ¦ Â¦8Â¦ ,â– Â¦inÂ¦ Â¦twoÂ¦ Â¦peopleÂ¦ Â¦whoÂ¦ Â¦returnedÂ¦ Â¦fromÂ¦ ğ‹‡Â¦italyÂ¦ Â¦andÂ¦ Â¦alsoÂ¦ Â¦theÂ¦ Â¦wifeÂ¦ Â¦ofÂ¦ Â¦oneÂ¦ Â¦ofÂ¦ Â¦themÂ¦ .
ğ‹‡ Â¦casesÂ¦ Â¦ref ersÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦numberÂ¦ Â¦ofÂ¦ Â¦peopleÂ¦ Â¦whoÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦testedÂ¦ Â¦forÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ ,â– Â¦andÂ¦ Â¦whoseÂ¦ Â¦testÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦confirmedÂ¦ Â¦positiveÂ¦ Â¦accordingÂ¦ Â¦toÂ¦ Â¦officialÂ¦ Â¦protocolsÂ¦ .
ğ‹‡ Â¦diarrheaÂ¦ Â¦isÂ¦ Â¦alsoÂ¦ Â¦seenÂ¦ Â¦inÂ¦ Â¦someÂ¦ Â¦patientsÂ¦ .
ğ‹‡Â¦theÂ¦ ğŠ£Â¦whoÂ¦ğŠ¼ Â¦hasÂ¦ Â¦com me ndedÂ¦ Â¦theÂ¦ Â¦effortsÂ¦ Â¦ofÂ¦ ğ‹‡Â¦chineseÂ¦ Â¦authoritiesÂ¦ Â¦inÂ¦ Â¦managingÂ¦ Â¦andÂ¦ Â¦containingÂ¦ Â¦theÂ¦ Â¦epidemicÂ¦ .
ğ‹‡Â¦theyÂ¦ Â¦stayÂ¦ Â¦inÂ¦ Â¦theirÂ¦ Â¦ownÂ¦ Â¦naturalÂ¦ Â¦reserv o irsÂ¦ Â¦untilÂ¦ Â¦thereÂ¦ Â¦isÂ¦ Â¦aÂ¦ Â¦chanceÂ¦ Â¦forÂ¦ Â¦sp il lo verÂ¦ .
ğ‹‡ Â¦whereasÂ¦ Â¦theÂ¦ Â¦highestÂ¦ Â¦sequenceÂ¦ Â¦homologyÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦foundÂ¦ Â¦inÂ¦ Â¦theÂ¦ ğŠ£Â¦rb d ğŠ¼sÂ¦ Â¦betweenÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦andÂ¦ Â¦pangolinÂ¦ ,â– ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ - Â¦relatedÂ¦ Â¦betaÂ¦ - ğ‹‡Â¦coğ‹‡vsÂ¦ ,â– ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦andÂ¦ ğ‹‡Â¦ra ğŠ£ t g ğŠ¼1 3Â¦ Â¦shareÂ¦ Â¦theÂ¦ Â¦highestÂ¦ Â¦genomeÂ¦ - Â¦wideÂ¦ Â¦sequenceÂ¦ Â¦homologyÂ¦ .
ğ‹‡Â¦secondÂ¦ ,â– Â¦ifÂ¦ Â¦batsÂ¦ Â¦playÂ¦ Â¦aÂ¦ Â¦moreÂ¦ Â¦directÂ¦ Â¦roleÂ¦ Â¦inÂ¦ Â¦humanÂ¦ Â¦transmissionÂ¦ ,â– Â¦howÂ¦ Â¦humansÂ¦ Â¦getÂ¦ Â¦intoÂ¦ Â¦contactÂ¦ Â¦withÂ¦ Â¦batsÂ¦ Â¦shouldÂ¦ Â¦beÂ¦ Â¦determinedÂ¦ .
ğ‹‡Â¦thailandÂ¦ ' Â¦sÂ¦ Â¦healthÂ¦ Â¦officialsÂ¦ Â¦areÂ¦ Â¦encoura gingÂ¦ Â¦peopleÂ¦ Â¦toÂ¦ Â¦makeÂ¦ Â¦clothÂ¦ Â¦fa ce m as ksÂ¦ Â¦atÂ¦ Â¦homeÂ¦ Â¦andÂ¦ Â¦washÂ¦ Â¦themÂ¦ Â¦dailyÂ¦ .
ğ‹‡Â¦theyÂ¦ Â¦shouldÂ¦ ,â– Â¦howeverÂ¦ ,â– Â¦beÂ¦ Â¦collectedÂ¦ Â¦inÂ¦ Â¦aÂ¦ Â¦syste maticÂ¦ Â¦f ash ionÂ¦ Â¦toÂ¦ Â¦comple mentÂ¦ Â¦currentÂ¦ Â¦surveillanceÂ¦ Â¦dataÂ¦ Â¦thatÂ¦ Â¦focusÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦numberÂ¦ Â¦ofÂ¦ Â¦reportedÂ¦ Â¦casesÂ¦ Â¦andÂ¦ Â¦theÂ¦ Â¦numberÂ¦ Â¦ofÂ¦ Â¦deathsÂ¦ .
ğ‹‡ Â¦particularlyÂ¦ ,â– Â¦batÂ¦ ğ‹‡Â¦coğ‹‡vsÂ¦ Â¦withÂ¦ Â¦zoonoticÂ¦ Â¦potentialÂ¦ Â¦areÂ¦ Â¦soÂ¦ Â¦diver seÂ¦ .
ğ‹‡ Â¦perÂ¦ Â¦mediaÂ¦ Â¦reportsÂ¦ Â¦onÂ¦ Â¦1Â¦ ğ‹‡Â¦aprilÂ¦ ,â– ğ‹‡Â¦southÂ¦ ğ‹‡Â¦koreaÂ¦ Â¦hasÂ¦ Â¦receivedÂ¦ Â¦re qu es tsÂ¦ Â¦forÂ¦ Â¦virusÂ¦ Â¦testingÂ¦ Â¦assistanceÂ¦ Â¦fromÂ¦ Â¦12 1Â¦ Â¦differentÂ¦ Â¦countriesÂ¦ .
ğ‹‡ Â¦supp ressionÂ¦ Â¦requiresÂ¦ Â¦moreÂ¦ Â¦ext re meÂ¦ Â¦measuresÂ¦ Â¦soÂ¦ Â¦asÂ¦ Â¦toÂ¦ Â¦reverseÂ¦ Â¦theÂ¦ Â¦pandemicÂ¦ Â¦byÂ¦ Â¦reducingÂ¦ Â¦theÂ¦ Â¦basicÂ¦ Â¦reprodu ctionÂ¦ Â¦numberÂ¦ Â¦toÂ¦ Â¦lessÂ¦ Â¦thanÂ¦ Â¦1Â¦ . ğ‹‡ Â¦partÂ¦ Â¦ofÂ¦ Â¦managingÂ¦ Â¦anÂ¦ Â¦infectiousÂ¦ Â¦diseaseÂ¦ Â¦outbreakÂ¦ Â¦isÂ¦ Â¦tryingÂ¦ Â¦toÂ¦ Â¦decreaseÂ¦ Â¦theÂ¦ Â¦epidemicÂ¦ Â¦peakÂ¦ ,â– Â¦knownÂ¦ Â¦asÂ¦ Â¦fl at teningÂ¦ Â¦theÂ¦ Â¦epidemicÂ¦ Â¦cur veÂ¦ .
ğ‹‡ Â¦tellÂ¦ Â¦meÂ¦ Â¦aboutÂ¦ Â¦yourÂ¦ Â¦chestÂ¦ Â¦painÂ¦
ğ‹‡Â¦mostÂ¦ Â¦businessesÂ¦ Â¦wereÂ¦ Â¦orderedÂ¦ Â¦toÂ¦ Â¦closeÂ¦ ,â– Â¦withÂ¦ Â¦ex ceptionsÂ¦ Â¦forÂ¦ Â¦businessesÂ¦ Â¦d ee medÂ¦ â–" Â¦essentialÂ¦ ",â– Â¦includingÂ¦ Â¦super mar ke tsÂ¦ ,â– Â¦pharm ac iesÂ¦ ,â– Â¦banksÂ¦ ,â– Â¦hard wareÂ¦ Â¦shopsÂ¦ ,â– Â¦pe trolÂ¦ Â¦stationsÂ¦ ,â– Â¦andÂ¦ Â¦gar agesÂ¦ .
ğ‹‡Â¦thisÂ¦ Â¦mightÂ¦ Â¦alsoÂ¦ Â¦gu ideÂ¦ Â¦orÂ¦ Â¦facilitateÂ¦ Â¦theÂ¦ Â¦searchÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦reservoirÂ¦ ,â– Â¦intermediateÂ¦ Â¦andÂ¦ Â¦ampli fyingÂ¦ Â¦animalÂ¦ Â¦hostÂ¦ ( Â¦sÂ¦ )â– Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ ,â– Â¦withÂ¦ Â¦importantÂ¦ Â¦implicationsÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦preventionÂ¦ Â¦ofÂ¦ Â¦futureÂ¦ Â¦sp il lo versÂ¦ .
ğ‹‡Â¦theyÂ¦ Â¦mightÂ¦ Â¦alsoÂ¦ Â¦accountÂ¦ Â¦forÂ¦ Â¦successfulÂ¦ Â¦adaptationÂ¦ Â¦ofÂ¦ Â¦theseÂ¦ ğ‹‡Â¦coğ‹‡vsÂ¦ Â¦inÂ¦ Â¦humansÂ¦ Â¦afterÂ¦ Â¦interspeciesÂ¦ Â¦transmissionÂ¦ Â¦fromÂ¦ Â¦theirÂ¦ Â¦animalÂ¦ Â¦hostsÂ¦ .
ğ‹‡Â¦itÂ¦ Â¦isÂ¦ Â¦thoughtÂ¦ Â¦toÂ¦ Â¦haveÂ¦ Â¦aÂ¦ Â¦zoonoticÂ¦ Â¦originÂ¦ .
ğ‹‡Â¦anÂ¦ Â¦un ass o ci atedÂ¦ Â¦clusterÂ¦ Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦casesÂ¦ Â¦wasÂ¦ Â¦laterÂ¦ Â¦detectedÂ¦ ,â– Â¦startingÂ¦ Â¦withÂ¦ Â¦16Â¦ Â¦confirmedÂ¦ Â¦casesÂ¦ Â¦inÂ¦ ğ‹‡Â¦lo mb ard yÂ¦ Â¦onÂ¦ Â¦21Â¦ ğ‹‡Â¦februaryÂ¦ . ğ‹‡Â¦onÂ¦ Â¦22Â¦ ğ‹‡Â¦februaryÂ¦ ,â– Â¦theÂ¦ ğ‹‡Â¦councilÂ¦ Â¦ofÂ¦ ğ‹‡Â¦ministersÂ¦ Â¦announcedÂ¦ Â¦aÂ¦ Â¦newÂ¦ Â¦dec r eeÂ¦ - Â¦lawÂ¦ Â¦toÂ¦ Â¦containÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ ,â– Â¦includingÂ¦ Â¦quar anti ningÂ¦ Â¦moreÂ¦ Â¦thanÂ¦ Â¦50Â¦ , Â¦000Â¦ Â¦peopleÂ¦ Â¦fromÂ¦ Â¦11Â¦ Â¦differentÂ¦ Â¦m uni cip alitiesÂ¦ Â¦inÂ¦ Â¦north ernÂ¦ ğ‹‡Â¦italyÂ¦ .
ğ‹‡Â¦onÂ¦ Â¦theÂ¦ Â¦sameÂ¦ Â¦dayÂ¦ ,â– Â¦theÂ¦ ğŠ£Â¦us n sÂ¦ğŠ¼ ğ‹‡ Â¦comfortÂ¦ ,â– Â¦aÂ¦ Â¦hospitalÂ¦ Â¦shipÂ¦ Â¦withÂ¦ Â¦aboutÂ¦ Â¦10 00Â¦ Â¦bedsÂ¦ ,â– Â¦madeÂ¦ Â¦an ch orÂ¦ Â¦inÂ¦ ğ‹‡Â¦newÂ¦ ğ‹‡Â¦yorkÂ¦ .
ğ‹‡Â¦someÂ¦ Â¦organizationsÂ¦ Â¦haveÂ¦ Â¦createdÂ¦ Â¦cr ow d s our cedÂ¦ Â¦appsÂ¦ Â¦forÂ¦ Â¦sy nd ro micÂ¦ Â¦surveillanceÂ¦ ,â– Â¦whereÂ¦ Â¦peopleÂ¦ Â¦canÂ¦ Â¦reportÂ¦ Â¦theirÂ¦ Â¦symptomsÂ¦ Â¦toÂ¦ Â¦helpÂ¦ Â¦researchersÂ¦ Â¦ma pÂ¦ Â¦areasÂ¦ Â¦withÂ¦ Â¦concentr ationÂ¦ Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦symptomsÂ¦ .
ğ‹‡Â¦schoolsÂ¦ Â¦andÂ¦ Â¦universitiesÂ¦ Â¦haveÂ¦ Â¦closedÂ¦ Â¦eitherÂ¦ Â¦onÂ¦ Â¦aÂ¦ Â¦nationwideÂ¦ Â¦orÂ¦ Â¦localÂ¦ Â¦basisÂ¦ Â¦inÂ¦ Â¦19 3Â¦ Â¦countriesÂ¦ ,â– Â¦affectingÂ¦ Â¦approximatelyÂ¦ Â¦99Â¦ . Â¦4Â¦ Â¦percentÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦worldÂ¦ ' Â¦sÂ¦ Â¦studentÂ¦ Â¦populationÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦responseÂ¦ Â¦toÂ¦ Â¦aÂ¦ Â¦developingÂ¦ Â¦outbreakÂ¦ Â¦inÂ¦ ğ‹‡Â¦iranÂ¦ ,â– Â¦theÂ¦ ğŠ£Â¦whoÂ¦ğŠ¼ Â¦sentÂ¦ Â¦aÂ¦ ğ‹‡ Â¦jointÂ¦ ğ‹‡Â¦missionÂ¦ ğ‹‡ Â¦teamÂ¦ Â¦thereÂ¦ Â¦toÂ¦ Â¦assessÂ¦ Â¦theÂ¦ Â¦situationÂ¦ . ğ‹‡Â¦onÂ¦ Â¦28Â¦ ğ‹‡Â¦februaryÂ¦ ,â– ğŠ£Â¦whoÂ¦ğŠ¼ Â¦officialsÂ¦ Â¦saidÂ¦ Â¦thatÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦threatÂ¦ Â¦assessmentÂ¦ Â¦atÂ¦ Â¦theÂ¦ Â¦globalÂ¦ Â¦levelÂ¦ Â¦wouldÂ¦ Â¦beÂ¦ Â¦raisedÂ¦ Â¦fromÂ¦ â–" Â¦highÂ¦ "â– Â¦toÂ¦ â–" Â¦veryÂ¦ Â¦highÂ¦ ",â– Â¦itsÂ¦ Â¦highestÂ¦ Â¦levelÂ¦ Â¦ofÂ¦ Â¦alertÂ¦ Â¦andÂ¦ Â¦riskÂ¦ Â¦assessmentÂ¦ .
ğ‹‡Â¦byÂ¦ Â¦theÂ¦ Â¦timeÂ¦ Â¦ofÂ¦ Â¦thisÂ¦ Â¦reportÂ¦ ,â– Â¦theÂ¦ Â¦diseaseÂ¦ Â¦hasÂ¦ Â¦alreadyÂ¦ Â¦spreadÂ¦ Â¦throughoutÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦andÂ¦ Â¦nearÂ¦ Â¦50Â¦ Â¦otherÂ¦ Â¦countriesÂ¦ Â¦allÂ¦ Â¦overÂ¦ Â¦theÂ¦ Â¦worldÂ¦ â–( ğ‹‡Â¦figÂ¦ .â– â€‹ ( ğ‹‡Â¦figÂ¦ . Â¦2Â¦ ). Â¦2Â¦ ).
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦ira ni anÂ¦ ğ‹‡Â¦parliamentÂ¦ Â¦wasÂ¦ Â¦shutÂ¦ Â¦downÂ¦ ,â– Â¦withÂ¦ Â¦23Â¦ Â¦ofÂ¦ Â¦itsÂ¦ Â¦2 90Â¦ Â¦membersÂ¦ Â¦reportedÂ¦ Â¦toÂ¦ Â¦haveÂ¦ Â¦hadÂ¦ Â¦testedÂ¦ Â¦positiveÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦onÂ¦ Â¦3Â¦ ğ‹‡Â¦marchÂ¦ .
ğ‹‡Â¦r d ğ‹‡ r pÂ¦ Â¦directlyÂ¦ Â¦me di atesÂ¦ Â¦theÂ¦ Â¦sy nt he sisÂ¦ Â¦ofÂ¦ Â¦negativeÂ¦ - Â¦senseÂ¦ Â¦genom icÂ¦ ğŠ£Â¦rnaÂ¦ğŠ¼ Â¦fromÂ¦ Â¦theÂ¦ Â¦positiveÂ¦ - Â¦senseÂ¦ Â¦genom icÂ¦ ğŠ£Â¦rnaÂ¦ğŠ¼ .
ğ‹‡Â¦am id stÂ¦ Â¦claimsÂ¦ Â¦ofÂ¦ Â¦aÂ¦ Â¦coverÂ¦ - Â¦upÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦extentÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ Â¦inÂ¦ ğ‹‡Â¦iranÂ¦ ,â– Â¦moreÂ¦ Â¦thanÂ¦ Â¦tenÂ¦ Â¦countriesÂ¦ Â¦hadÂ¦ Â¦tracedÂ¦ Â¦theirÂ¦ Â¦casesÂ¦ Â¦backÂ¦ Â¦toÂ¦ ğ‹‡Â¦iranÂ¦ Â¦byÂ¦ Â¦28Â¦ ğ‹‡Â¦februaryÂ¦ ,â– Â¦indicatingÂ¦ Â¦thatÂ¦ Â¦theÂ¦ Â¦extentÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ Â¦mayÂ¦ Â¦beÂ¦ Â¦moreÂ¦ Â¦severeÂ¦ Â¦thanÂ¦ Â¦theÂ¦ Â¦38 8Â¦ Â¦casesÂ¦ Â¦reportedÂ¦ Â¦byÂ¦ Â¦theÂ¦ ğ‹‡Â¦ira ni anÂ¦ Â¦governmentÂ¦ Â¦byÂ¦ Â¦thatÂ¦ Â¦dateÂ¦ .
ğ‹‡Â¦aÂ¦ Â¦numberÂ¦ Â¦ofÂ¦ Â¦li ne ageÂ¦ - Â¦specificÂ¦ Â¦acc ess oryÂ¦ Â¦proteinsÂ¦ Â¦areÂ¦ Â¦alsoÂ¦ Â¦enco dedÂ¦ Â¦byÂ¦ Â¦differentÂ¦ Â¦li ne agesÂ¦ Â¦ofÂ¦ ğ‹‡Â¦coğ‹‡vsÂ¦ .
ğ‹‡Â¦allÂ¦ Â¦countriesÂ¦ Â¦canÂ¦ Â¦stillÂ¦ Â¦changeÂ¦ Â¦theÂ¦ Â¦courseÂ¦ Â¦ofÂ¦ Â¦thisÂ¦ Â¦pandemicÂ¦ .
ğ‹‡Â¦coğ‹‡vsÂ¦ Â¦areÂ¦ Â¦aÂ¦ Â¦sub fa mi lyÂ¦ Â¦ofÂ¦ Â¦largeÂ¦ Â¦andÂ¦ Â¦en velop edÂ¦ Â¦virusesÂ¦ Â¦containingÂ¦ Â¦aÂ¦ Â¦singleÂ¦ Â¦str andÂ¦ Â¦ofÂ¦ Â¦senseÂ¦ ğŠ£Â¦rnaÂ¦ğŠ¼ .
ğ‹‡Â¦theÂ¦ Â¦testÂ¦ Â¦usesÂ¦ Â¦realÂ¦ - Â¦timeÂ¦ Â¦reverseÂ¦ Â¦transcriptionÂ¦ Â¦polymeraseÂ¦ Â¦chainÂ¦ Â¦reactionÂ¦ â–( Â¦r ğŠ£r tÂ¦ - Â¦pcrÂ¦ğŠ¼ ).
ğ‹‡Â¦followingÂ¦ Â¦theÂ¦ Â¦prog ressionÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ Â¦toÂ¦ Â¦newÂ¦ Â¦hotspotÂ¦ Â¦countriesÂ¦ ,â– Â¦peopleÂ¦ Â¦fromÂ¦ ğ‹‡Â¦italyÂ¦ ,â– Â¦theÂ¦ Â¦firstÂ¦ Â¦countryÂ¦ Â¦inÂ¦ ğ‹‡Â¦europeÂ¦ Â¦toÂ¦ Â¦experienceÂ¦ Â¦aÂ¦ Â¦seriousÂ¦ Â¦outbreakÂ¦ Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ ,â– Â¦couldÂ¦ Â¦alsoÂ¦ Â¦beÂ¦ Â¦sub jectedÂ¦ Â¦toÂ¦ Â¦susp ic ionÂ¦ Â¦andÂ¦ Â¦ x en ophobiaÂ¦ . ğ‹‡Â¦citizensÂ¦ Â¦inÂ¦ Â¦countriesÂ¦ Â¦includingÂ¦ ğ‹‡Â¦mala y siaÂ¦ ,â– ğ‹‡Â¦newÂ¦ ğ‹‡Â¦z ea landÂ¦ ,â– ğ‹‡Â¦singaporeÂ¦ ,â– Â¦andÂ¦ ğ‹‡Â¦southÂ¦ ğ‹‡Â¦koreaÂ¦ Â¦initiallyÂ¦ Â¦signedÂ¦ Â¦pe ti tionsÂ¦ Â¦lo bb yingÂ¦ Â¦toÂ¦ Â¦banÂ¦ ğ‹‡Â¦chineseÂ¦ Â¦peopleÂ¦ Â¦fromÂ¦ Â¦enteringÂ¦ Â¦theirÂ¦ Â¦countriesÂ¦ Â¦inÂ¦ Â¦anÂ¦ Â¦effortÂ¦ Â¦toÂ¦ Â¦stopÂ¦ Â¦theÂ¦ Â¦diseaseÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦additionÂ¦ Â¦toÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ ,â– Â¦thisÂ¦ Â¦alsoÂ¦ Â¦app l iesÂ¦ Â¦toÂ¦ ğŠ£Â¦mersÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ ,â– Â¦whichÂ¦ Â¦isÂ¦ Â¦wellÂ¦ Â¦adaptedÂ¦ Â¦toÂ¦ Â¦dromedaryÂ¦ Â¦camelsÂ¦ .
ğ‹‡Â¦asÂ¦ Â¦ofÂ¦ Â¦yesterdayÂ¦ ,â– ğ‹‡Â¦bangladeshÂ¦ ' Â¦sÂ¦ ğ‹‡Â¦instituteÂ¦ Â¦ofÂ¦ ğ‹‡ Â¦epidemiologyÂ¦ ,â– ğ‹‡Â¦diseaseÂ¦ ğ‹‡Â¦controlÂ¦ Â¦andÂ¦ ğ‹‡Â¦researchÂ¦ â–( ğŠ£Â¦i ed c rÂ¦ğŠ¼ )â– Â¦reportedÂ¦ Â¦theÂ¦ Â¦numberÂ¦ Â¦ofÂ¦ Â¦recordedÂ¦ Â¦infectedÂ¦ Â¦casesÂ¦ Â¦includedÂ¦ Â¦11 4Â¦ Â¦activeÂ¦ Â¦casesÂ¦ Â¦andÂ¦ Â¦33Â¦ Â¦recoveredÂ¦ Â¦casesÂ¦ Â¦whoÂ¦ Â¦wereÂ¦ Â¦stayingÂ¦ Â¦homeÂ¦ .
ğ‹‡Â¦mostÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦effectiveÂ¦ Â¦componentsÂ¦ Â¦remainÂ¦ Â¦unknownÂ¦ Â¦orÂ¦ Â¦areÂ¦ Â¦ va g ueÂ¦ Â¦asÂ¦ Â¦itÂ¦ Â¦isÂ¦ Â¦difficultÂ¦ Â¦toÂ¦ Â¦extr actÂ¦ Â¦andÂ¦ Â¦ve ri fyÂ¦ Â¦suchÂ¦ Â¦componentsÂ¦ Â¦orÂ¦ Â¦theirÂ¦ Â¦op ti malÂ¦ Â¦comb in ationsÂ¦ .
ğ‹‡Â¦itÂ¦ Â¦isÂ¦ Â¦possibleÂ¦ ,â– Â¦similarÂ¦ Â¦toÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ ,â– Â¦thatÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦mightÂ¦ Â¦becomeÂ¦ Â¦wea kerÂ¦ Â¦inÂ¦ Â¦inf ectivityÂ¦ Â¦andÂ¦ Â¦e vent uallyÂ¦ Â¦dieÂ¦ Â¦downÂ¦ Â¦orÂ¦ Â¦becomeÂ¦ Â¦aÂ¦ Â¦lessÂ¦ Â¦pathogenicÂ¦ Â¦virusÂ¦ Â¦coÂ¦ - Â¦e xi st entÂ¦ Â¦withÂ¦ Â¦humansÂ¦ .
ğ‹‡Â¦onÂ¦ ğ‹‡Â¦februaryÂ¦ Â¦18Â¦ ,â– Â¦2020Â¦ ,â– Â¦theÂ¦ Â¦firstÂ¦ Â¦patho logicalÂ¦ Â¦analysisÂ¦ Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦demonstratedÂ¦ Â¦theÂ¦ Â¦d es qu a mationÂ¦ Â¦ofÂ¦ Â¦pneum ocytesÂ¦ ,â– Â¦h ya lineÂ¦ Â¦membraneÂ¦ Â¦for mationÂ¦ ,â– Â¦andÂ¦ Â¦inter s ti tialÂ¦ Â¦lymphocy teÂ¦ Â¦inf il trationÂ¦ ,â– Â¦andÂ¦ Â¦mult in uc le atedÂ¦ Â¦sy nc y tialÂ¦ Â¦cellsÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦lungsÂ¦ Â¦ofÂ¦ Â¦aÂ¦ Â¦patientÂ¦ Â¦whoÂ¦ Â¦diedÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦diseaseÂ¦ ,â– Â¦consistentÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦path ologyÂ¦ Â¦ofÂ¦ Â¦viralÂ¦ Â¦infectionÂ¦ Â¦andÂ¦ ğŠ£Â¦ardsÂ¦ğŠ¼ Â¦andÂ¦ Â¦similarÂ¦ Â¦toÂ¦ Â¦thatÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ Â¦andÂ¦ ğŠ£Â¦mersÂ¦ğŠ¼ Â¦patientsÂ¦ .
ğ‹‡Â¦wi ld li f eÂ¦ Â¦s m u gg lingÂ¦ Â¦andÂ¦ Â¦z oo no sesÂ¦ â–â€“â– ğ‹‡Â¦healthÂ¦ Â¦risksÂ¦ Â¦associatedÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦tradeÂ¦ Â¦inÂ¦ Â¦ex o ticÂ¦ Â¦wi ld li f eÂ¦
ğ‹‡Â¦forÂ¦ ğŠ£ Â¦cl tÂ¦ğŠ¼ Â¦aÂ¦ Â¦singleÂ¦ Â¦specimenÂ¦ Â¦ofÂ¦ Â¦peri ph er alÂ¦ Â¦bloodÂ¦ Â¦isÂ¦ Â¦commonlyÂ¦ Â¦usedÂ¦ ,â– Â¦althoughÂ¦ Â¦se rialÂ¦ Â¦specimensÂ¦ Â¦canÂ¦ Â¦beÂ¦ Â¦usedÂ¦ Â¦toÂ¦ Â¦followÂ¦ Â¦theÂ¦ Â¦immuneÂ¦ Â¦responseÂ¦ .
ğ‹‡Â¦thisÂ¦ Â¦virusÂ¦ Â¦mayÂ¦ Â¦beÂ¦ Â¦onÂ¦ Â¦itsÂ¦ Â¦wayÂ¦ Â¦andÂ¦ Â¦youÂ¦ Â¦needÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦readyÂ¦ ,"â– Â¦ur gingÂ¦ Â¦thatÂ¦ Â¦theÂ¦ Â¦rightÂ¦ Â¦responseÂ¦ Â¦measuresÂ¦ Â¦couldÂ¦ Â¦helpÂ¦ Â¦theÂ¦ Â¦worldÂ¦ Â¦avoidÂ¦ â–" Â¦theÂ¦ Â¦worstÂ¦ Â¦ofÂ¦ Â¦itÂ¦ ".
ğ‹‡Â¦ourÂ¦ Â¦teamÂ¦ Â¦willÂ¦ Â¦alsoÂ¦ Â¦timelyÂ¦ Â¦updateÂ¦ Â¦ourÂ¦ Â¦gui de lineÂ¦ Â¦toÂ¦ Â¦off erÂ¦ Â¦helpÂ¦ .
ğ‹‡Â¦aÂ¦ Â¦studyÂ¦ Â¦performedÂ¦ Â¦inÂ¦ Â¦201 0Â¦ â€“ Â¦11Â¦ Â¦showedÂ¦ Â¦aÂ¦ Â¦largeÂ¦ Â¦v ari ationÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦availabilityÂ¦ Â¦ofÂ¦ Â¦intensiveÂ¦ Â¦careÂ¦ Â¦andÂ¦ Â¦intermediateÂ¦ Â¦careÂ¦ Â¦bedsÂ¦ Â¦inÂ¦ ğ‹‡Â¦europeÂ¦ ,â– Â¦ran gingÂ¦ Â¦fromÂ¦ Â¦29Â¦ . Â¦2Â¦ Â¦inÂ¦ ğ‹‡Â¦germanyÂ¦ Â¦toÂ¦ Â¦4Â¦ . Â¦2Â¦ Â¦bedsÂ¦ Â¦perÂ¦ Â¦100Â¦ , Â¦000Â¦ Â¦populationÂ¦ Â¦inÂ¦ ğ‹‡Â¦p ort ug alÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦contrastÂ¦ ,â– Â¦ifÂ¦ Â¦theÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ Â¦isÂ¦ Â¦new lyÂ¦ Â¦introducedÂ¦ Â¦toÂ¦ Â¦anÂ¦ Â¦intermediateÂ¦ Â¦hostÂ¦ Â¦rightÂ¦ Â¦beforeÂ¦ Â¦orÂ¦ Â¦aroundÂ¦ Â¦itsÂ¦ Â¦introdu ctionÂ¦ Â¦toÂ¦ Â¦humansÂ¦ ,â– Â¦itÂ¦ Â¦isÂ¦ Â¦notÂ¦ Â¦wellÂ¦ Â¦adaptedÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦newÂ¦ Â¦hostÂ¦ Â¦andÂ¦ Â¦isÂ¦ Â¦oftenÂ¦ Â¦pathogenicÂ¦ .
ğ‹‡Â¦thusÂ¦ ,â– Â¦itÂ¦ Â¦isÂ¦ Â¦muchÂ¦ Â¦moreÂ¦ Â¦challengingÂ¦ Â¦toÂ¦ Â¦controlÂ¦ Â¦theÂ¦ Â¦epidemicÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦thanÂ¦ Â¦thoseÂ¦ Â¦ofÂ¦ ğŠ£Â¦mersÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦andÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ .
ğ‹‡Â¦firstÂ¦ ,â– Â¦ifÂ¦ Â¦batsÂ¦ Â¦trans mitÂ¦ Â¦anÂ¦ Â¦anc es tr alÂ¦ Â¦virusÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦toÂ¦ Â¦pangolinsÂ¦ ,â– Â¦itÂ¦ Â¦willÂ¦ Â¦beÂ¦ Â¦ofÂ¦ Â¦interestÂ¦ Â¦toÂ¦ Â¦seeÂ¦ Â¦underÂ¦ Â¦whatÂ¦ Â¦circumstancesÂ¦ Â¦batsÂ¦ Â¦andÂ¦ Â¦pangolinsÂ¦ Â¦couldÂ¦ Â¦shareÂ¦ Â¦theÂ¦ Â¦sameÂ¦ Â¦e co logicalÂ¦ Â¦ ni ch eÂ¦ .
ğ‹‡Â¦iranÂ¦ Â¦all oc atedÂ¦ Â¦fiveÂ¦ Â¦tri ll ionÂ¦ Â¦ri alsÂ¦ Â¦toÂ¦ Â¦comb atÂ¦ Â¦theÂ¦ Â¦virusÂ¦ .
ğ‹‡Â¦li ke w iseÂ¦ ,â– Â¦aÂ¦ Â¦reservoirÂ¦ Â¦hostÂ¦ Â¦h arb oursÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ Â¦continu ouslyÂ¦ Â¦andÂ¦ Â¦forÂ¦ Â¦longÂ¦ Â¦termÂ¦ .
ğ‹‡Â¦howeverÂ¦ ,â– Â¦viaÂ¦ Â¦strictÂ¦ Â¦quarantineÂ¦ Â¦andÂ¦ Â¦isolationÂ¦ ,â– Â¦theÂ¦ Â¦diseaseÂ¦ Â¦hasÂ¦ Â¦e vent uallyÂ¦ Â¦beenÂ¦ Â¦putÂ¦ Â¦underÂ¦ Â¦controlÂ¦ .
ğŠ£Â¦mersÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦ser vesÂ¦ Â¦asÂ¦ Â¦anÂ¦ Â¦ex ce ll entÂ¦ Â¦exampleÂ¦ Â¦ofÂ¦ Â¦interspeciesÂ¦ Â¦transmissionÂ¦ Â¦fromÂ¦ Â¦batsÂ¦ Â¦toÂ¦ Â¦dromedaryÂ¦ Â¦camelsÂ¦ Â¦andÂ¦ Â¦fromÂ¦ Â¦dromedaryÂ¦ Â¦camelsÂ¦ Â¦toÂ¦ Â¦humansÂ¦ .
ğ‹‡Â¦anÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ Â¦canÂ¦ Â¦undergoÂ¦ Â¦aÂ¦ Â¦deadÂ¦ - Â¦endÂ¦ Â¦infectionÂ¦ Â¦ifÂ¦ Â¦itÂ¦ Â¦cannotÂ¦ Â¦s ust ainÂ¦ Â¦itsÂ¦ Â¦transmissionÂ¦ Â¦withinÂ¦ Â¦theÂ¦ Â¦intermediateÂ¦ Â¦hostÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦searchÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦animalÂ¦ Â¦originsÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦isÂ¦ Â¦stillÂ¦ Â¦onÂ¦ .
ğ‹‡Â¦nowÂ¦ Â¦ourÂ¦ Â¦gui de lineÂ¦ Â¦receivedÂ¦ Â¦aÂ¦ Â¦com mentÂ¦ Â¦byÂ¦ ğ‹‡Â¦z ho uÂ¦ Â¦etÂ¦ Â¦alÂ¦ .,â– Â¦theyÂ¦ Â¦introducedÂ¦ Â¦aÂ¦ Â¦simpleÂ¦ Â¦s co ringÂ¦ Â¦proposalÂ¦ Â¦basedÂ¦ Â¦onÂ¦ Â¦theirÂ¦ Â¦clinicalÂ¦ Â¦experienceÂ¦ .
ğ‹‡ Â¦numerousÂ¦ Â¦candidateÂ¦ Â¦drugsÂ¦ Â¦underÂ¦ Â¦studyÂ¦ Â¦asÂ¦ â–" Â¦suppor tiveÂ¦ "â– Â¦treatmentsÂ¦ Â¦toÂ¦ Â¦relie veÂ¦ Â¦disc omf ortÂ¦ Â¦duringÂ¦ Â¦illnessÂ¦ ,â– Â¦suchÂ¦ Â¦asÂ¦ ğŠ£Â¦ ns a id ğŠ¼sÂ¦ Â¦orÂ¦ Â¦bronch od il atorsÂ¦ ,â– Â¦areÂ¦ Â¦notÂ¦ Â¦includedÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦tableÂ¦ Â¦belowÂ¦ .
ğ‹‡ Â¦whereasÂ¦ Â¦aÂ¦ Â¦batÂ¦ Â¦betaÂ¦ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦sharingÂ¦ Â¦95Â¦ %â– Â¦nucleotideÂ¦ Â¦homologyÂ¦ Â¦withÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦foundÂ¦ ,â– Â¦thereÂ¦ Â¦alsoÂ¦ Â¦ex istsÂ¦ Â¦aÂ¦ Â¦batÂ¦ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦sharingÂ¦ Â¦96Â¦ %â– Â¦nucleotideÂ¦ Â¦homologyÂ¦ Â¦withÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ .
ğ‹‡Â¦thisÂ¦ Â¦isÂ¦ Â¦notÂ¦ Â¦usuallyÂ¦ Â¦passedÂ¦ Â¦fromÂ¦ Â¦motherÂ¦ Â¦toÂ¦ Â¦fe t usÂ¦ Â¦soÂ¦ Â¦furtherÂ¦ Â¦researchÂ¦ Â¦isÂ¦ Â¦requiredÂ¦ Â¦toÂ¦ Â¦knowÂ¦ Â¦whetherÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦crossedÂ¦ Â¦theÂ¦ Â¦pla cent aÂ¦ Â¦orÂ¦ Â¦whetherÂ¦ Â¦pla cent asÂ¦ Â¦ofÂ¦ Â¦womenÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦studyÂ¦ Â¦wereÂ¦ Â¦da ma gedÂ¦ Â¦orÂ¦ Â¦ab n or malÂ¦ .
ğ‹‡Â¦onÂ¦ ğ‹‡Â¦februaryÂ¦ Â¦11Â¦ ,â– Â¦2020Â¦ ,â– Â¦aÂ¦ Â¦multiÂ¦ - Â¦centerÂ¦ Â¦studyÂ¦ Â¦onÂ¦ Â¦8Â¦ , Â¦86 6Â¦ Â¦patientsÂ¦ Â¦includingÂ¦ Â¦4Â¦ , Â¦0 2 1Â¦ Â¦confirmedÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦patientsÂ¦ Â¦presentedÂ¦ Â¦aÂ¦ Â¦moreÂ¦ Â¦updatedÂ¦ Â¦i ll us trationÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦epidemicÂ¦ Â¦asÂ¦ Â¦followsÂ¦ â–( Â¦httpsÂ¦ :// Â¦m pÂ¦ . Â¦we i x inÂ¦ . Â¦ q qÂ¦ . Â¦comÂ¦ / Â¦sÂ¦ / ğ‹‡ Â¦ul ğ‹‡ b iÂ¦ - ğŠ£Â¦h x ğŠ¼ _ r ğŠ£ h p x ğŠ¼ a 1 q ğŠ£ ha ğŠ¼ 2 b h d ğ‹‡ aÂ¦ ).
ğ‹‡Â¦butÂ¦ Â¦alsoÂ¦ Â¦weÂ¦ Â¦sh ouldnÂ¦ ' Â¦tÂ¦ Â¦beÂ¦ Â¦putÂ¦ Â¦as ideÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦heartÂ¦ Â¦cardiacÂ¦ Â¦originÂ¦ Â¦chestÂ¦ Â¦painÂ¦
ğ‹‡Â¦severalÂ¦ Â¦loc alitiesÂ¦ Â¦alsoÂ¦ Â¦witnes sedÂ¦ Â¦panicÂ¦ Â¦bu yingÂ¦ Â¦thatÂ¦ Â¦ledÂ¦ Â¦toÂ¦ Â¦sh el vesÂ¦ Â¦beingÂ¦ Â¦clea redÂ¦ Â¦ofÂ¦ Â¦groceryÂ¦ Â¦ ess enti alsÂ¦ Â¦suchÂ¦ Â¦asÂ¦ Â¦foodÂ¦ ,â– Â¦toiletÂ¦ Â¦paperÂ¦ ,â– Â¦andÂ¦ Â¦bott ledÂ¦ Â¦waterÂ¦ ,â– Â¦indu c ingÂ¦ Â¦supplyÂ¦ Â¦shortagesÂ¦ .
ğ‹‡Â¦itÂ¦ Â¦isÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦centerÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦chestÂ¦
ğ‹‡ Â¦econom icallyÂ¦ Â¦significantÂ¦ Â¦coronavirusesÂ¦ Â¦ofÂ¦ Â¦far mÂ¦ Â¦animalsÂ¦ Â¦includeÂ¦ Â¦por c ineÂ¦ Â¦coronavirusÂ¦ â–( Â¦transmis sibleÂ¦ Â¦g ast ro en teritisÂ¦ Â¦coronavirusÂ¦ ,â– ğŠ£Â¦t ge Â¦ğŠ¼ )â– Â¦andÂ¦ Â¦b ov ineÂ¦ Â¦coronavirusÂ¦ ,â– Â¦whichÂ¦ Â¦bothÂ¦ Â¦resultÂ¦ Â¦inÂ¦ Â¦diarrheaÂ¦ Â¦inÂ¦ Â¦youngÂ¦ Â¦animalsÂ¦ .
ğ‹‡Â¦iÂ¦ Â¦hadÂ¦ Â¦aÂ¦ Â¦feverÂ¦ Â¦yesterdayÂ¦
ğ‹‡Â¦asÂ¦ Â¦theseÂ¦ Â¦noti fic ationsÂ¦ Â¦occurredÂ¦ ,â– Â¦doctorsÂ¦ Â¦inÂ¦ ğ‹‡Â¦wuhanÂ¦ Â¦wereÂ¦ Â¦warnedÂ¦ Â¦byÂ¦ Â¦policeÂ¦ Â¦forÂ¦ â–" Â¦spreadingÂ¦ Â¦r um oursÂ¦ "â– Â¦aboutÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ .
ğ‹‡ Â¦identi fyingÂ¦ Â¦theÂ¦ Â¦animalÂ¦ Â¦hostsÂ¦ Â¦hasÂ¦ Â¦directÂ¦ Â¦implicationsÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦preventionÂ¦ Â¦ofÂ¦ Â¦humanÂ¦ Â¦diseasesÂ¦ .
ğ‹‡ Â¦mandatoryÂ¦ Â¦contactÂ¦ Â¦tracingÂ¦ Â¦andÂ¦ Â¦quarantineÂ¦ ,â– Â¦asÂ¦ Â¦aÂ¦ Â¦partÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦publicÂ¦ Â¦healthÂ¦ Â¦responsesÂ¦ Â¦toÂ¦ Â¦theÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦outbreakÂ¦ ,â– Â¦canÂ¦ Â¦makeÂ¦ Â¦peopleÂ¦ Â¦moreÂ¦ Â¦an xi ousÂ¦ Â¦andÂ¦ Â¦gu il tyÂ¦ Â¦aboutÂ¦ Â¦theÂ¦ Â¦effectsÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦conta gionÂ¦ ,â– Â¦quarantineÂ¦ ,â– Â¦andÂ¦ Â¦s tig maÂ¦ Â¦onÂ¦ Â¦theirÂ¦ Â¦familiesÂ¦ Â¦andÂ¦ Â¦friendsÂ¦ .
ğ‹‡Â¦onÂ¦ Â¦19Â¦ ğ‹‡Â¦februaryÂ¦ ,â– Â¦theÂ¦ ğ‹‡Â¦singaporeÂ¦ ğ‹‡Â¦redÂ¦ ğ‹‡ Â¦crossÂ¦ Â¦announcedÂ¦ Â¦thatÂ¦ Â¦itÂ¦ Â¦wouldÂ¦ Â¦sendÂ¦ â–$ Â¦2Â¦ . Â¦26Â¦ Â¦millionÂ¦ Â¦worthÂ¦ Â¦ofÂ¦ Â¦aidÂ¦ Â¦toÂ¦ ğ‹‡Â¦chinaÂ¦ .
ğ‹‡Â¦similarÂ¦ Â¦toÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - ğŠ£Â¦n l 63Â¦ ,â– Â¦h cğŠ¼oğ‹‡vÂ¦ - Â¦229ğ‹‡eÂ¦ Â¦andÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - ğŠ£ Â¦oc 43Â¦ ,â– Â¦h cğŠ¼oğ‹‡vÂ¦ - ğŠ£Â¦hkuğŠ¼1Â¦ Â¦wasÂ¦ Â¦foundÂ¦ Â¦worldwideÂ¦ ,â– Â¦causingÂ¦ Â¦mildÂ¦ Â¦respiratoryÂ¦ Â¦diseasesÂ¦ .
ğ‹‡Â¦itÂ¦ Â¦isÂ¦ Â¦sp ec ulatedÂ¦ Â¦thatÂ¦ Â¦theÂ¦ Â¦fluÂ¦ Â¦pandemicÂ¦ Â¦ofÂ¦ Â¦18 90Â¦ Â¦mayÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦causedÂ¦ Â¦byÂ¦ Â¦thisÂ¦ Â¦sp il lo verÂ¦ Â¦eventÂ¦ ,â– Â¦andÂ¦ Â¦notÂ¦ Â¦byÂ¦ Â¦theÂ¦ Â¦influenzaÂ¦ Â¦virusÂ¦ ,â– Â¦becauseÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦relatedÂ¦ Â¦ti mingÂ¦ ,â– Â¦n eu ro logicalÂ¦ Â¦symptomsÂ¦ ,â– Â¦andÂ¦ Â¦unknownÂ¦ Â¦ca us ativeÂ¦ Â¦agentÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦pandemicÂ¦ .
ğ‹‡Â¦allÂ¦ Â¦sevenÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vsÂ¦ Â¦haveÂ¦ Â¦aÂ¦ Â¦zoonoticÂ¦ Â¦originÂ¦ Â¦fromÂ¦ Â¦batsÂ¦ ,â– Â¦miceÂ¦ Â¦orÂ¦ Â¦domesticÂ¦ Â¦animalsÂ¦ .
ğ‹‡Â¦doÂ¦ Â¦youÂ¦ Â¦haveÂ¦ Â¦someÂ¦ Â¦shortnessÂ¦ Â¦ofÂ¦ Â¦breathÂ¦ Â¦goesÂ¦ Â¦withÂ¦ Â¦thatÂ¦ ?
ğ‹‡Â¦thisÂ¦ ,â– Â¦howeverÂ¦ ,â– Â¦variesÂ¦ Â¦basedÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦hum id ityÂ¦ Â¦andÂ¦ Â¦temperatureÂ¦ . ğ‹‡Â¦pe tsÂ¦ Â¦andÂ¦ Â¦otherÂ¦ Â¦animalsÂ¦ Â¦haveÂ¦ Â¦testedÂ¦ Â¦positiveÂ¦ Â¦forÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ .
ğ‹‡ Â¦qu estÂ¦ ğ‹‡Â¦diagn o sticsÂ¦ Â¦simil ar lyÂ¦ Â¦madeÂ¦ Â¦nationwideÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦testingÂ¦ Â¦availableÂ¦ Â¦asÂ¦ Â¦ofÂ¦ Â¦9Â¦ ğ‹‡Â¦marchÂ¦ Â¦2020Â¦ .
ğ‹‡Â¦asÂ¦ Â¦aÂ¦ Â¦novelÂ¦ Â¦diseaseÂ¦ ,â– ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦hasÂ¦ Â¦justÂ¦ Â¦startedÂ¦ Â¦toÂ¦ Â¦ma ni f estÂ¦ Â¦itsÂ¦ Â¦fullÂ¦ Â¦clinicalÂ¦ Â¦courseÂ¦ Â¦throughoutÂ¦ Â¦thousandsÂ¦ Â¦ofÂ¦ Â¦patientsÂ¦ .
ğ‹‡Â¦byÂ¦ ğ‹‡Â¦februaryÂ¦ Â¦14Â¦ ,â– Â¦theÂ¦ Â¦mortalityÂ¦ Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦wasÂ¦ Â¦2Â¦ %â– Â¦whenÂ¦ Â¦theÂ¦ Â¦confirmedÂ¦ Â¦casesÂ¦ Â¦reachedÂ¦ Â¦66Â¦ , Â¦5 7 6Â¦ Â¦globallyÂ¦ .
ğ‹‡Â¦mostÂ¦ Â¦imp res si velyÂ¦ ,â– Â¦theÂ¦ Â¦rateÂ¦ Â¦forÂ¦ Â¦symptomaticÂ¦ Â¦worse ningÂ¦ â–( Â¦fromÂ¦ Â¦lightÂ¦ Â¦toÂ¦ Â¦severeÂ¦ )â– Â¦wasÂ¦ Â¦remar k ablyÂ¦ Â¦lowerÂ¦ Â¦forÂ¦ Â¦theÂ¦ ğŠ£Â¦w mÂ¦ + Â¦t c mÂ¦ğŠ¼ Â¦groupÂ¦ Â¦thanÂ¦ Â¦forÂ¦ Â¦theÂ¦ ğŠ£Â¦w mÂ¦ğŠ¼ Â¦onlyÂ¦ Â¦groupÂ¦ â–( Â¦7Â¦ . Â¦4Â¦ %â– Â¦ vers usÂ¦ Â¦4 6Â¦ . Â¦2Â¦ %)â– Â¦andÂ¦ Â¦theÂ¦ Â¦mortalityÂ¦ Â¦wasÂ¦ Â¦lowerÂ¦ Â¦inÂ¦ Â¦theÂ¦ ğŠ£Â¦w mÂ¦ + Â¦t c mÂ¦ğŠ¼ Â¦groupÂ¦ Â¦thanÂ¦ ğŠ£Â¦w mÂ¦ğŠ¼ Â¦onlyÂ¦ Â¦groupÂ¦ â–( Â¦8Â¦ . Â¦8Â¦ %â– Â¦ vers usÂ¦ Â¦39Â¦ % ).
ğ‹‡Â¦drugÂ¦ Â¦candidatesÂ¦ Â¦inÂ¦ ğ‹‡Â¦phaseÂ¦ ğ‹‡Â¦iÂ¦ - ğŠ£Â¦iiÂ¦ğŠ¼ Â¦trialsÂ¦ Â¦haveÂ¦ Â¦aÂ¦ Â¦lowÂ¦ Â¦rateÂ¦ Â¦ofÂ¦ Â¦successÂ¦ â–( Â¦underÂ¦ Â¦12Â¦ %)â– Â¦toÂ¦ Â¦passÂ¦ Â¦throughÂ¦ Â¦allÂ¦ Â¦trialÂ¦ Â¦phasesÂ¦ Â¦toÂ¦ Â¦g ainÂ¦ Â¦e vent ualÂ¦ Â¦approvalÂ¦ .
ğ‹‡ Â¦cytokineÂ¦ Â¦stormÂ¦ Â¦isÂ¦ Â¦aÂ¦ Â¦formÂ¦ Â¦ofÂ¦ Â¦syste micÂ¦ Â¦inflammatoryÂ¦ Â¦responseÂ¦ Â¦fe at uredÂ¦ Â¦byÂ¦ Â¦theÂ¦ Â¦releaseÂ¦ Â¦ofÂ¦ Â¦aÂ¦ Â¦seriesÂ¦ Â¦ofÂ¦ Â¦cyto k inesÂ¦ Â¦includingÂ¦ ğŠ£Â¦t n f ğŠ¼ Î± Â¦ ,â– ğŠ£Â¦i lÂ¦ğŠ¼ - Â¦ 1 Î² Â¦ ,â– ğŠ£Â¦ ilÂ¦ - Â¦2Â¦ ,â– Â¦ ilÂ¦ - Â¦6Â¦ ,â– Â¦i f n ğŠ¼ Î± Â¦ ,â– ğŠ£Â¦i f n ğŠ¼ Î² Â¦ ,â– ğŠ£Â¦i f n ğŠ¼ Î³ Â¦ ,â– Â¦andÂ¦ ğŠ£Â¦m c pÂ¦ğŠ¼ - Â¦1Â¦ .
ğ‹‡Â¦basedÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦compar ativeÂ¦ Â¦analysisÂ¦ Â¦betweenÂ¦ Â¦isol atesÂ¦ Â¦ofÂ¦ Â¦humanÂ¦ Â¦andÂ¦ Â¦civ etÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vsÂ¦ ,â– ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦isÂ¦ Â¦thoughtÂ¦ Â¦toÂ¦ Â¦undergoÂ¦ Â¦rapidÂ¦ Â¦adaptationÂ¦ Â¦inÂ¦ Â¦differentÂ¦ Â¦hostsÂ¦ ,â– Â¦particularlyÂ¦ Â¦withÂ¦ Â¦mutationsÂ¦ Â¦atÂ¦ Â¦theÂ¦ ğŠ£Â¦rb dÂ¦ğŠ¼ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡Â¦sÂ¦ Â¦proteinÂ¦ .
ğ‹‡ Â¦particularlyÂ¦ ,â– Â¦pangolinÂ¦ Â¦betaÂ¦ - ğ‹‡Â¦coğ‹‡vsÂ¦ Â¦areÂ¦ Â¦highlyÂ¦ Â¦pathogenicÂ¦ Â¦inÂ¦ Â¦pangolinsÂ¦ .
ğ‹‡ Â¦faceÂ¦ Â¦masksÂ¦ Â¦haveÂ¦ Â¦alsoÂ¦ Â¦beenÂ¦ Â¦widelyÂ¦ Â¦usedÂ¦ Â¦inÂ¦ ğ‹‡Â¦japanÂ¦ ,â– ğ‹‡Â¦southÂ¦ ğ‹‡Â¦koreaÂ¦ ,â– ğ‹‡Â¦mala y siaÂ¦ ,â– Â¦andÂ¦ ğ‹‡Â¦singaporeÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦thisÂ¦ Â¦regardÂ¦ ,â– ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦followsÂ¦ Â¦theÂ¦ Â¦generalÂ¦ Â¦tr endÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦otherÂ¦ Â¦sixÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vsÂ¦ .
ğ‹‡Â¦inÂ¦ ğ‹‡Â¦marchÂ¦ Â¦2020Â¦ ,â– Â¦theÂ¦ Â¦mainÂ¦ Â¦proteaseÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦virusÂ¦ Â¦wasÂ¦ Â¦identifiedÂ¦ Â¦asÂ¦ Â¦aÂ¦ Â¦targetÂ¦ Â¦forÂ¦ Â¦postÂ¦ - Â¦infectionÂ¦ Â¦drugsÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦firstÂ¦ Â¦knownÂ¦ Â¦caseÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦novelÂ¦ Â¦coronavirusÂ¦ Â¦mayÂ¦ Â¦tr aceÂ¦ Â¦backÂ¦ Â¦toÂ¦ Â¦1Â¦ ğ‹‡Â¦decemberÂ¦ Â¦2019Â¦ Â¦inÂ¦ ğ‹‡Â¦wuhanÂ¦ ,â– ğ‹‡Â¦hubeiÂ¦ ,â– ğ‹‡Â¦chinaÂ¦ .
ğ‹‡Â¦allÂ¦ Â¦featuresÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦novelÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦virusÂ¦ Â¦occurÂ¦ Â¦inÂ¦ Â¦relatedÂ¦ Â¦coronavirusesÂ¦ Â¦inÂ¦ Â¦natureÂ¦ . ğ‹‡ Â¦outsideÂ¦ Â¦theÂ¦ Â¦humanÂ¦ Â¦bodyÂ¦ ,â– Â¦theÂ¦ Â¦virusÂ¦ Â¦isÂ¦ Â¦killedÂ¦ Â¦byÂ¦ Â¦householdÂ¦ Â¦soapÂ¦ ,â– Â¦whichÂ¦ Â¦diss ol vesÂ¦ Â¦itsÂ¦ Â¦protectiveÂ¦ Â¦envelopeÂ¦ . ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦isÂ¦ Â¦closelyÂ¦ Â¦relatedÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦originalÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ .
ğ‹‡Â¦andÂ¦ Â¦canÂ¦ Â¦youÂ¦ Â¦tellÂ¦ Â¦meÂ¦ Â¦whatÂ¦ Â¦otherÂ¦ Â¦symptomsÂ¦ Â¦areÂ¦ Â¦youÂ¦ Â¦havingÂ¦ Â¦alongÂ¦ Â¦withÂ¦ Â¦thisÂ¦ ?
ğŠ£Â¦sarsÂ¦ğŠ¼ Â¦hasÂ¦ Â¦higherÂ¦ Â¦mortalityÂ¦ Â¦thanÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ â–( Â¦10Â¦ . Â¦9 1Â¦ %â– Â¦ vers usÂ¦ Â¦1Â¦ . Â¦44Â¦ % ).
ğ‹‡Â¦anyÂ¦ Â¦otherÂ¦ Â¦symptomsÂ¦ Â¦orÂ¦ Â¦problemsÂ¦ Â¦thatÂ¦ Â¦youÂ¦ Â¦noticeÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦muscleÂ¦ Â¦achesÂ¦ ?
ğ‹‡Â¦theÂ¦ Â¦expertsÂ¦ Â¦under s co redÂ¦ Â¦thatÂ¦ Â¦everyÂ¦ Â¦individualÂ¦ Â¦hasÂ¦ Â¦theÂ¦ Â¦rightÂ¦ Â¦toÂ¦ Â¦healthÂ¦ ,â– Â¦includingÂ¦ Â¦peopleÂ¦ Â¦withÂ¦ Â¦dis ab ilitiesÂ¦ ,â– Â¦bel on gingÂ¦ Â¦toÂ¦ Â¦min or ityÂ¦ Â¦groupsÂ¦ ,â– Â¦olderÂ¦ Â¦peopleÂ¦ ,â– Â¦inter n allyÂ¦ Â¦dis pla cedÂ¦ Â¦peopleÂ¦ ,â– Â¦theÂ¦ Â¦home lessÂ¦ ,â– Â¦thoseÂ¦ Â¦livingÂ¦ Â¦inÂ¦ Â¦extremelyÂ¦ Â¦poorÂ¦ Â¦conditionsÂ¦ ,â– Â¦peopleÂ¦ Â¦inÂ¦ Â¦det entionÂ¦ ,â– Â¦asÂ¦ Â¦wellÂ¦ Â¦asÂ¦ Â¦ref ug eesÂ¦ Â¦andÂ¦ Â¦otherÂ¦ Â¦un spe ci fiedÂ¦ Â¦groupsÂ¦ Â¦inÂ¦ Â¦needÂ¦ Â¦ofÂ¦ Â¦governmentÂ¦ Â¦supportÂ¦ .
